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1 Zusammenfassung 
Eine der treibenden Kräfte in der Synthetischen Biologie ist das Bestreben programmierbare Zellsysteme nach 
ihren natürlichen Vorbildern zu konstruieren. Um dies zu erreichen müssen Systeme enwickelt werden, die 
sensitiv auf Umwelteinflüsse reagieren und die empfangenen Signale prozessieren. Entsprechende Sensoren 
und Reglereinheiten können gemäß natürlich vorkommenden RNA-Schaltern, so genannten Riboswitches, 
generiert werden. Die Etablierung von Systemen, die mehrere verschiedene Signale verarbeiten können, 
erfordert zunächst die Verfügbarkeit geeigneter Sensoren, z.B. RNA Aptamere. Viele der derzeit verwendeten 
synthetischen Riboswitches können nur wenige verschiedene Liganden wahrnehmen, die dementsprechend 
als Input genutzt werden können. Die Erweiterung des Repertoires and nutzbaren Liganden ist ein 
unabdingbarer Schritt hin zur Implementierung entsprechender Regelkreise. Die Eigenschaft in vitro-generierter 
Aptamere auch gleichzeitig als Regulatoren in Hefen verwendet werden zu können, wurde genutzt um die 
aktuelle Literatur auf geeignete synthetische und natürliche Aptamere zu durchsuchen. Identifizierte Kandidaten 
wuden hinsichtlich ihrer Eignung die Expression eines Reportergens in Anwesenheit ihrer spezifischen 
Liganden zu verringern getestet. Diese Regulation auf translationaler Ebene basiert auf der Blockade des 
Translationsinitiationskomplexes, während dieser die mRNA auf der Suche nach dem Translationsstartpunkt 
abtastet. Zwar konnten verschiedenste Basalexpressionen ermittelt werden, jedoch blieb die Entdeckung eines 
regulatorischen Phänotyps aus. Diese Ergebnisse bestätigen zum einen, dass in vitro hochevolvierte Aptamere 
nicht in der Lage sind ihre Struktur dahingehend zu ändern, dass sie eine Genregulation herbeiführen können 
und zum anderen, dass natürliche Aptamerdomänen eine dedizierte Expressionsplattform für ihre Aktivität 
benötigen. Im Falle des in vitro generierten Neomycin-Aptamers ermöglichte ein in vivo Screening Ansatz 
jedoch Identifikation von Aptameren, die regulatorische Aktivität aufwiesen. Gemäß dieses Beispieles wurde 
ein in vivo Screening mit Ciprofloxacin-bindenden Aptamere durchgeführt. Auf diese Weise konnte ein Aptamer 
identifiziert werden, das eine 2-fache Genregulation zeigte.  
In einem weiteren Ansatz zur Verbesserung bereits verwendeter Riboswitches und mit dem Ziel Regel für die 
Riboswitch-Konstruktion zu ermitteln, wurden Dimere des Tetrazyklin-bindenenden Riboswitches in einem 
Reportergenassay untersucht, der den bereits beschriebenen Regulationsmechanismus auf translationaler 
Ebene verwendet. Bereits die Modifikation eines der beiden Riboswitches genügte um eine groβE Bandbreite 
an Basalexpressionen und Schaltfaktoren zu erhalten. Die von mehr als 100 Konstrukten erhobenen Daten 
wurde im Anschluss genutzt um ein Computermodell zu trainieren. Nachdem Werte für die Parameter 
Basalexpression und Schaltfaktor  festgesetzt worden waren, die für eine Verbesserung der regulatorischen 
Aktivität nötig sind, klassifizierte das Computermodell entsprechende Sequenzen aus einem randomisierten 
Sequenzraum, die im Anschluss in vivo getestet wurden. Diese Ergebnisse spiegelten teilweise die erste 
Datenaufnahme wider, zeigten jedoch zugleich, dass das Computermodell die erlernten Sequenz-Aktivitäts-
Beziehungen wiedergeben konnte. Überdies konnten regulatorisch inaktive Sequenzen praktisch komplett 
eliminiert und die Häufigkeit von Schaltern mit gewünschten Phänotypen erhöht werden.  
Der beschriebene Ansatz zur Verbesserung von existierenden Riboswitches wurde auf Einzelnukleotidebene 
durchgeführt. In einer dritten Studie sollte die regulatorische Leistung eines logischen NOR Gatters bestehend 
aus Neomycin- und Tetrazyklin-bindenden Riboswitches auf Ebene des Logikgatters untersucht werden. Ein 
Deskriptor für die regulatorische Leistung des beschriebenen Gatters sollte angewendet werden um seine 
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Funktion auf Einzelzellebene zu bestimmen, da die korrekte Funktionalität von (RNA-) Gattern eine 
unabdingbare Voraussetzung für ihre Verwendung in einem genetischen Schaltkreis darstellt. In diesem 
Zusammenhang wurde die Empfänger-Operator-Charakteristik (Receiver-Operator-Characteristics, ROC) 
Analyse als geeigneter Deskriptor identifiziert, um die Variabilität zwischen Einzelzellen, die die vollständige 
Trennung von zwei Logikzuständen durch Überlappung der beteiligten Populationen erschweren,  zu 
berücksichtigen. Vervollständigt durch die transiente Messung der Induktions- und Repressionskinetiken des 
konstruierten NOR-Gatters mittels Durchflusszytometrie und Mikrofluidik-basierter Fluoreszenzspektroskopie, 
konnten die aufgenommenen Daten zur Charakterisierung der regulatorischen Leistung hinsichtlich 
Geschwindigkeit und Genauigkeit der Logikverarbeitung genutzt werden. Die meisten Studien verwenden nur 
Endpunktmessungen einer Bulkkultur, in der diese Daten nicht zu differenzieren und dementsprechend nicht 
zugänglich sind. Anhand der transienten Einzelzelldaten wurde ein hierarchisches stochastisches Modell 
konstruiert und kalibriert, das die in silico Vervollständigung der Gattercharakterisierung im 
Gleichgewichtszustand der beteiligten Komponenten über verschiedene Induktionslevel und 
Repressorkonzentrationen ermöglichte. General können solche Daten genutzt werden um experimentell 
unzugängliche Leistungsdaten zu erhalten. Darüber hinaus erlaubte das Modell die Computer-gestützte 
Untersuchung eines möglichen Neudesigns des Gatters, das nach experimenteller Umsetzung die Vorhersage 
des Modells bestätigte. Dies hebt sowohl die Eignung des experimentellen Aufbaus geeignete Daten zu 
generieren, als auch die Anwendbarkeit von computergestützen Ansätzen den korrekten in vivo Phänotyp zu 
bestimmen, hervor.     
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1 Summary 
The driving force of synthetic biology is the desire to build programmable cellular systems de novo modeled on 
their natural counterparts. To achieve this, environmental signals must be sensed and integrated to generate 
an appropriate output. Sensors and actuators can be created according to naturally occurring riboswitches. The 
implementation of systems that can process many inputs initially requires the availability of the corresponding 
sensor domains, called aptamers. Many of the currently used synthetic riboswitches rely on only a handful of 
ligands as their external input. It is therefore desirable to expand the toolbox by adding other ligand specificities. 
Harnessing the potential of in vitro selected aptamers to function as in vivo regulators in yeast, the current 
literature was screened for suitable synthetic and natural aptamers. Candidates were then assayed for their 
ability to reduce reporter gene expression at the translational level in presence of their cognate ligands, 
essentially functioning as a roadblock to the scanning ribosome in the 5’-UTR. The results revealed a wide 
range of basal expressions, but no switching phenotypes. Since the aptamers had not been adapted to the 
expression system, the results confirmed either the inability of most highly in vitro evolved aptamers to exhibit 
the structural changes necessary for riboswitching or the requirement of natural aptamers for a dedicated 
expression platform. In case of the in vitro generated neomycin aptamer, an in vivo screening yielded aptamers 
with regulatory activity. Following this example, ciprofloxacin-binding aptamers were subjected to the screening 
and one aptamer was found that exhibited 2-fold regulation. This aptamer was then subjected to further analysis. 
In an approach to improve existing riboswitches and derive rules for riboswitch design, dimers of the tetracycline 
riboswitch were set to control reporter expression by the described regulatory mechanisms. Modifying one 
riboswitch was sufficient to obtain a range of basal expressions levels and switching factors that could then be 
used to train a computational model based on data from more than 100 different constructs. After setting desired 
output parameters with respect to basal expression and switching factors the model computed corresponding 
sequences that were tested in a second iterative approach. These results partly mirrored the first data recording, 
but also showed that the model could reproduce the sequence-activity relationships learned from the first 
recording. Moreover, non-regulating sequences were almost completely erased and the abundance of switches 
with desired switching factors was increased.     
Leaving the refinement of riboswitches at the nucleotide level, a third study was conducted to elucidate the 
performance of a logic NOR gate constructed from the neomycin and tetracycline riboswitches at the device 
level. A descriptor for the performance of this RNA logic gate was sought to be applied to assess its functionality 
at the single-cell level, since the correct functionality of (RNA) devices in each single cell is a prerequisite for 
their adaption to a genetic circuit. To this end the Receiver-Operator-Characteristics (ROC) analysis was 
identified as a suitable performance measure to account for cell-to-cell variability compromising the full 
separation of two Boolean states by overlapping populations. Complemented by the transient induction and 
repression kinetics of the constructed NOR gate recorded by flow cytometry and microfluidics-based 
fluorescence microscopy, data was derived that allowed mapping the performance of the NOR gate with respect 
to speed and accuracy of the logic operation. In most studies only steady state data from bulk cultures are 
collected and these information are lost.  
A hierarchical stochastic model was built and calibrated with the transient single-cell data that enabled the in 
silico completion of the device characterization at the steady state level for various induction levels and 
repressor concentrations. In general, such data can then be used to simulate the experimentally inaccessible 
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gate performance. Additionally, the model facilitated the computational investigation of a possible re-design of 
the gate for which the model prediction proved to be correct in vivo, highlighting both the appropriateness of the 
experiment design to obtain meaningful data and the applicability of in silico approaches to predict the correct 
in vivo phenotype.  
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2 Introduction 
2.1 Synthetic biology 
Essentially a spin-off from molecular biology, synthetic biology set out to build things that do not exist yet – as 
a discipline in its making for nearly two decades. Having survived the prime years of orientation-seeking in the 
late 1990’s, this new research field has established itself as a discipline of applied science and is widely 
acknowledged today 1. Among the many definitions and envisioned goals, the forward engineering of genetic 
parts into cellular systems with defined functionality represents a prominent example 2. In the early stages the 
field had greatly benefited from the introduction and refinement of cloning strategies, automated DNA 
sequencing, high-throughput techniques (HTS) and the elucidation of microbial genomes and subsequently 
focused on the development of simple genetic devices constructed from parts like promoters and transcription 
factors. Quickly, parts and devices were connected to the first synthetic genetic circuits that could perform logic 
functions in analogy to electrical circuits 3,4. Although nowhere near to computing digital behavior, these 
approaches demonstrated the feasibility of such designs in bacterial cells. The driving organism Escherichia 
coli facilitated these advances by its ease of genetic manipulation and the well-studied and accessible regulatory 
mechanisms that provided the necessary parts to begin with. Genetic oscillators were built in proof-of-concept 
studies, tapping the potential of iterative design-built-test-debug approaches that remain until today as a 
necessity to tune the genotype towards the desired phenotype 5–7. Computational modeling was introduced as 
a means to aid in the design of small circuitries and autoregulatory negative- and positive-feedback modules 
emerged 8–10. Practically all designs were implemented with transcriptional parts, because tools for the 
regulation at the translational level had not been developed yet 6,11.  
From roughly 2003 on the overall scope had begun to increase and as a matter a new long term goal of whole-
genome engineering manifested 12,13. Realizing that it was still a far way to go, efforts were put on the 
standardization of parts and the indexing of complicated cellular systems into hierarchical abstractions 14,15. 
Novel regulatory mechanisms that were derived from RNA parts expanded the possibilities of circuit construction 
to the post-transcriptional and translational level 16,17. Cell population-wide engineering by quorum-sensing set 
new standards of what was feasible to manipulate 18–20. A breakthrough in metabolic engineering was achieved 
by the heterologous production of precursors to artemisinin – a potent antimalarial drug – in bacteria that was 
later fully implemented in yeast and eventually commercialized  21–23. These progressions were made possible 
by further improvement in the modeling and construction of higher order genetic circuits that could integrate and 
process various in- and outputs 24–26. Additionally, HTS DNA assembly methods and ever decreasing costs of 
gene-synthesis further accelerated the field 2,27. Advances in the reprogramming of fundamental cellular 
processes that operate orthogonally across several species like new RNA regulatory tools derived from the 
Clustered-Regulatory-Interspaced-Short-Palindromic-Repeats (CRISPR) immune system from bacteria and the 
expansion of the genetic code by unnatural amino acids provided further opportunities in the framework of 
cellular engineering 28–30. Another milestone in the field was accomplished by the first total synthesis and 
assembly of a mini genome in a bacterial cell 31. Capitalizing on this approach also the synthesis of the first 
synthetic eukaryote – yeast SC2.0 – was initiated and two chromosome arms have already been constructed 
32.  
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Despite the many advances and spectacular highlights, many fundamental problems remain. For once, part 
characterization is still very poor and thus they may not simply be transferred from one study to another without 
compromising their functionality 2,33. Hence, parts have to be tweaked anew and circuits correspondingly re-
designed, unnecessarily increasing time and labor 34. Secondly, and closely related to the first issue, as parts 
characterization remains confounding, the elucidation of context effects, be it neighboring sequences or 
interfering metabolic pathways, pose a significant obstacle to the overall progress 35. Several studies have tried 
to alleviate this problem by reducing genetic complexity or insulating expressed parts from the context 36–38. 
Still, as especially most developed circuits are not used by others than the creators, they experience slowed 
improvement or even premature death and vanish from the synthetic biology (synbio) toolbox. A rethinking of 
traditional practices is wishful to build on the work of others and to foster synbio approaches on their way 
forward. 
2.2 Yeast – A patriarchal and tame cell factory for synthetic biology applications 
Mankind has benefited from yeast for several millennia by its easy-to-culture and non-toxic nature 39,40. The 
predominant strain Saccharomyces cerevisiae has been used for baking and brewing ever since and it appears 
that we are now paying tribute to this microbe by constructing the first synthetic eukaryote – yeast strain SC2.0 
32,41. S. cerevisiae features many desirable properties that paved its way for world-wide industrial and scientific 
use and ultimately the re-engineering of its genetic chassis for synbio applications 42. The proficiency in DNA 
recombination and the occurrence of tried and tested selection markers enable the straight-forward introduction, 
expression and analysis of heterologous genes and the effective and targeted manipulation of the yeast genome 
itself 43–46. Its ability to grow to high cell density, all the while tolerant to a wide range of carbon sources, and 
availability of extensive Omics data (genome, proteome, metabolome) facilitate the exploitation of S. cerevisiae 
as host and model organism not only for food and biotech industry, but also for academic purposes in the field 
of synthetic biology. Especially here, applied basic research is conducted to unravel and expand the possibilities 
this organism offers for developing new synthetic regulatory pathways and circuits as reviewed by Ellis et al. 47. 
Being a lower eukaryote, S. cerevisiae has typically served as a link between Synbio research in bacteria, 
foremost E. coli, and higher eukaryotes represented by several human cell lines like HEK-293 and HeLa cells 
since the Synbio field emerged nearly 20 years ago 48. Interestingly, nowadays least studies report the 
introduction of engineered genetic devices in yeast compared to massive approaches using more simply 
structured E. coli or the rather complicated biology of human cells that is supposedly more frequently tackled, 
because of the high demand on promising Synbio applications for human gene therapy 49. Nevertheless, the 
paramount value of S. cerevisiae to the production of fine chemicals, pharmaceuticals and fuel is reflected by a 
long history of industrial application 42,50,51 as is its capability for rapid prototyping of expression systems 43,52. 
Exemplified by the semi-synthetic production of artemisinic acid, a precursor of the potent antimalarial drug 
artemisinin 21 and the assembly of entire bacterial genomes 31, the possibilities to host orthogonal components 
at a large scale were impressively demonstrated and highlight the potential of S. cerevisiae to stably maintain 
such critical genetic modifications 35,47. 
Advancing Synbio research has generated several gene expression tools especially for yeast metabolic 
engineering. Among these genetically encoded parts are foremost promoters, terminators, transcription factors 
and reporters that are coupled to exert control over implemented metabolic pathways 42,47,53. Figure 2.1 presents 
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an overview about recently applied tools for improving chemical and fuel production 42. Promoters and 
terminators operate as functional units flanking the gene of interest (GOI) and determine its expression level 
and mRNA stability 54–56. Promoters can be fine-tuned on the single-nucleotide (nt) level to regulate their activity 
and promoter-terminator couples may be tailored to match desired expression levels and mRNA half-lives 54,56. 
This is especially important for controlling the expression of key intermediates and thus neutralizing flux 
imbalances that would otherwise compromise pathway performance and product titers 42. The power and impact 
of promoters on integer metabolic pathways is ideally complemented by the introduction of regulatory elements 
facilitating the binding of transcription factors (TF) that in turn modulate promoter activity. Essentially composed 
of an interchangeable DNA-binding and transcription activation domain, their modular nature allows the re-
engineering of TFs to orthogonally regulate synthetic transcriptional expression systems in yeast. Their 
functionality and aptitude has been even further expanded by the addition of sensor domains or fusions to 
heterologous enzymes 57–59. Sensor domains may either be used to create feedback loops in response to 
metabolite flux 60 or to sense external stimuli targeting only the modified TF and thus exhibit single-gene 
specificity 57,58,61. To achieve orthogonal single-gene specificity these and other studies underline the focus on 
highly programmable zinc-finger TFs and correspondingly modified promoter sequences. In this context 
McIsaac et al. have designed zinc-finger TFs that may be multiplexed to target several genes with identical 
promoters or to address multiple promoters specifically with a set of corresponding TFs. Here, the TFs are 
activated by 17ß-estradiol that binds to its cognate receptor domain, the human estrogen receptor, fused to the 
TF 57,58. As indicated in Figure 2.1a, not only subdomains of TFs are engineered, but rather fusions with (dys) 
functional enzymes from heterologous origins are conducted to further enlarge the versatility of TFs. The 
illustrated hallmark example describes the transcriptional regulation by the CRISPR/Cas system 62. The fusion 
of the deactivated Cas9 endonuclease (dCas9) to a TF or a transcription activating or repressing domain 
provides promoter silencing or activation by simple occupancy or use of the functional domains, respectively 
59,63,64. The promoters are conveniently targeted by the guide RNA (gRNA) inherent to the CRISPR system, 
allowing the specific regulation of virtually any promoter without or with only minor sequence adaptions to meet 
the criteria for gRNA recognition. 
Promoters and TFs are means to tune gene expression before transcription has been initiated. Co- or 
posttranscriptional regulation has been achieved by the application of RNA-based tools, so called riboswitches, 
and RNA interference mechanisms. As riboswitches are subject to a separate section and have not yet been 
used in metabolic engineering, the will only be described briefly. Riboswitches are comprised of a sensing and 
actuating domain facilitating control over transcription or translation in response to rearrangements of their 
global architecture triggered by external stimuli 65. Figure 2.1b shows an approach by Galloway et al. utilizing 
riboswitches responsive to theophylline and tetracycline to enhance or reduce STE4 expression level, ultimately 
determining cell fate 66. Although riboswitches present the possibility to gain control over gene expression in a 
tight spatiotemporal manner, they have not been used for biotech applications due to limitations of suitable 
ligand specificities coupled to robust functionality 42. As the field is growing rapidly and due to their magnificent 
engineering capacity, riboswitches are anticipated to largely contribute to the optimization of metabolic 
pathways 67,68. RNA interference, another posttranscriptional regulatory mechanism, was heterologously 
expressed in S. cerevisiae after transfer of the required machinery from S. castelli 69 (Figure 2.1c). A proof-of-
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concept study revealed the aptitude of this portable system to downregulate ADE3 by siRNA interference to 
increase levels of itaconic acid 69,70.   
 
Figure 2.1 Synthetic biology tools applied to metabolic engineering in S. cerevisiae. (a) Transcription is controlled by engineered 
promoter and terminator sequences. Synthetic TFs with zinc-finger DNA binding domains are predominantly used to confer single-gene 
specificity. The CRISPR/Cas system is modified to gain targeted attenuation of transcription initiation by adaption of gRNA and Cas9 
endonuclease. (b) RNA regulators, exemplified with riboswitches sensitive to tetracycline and theophylline, are increasingly used to confer 
co- and posttranscriptional gene regulation, although they have not yet been applied to metabolic engineering. Here the stability of the 
mRNA was influenced by the ligand-dependent removal of the poly-A tail, determining cell fate. (c) Molecular components of RNA 
interference (Dicer and Argonaute) can be transferred to S. cerevisiae to orthogonally introduce mRNA silencing and thus facilitate gene 
knockdown. (d,e) Genome-editing tools allow the targeted and multiplex integration of different DNA inserts into the desired locus using 
Yeast Oligo-mediated Genome Engineering (YOGE), CRISPRi and Transcription Activator-like Endonucleases. Adopted from 42. 
The modification of the genome is another important branch of genetic tools available in different facets (Figure 
2.1d, e). Multiplexed yeast oligo-mediated genome engineering (YOGE) is a fast method to simultaneously 
conduct editing of multiple genomic loci with varying donor templates. The technique yields 0.2-2% insertion 
efficiency without applied selection pressure and can thus be used to confer moderate screening approaches 
of library sizes between 102 and 105 recombinants per locus per cycle 71. The methods relies entirely on the 
high proficiency of S. cerevisiae to perform homologous DNA repair. This feature is also exploited by the 
CRISPR interference (CRISPRi) -based technique for genome manipulations. The targeted double-strand break 
facilitates high efficiency recombinations with any insert DNA homologous to the integration site. Moreover, the 
design of the gRNA allows integration in many user-specific loci 45,72,73.  
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Besides the genetic tools presented in Figure 2.1 also metabolic tools are accessible to efficiently facilitate 
metabolic flux through a constructed pathway. The spatio-temporal organization of multienzymatic cascades by 
compartmentalization and scaffolds has frequently been used to increase titer and rate constants, as they 
physically connect the participating components 74,75. 
Thus, further Synbio research on S. cerevisiae can readily capitalize on its inherent cellular, metabolic and 
genetic properties and concentrate on the design, characterization and in vivo assembly of genetic parts needed 
to de novo construct and spatiotemporally regulate higher order expression networks.   
2.3 RNA-engineered gene regulation 
RNA-engineered systems offer simple and versatile control over gene expression in many organisms 76–78. 
Realizing their potential as highly programmable synthetic parts, they are beginning to seriously compete with 
the established engineered transcription factor-promoter couples that have dominated as regulators of gene 
expression so far 48,79,80. RNA parts promote the rapid design and implementation of gene regulators due to 
their simple make up of only four different nucleotides, their superior structural flexibility at low sequence loads 
and the emergence of increasingly sophisticated computational methods to facilitate in silico modeling and 
structure prediction 76,81–84. Additionally, RNA parts can be configured to respond to a plethora of external inputs, 
rendering RNA-derived regulation suitable to quantitatively tune the expression profile of the hosting system 
77,85,86. The indispensability of RNA as a component of larger, protein dominated systems, such as CRISPR/Cas, 
has further expanded its versatility and applicability to tailor conditional gene expression systems 59,62,76. 
Driven by these compelling benefits, several different synthetic RNA regulatory mechanism inspired by the 
natural RNA templates have been prototyped to date 76,77,86.     
2.3.1 Synthetic RNA regulatory mechanisms 
Synthetic RNA-based regulation has particularly resurfaced during the last several years 76,77,80. The old 
pacemakers of the field, small trans-activating riboregulators and classical riboswitches, have been refurbished 
and complemented by new teammates. As a result, the current toolbox is geared towards controlling gene 
expression at the levels of transcription and translation in bacteria as well as transcription, translation and 
splicing in yeast and mammals (reviewed in 76,77,87). The following chapter deals with regulatory mechanisms 
other than those exerted by riboswitches. Their contribution to the toolbox is described in 2.3.3 Synthetic 
riboswitches.  
Figure 2.2 illustrates two major classes of promising state-of-the-art design principles applied in E .coli, S. 
cerevisiae and mammalian cells. The class of synthetic riboregulators emerged in 2004 as a direct mimic of 
small bacterial RNAs (sRNA) (Figure 2.2a, b) 88. Natural sRNAs were the first trans-acting RNAs discovered 
that specifically regulate gene expression by an anti-sense mechanism 89. They facilitate binding to their target 
sequence with a 6-8 nucleotide (nt) seed region, base-pairing in the direct vicinity of the ribosome binding site 
(RBS) further upstream to a ribosome stand-by site or a translational enhancer sequenced of the respective 
mRNA and thus control translation. Their mode of action is not only limited to inhibit translation, as they were 
additionally shown to activate translation by disruption of inhibitory secondary structures in the 5’-UTR 90,91. The 
latter process was harnessed in several approaches to regulate gene expression in bacteria, since the used 
RNA molecule allowed for high sequence variability during the design process according to computable RNA-
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RNA interactions 16,25,92,93.  Further, RNA-RNA interactions are tunable over a wide range of the desired effect 
and the response times are very short. The prototypes constructed by Isaacs et al. were composed of a cis-
repressive RNA (crRNA) and a trans-activating RNA (taRNA) counterpart. The crRNA prevented docking of the 
ribosome to the RBS by sequestering the SD sequence in a hairpin structure. Stem- loop formation was 
promoted by a 25 nt cis-repressive sequence. The taRNA contained a 26 nt region of large complementarity to 
the crRNA and was capable to unzip the hairpin, resulting in translation initiation by the ribosome. This system 
showed minimized leakiness of reporter gene expression in the absence of the taRNA and elevated reporter 
levels up to 100-fold of the repressed state 16. This system was extensively employed and modified in 
successive investigations to yield a genetic switchboard in which several orthogonal taRNA-crRNA pairs were 
used to independently regulate the expression of three different genes. These works used promoters that 
responded to environmental signals as sensing units 25.  
As mentioned before, a wide sequence space for the design of taRNAs and their respective counterparts can 
be utilized. To access the possibilities such sequence variability offers, Rodrigo et al. showed that de novo 
computation of small RNA circuits is quite feasible, if certain rationales are imposed on the algorithm calculating 
possible candidate structures. Kinetic considerations as well as the free energies of the folded and unfolded 
states of the single RNAs and the proposed complex showed that RNA interactions are predominantly 
influenced by the energy of complex formation and activation of the educts 93. The latest and most extensive 
approach by Green et al. is displayed in Figure 2.2a. They picked up the “toehold” principle introduced by Zhang 
et al. and re-designed the riboregulator prototypes from Isaac et al. 94. The combination of both principles turned 
out to be very powerful by means of dynamic ranges and high orthogonality between the different RNA parts. 
The taRNA, or trigger RNA, grasps a nucleotide stretch (toehold) of the mRNA upstream of the crRNA structure 
occluding the RBS and is thus able to efficiently unfold the crRNA and promote translation. A set of 168 toehold 
switches was designed using NUPACK, a suite of computational tools that enable the user to design RNA 
sequences that will fold to specified structures 95. Extended use of NUPACK was then used to identify a set of 
26 highly orthogonal switches that were further narrowed to 13 variants with dynamic ranges up to 400-fold. 
The high degree of orthogonality allowed the simultaneously regulation of 12 genes in the same cell. All 
discussed approaches targeted translation and were designed as ON switches. Recently, Chappell et al. 
engaged in the design of small transcription-activating RNAs (STARs) (Figure 2.2b) 96. They rely on RNA 
hairpins that, if formed, terminate transcription. In analogy to the crRNA-taRNA pairs, trans-acting STAR 
antisense RNAs are used to reverse the hairpin formation by complementary hybridization. STARs were also 
shown to exhibit high orthogonality and high dynamic ranges up to 94-fold. The fusion to each other and to 
transcriptional repressors extended their inherent activating functionality by an OFF switch characteristic 
allowing to build RNA-only logic devices and genetic circuits. Additionally, STAR design rules were inferred, 
facilitating their de novo construction and paving the way for the application of recently developed libraries of 
transcriptional terminators. 
Summarizing the class of riboregulators, it should be noted that they are insensitive to external stimuli. This 
requirement must in turn be met by the promoter driving mRNA expression. As demonstrated some years ago 
with a riboregulator-aptamer pair, it may only be a matter of time until sensor domains are incorporated into the 
new and refined toehold regulators to enable a fully independent functionality of these riboregulators from other 
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genetic parts like promoters. However, as they are currently only applicable to bacteria, their portability to 
eukaryotes has yet to be investigated. 
 
Figure 2.2 New and refined synthetic RNA regulatory mechanisms of gene expression. (a) Riboregulators termed toehold switches 
control translation in bacteria. The crRNA occludes the RBS and inhibits ribosome binding. The trigger RNA invades the hairpin structure 
and liberates the RBS, switching gene expression from OFF to ON. (b) Riboregulators termed STARs exploit the natural transcription 
termination mechanism in bacteria. The STAR antisense RNA unfolds the terminator hairpin and transcription continues, resulting in an ON 
state of gene expression. (c) CRISPR-based control over gene expression is constituted by CRISPRi (blockade of transcription by 
gRNA/Cas9), TFs fused to Cas9 (activation or inhibition of transcription) and tandem constructs of an aptamer and a gRNA (triggered 
transcription activation or inhibition by external inputs). Riboregulators and CRISPR tools exhibit high dynamic ranges and orthogonality. 
Graph adopted from 76. 
Turning to the second major class of novel RNA regulatory mechanisms, the versatility of RNA itself is 
impressively demonstrated by its marriage with functional protein components (Figure 2.2c). Here, the bacterial 
immune system CRISPR, originally discovered in Streptococcus pyogenes, serves as a highly adaptive starting 
platform 62. Essentially, it consists of an RNA component, the small gRNA, and a protein component, the 
endonuclease Cas9. Evolved to defend the bacterial cell against foreign phage DNA, the gRNA specifically 
targets complementary DNA sequences next to the defined proto-spacer adjacent motif (PAM), directing 
endonucleolytic degradation by Cas9. Taking full advantage of this system, CRISPR interference was 
developed as a mechanism for the knockdown of target genes in bacteria 28,29,97. The catalytic activity of Cas9 
can either be deleted or replaced and thus gave rise to a multitude of heterologous protein fusions. These can 
subsequently be combined with re-programmed gRNAs to two-component mini-systems. Figure 2.2c highlights 
the use of CRISPRi to block transcription by a dead Cas9 28,29, the fusion of a transcription activating domain to 
Cas9 promoting transcription in eukaryotes 63,64 and the elegant combination of an aptamer with the gRNA 
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facilitating the sensitivity to external inputs 59. In other studies the system was further expanded for optogenetic 
control mechanisms 98,99 and in an situ imaging platform 100. The regulatory efficiency achieved by CRISPR-
based tools far exceeded those obtained with common RNA regulation alone. Only the toehold switches 
previously described exhibited comparable activity of up to several hundred-fold changes between ON and OFF 
states. 
Both, riboregulators and CRISPR-engineered tools, offer high degrees of modular flexibility and applicability to 
different genetic contexts. Their regulatory power has set new standards for RNA-based gene expression 
control. Advances in computational engineering have allowed their de novo design and implementation mainly 
in bacteria, but also in yeast and mammalian cells. A current drawback of especially riboregulators is their limited 
ability to respond to external stimuli. While this feature might be the next to be added in near future, it has always 
been inherent to another class of RNA regulators – riboswitches. Riboswitches uniquely unite the ability to sense 
environmental signals and react in cis by a corresponding modulation of gene expression. 
2.3.2 Natural riboswitches: Occurrence, structure and function 
The importance of natural RNA regulation and the feasibility of RNA mimicry has been mostly neglected until 
the late discovery of such regulatory elements in prokaryotes in 2002 65,101. The term riboswitch unites all RNA-
based regulatory elements that are sensitive to an external input, typically a cellular metabolite, and transmit 
this input signal by a rearrangement of their global architecture into an altered expression of the controlled gene. 
Since the sequences of sensor and actuator are subdomains of a mutual architecture, riboswitches constitute 
an ideal scaffold to design synthetic derivatives with different ligand specificities and actuation profiles that 
operate in cis. 
Riboswitches have been discovered in all kingdoms of life. Initially, researchers tried to elucidate the regulatory 
mechanism of vitamin B1-, B2-, and B12-biosynthesis. After having searched in vain for protein-based feedback 
control, it was speculated on the involvement of conserved mRNA sequences to act as regulators. Eventually, 
the direct interactions of three vitamin derivatives with their respective mRNAs were shown and confirmed the 
regulatory role of RNA in metabolite biosynthesis 101,102.  
In bacteria, the vast majority of riboswitches were found to exclusively control either transcription termination or 
translation initiation. Their regulatory function is for instance embedded in the control of metabolic pathways of 
cellular substrates as vitamins, amino acids and nucleotide analogs (Figure 2.3) 65,103. Here, they contribute to 
a stable steady state of educts and products consumed and synthesized during the biogenesis of a particular 
metabolite, thus controlling its flux and abundance. Despite the limited set of four nt as building blocks, the 
sensor domain, also called aptamer, has evolved to sense many different ligands (Figure 2.3A). While this highly 
specific ligand-binding site has remained conserved throughout evolution, the actuating domain, also termed 
expression platform, exhibits greater sequence variability to control the downstream coding sequence. The 
received external signal is transduced by a conformational change of the aptamer, in turn leading to 
conformational rearrangements of the expression platform. In this way the ligand triggers the “riboswitching” 
between two mutually exclusive conformations of the expression platform oppositely affecting gene expression. 
Transcription controlling riboswitches typically flip between Rho-independent terminator and anti-terminator 
hairpins, causing the RNA Polymerase II (RNA Pol II) to stall and fall of or continue mRNA elongation, 
respectively. Recently, also Rho-dependent transcriptional termination has been observed and appears to be a 
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widespread mechanism as some riboswitches lack Rho-independent terminators or RBS-sequestering hairpins 
104. RBS occlusion prevents the 70S ribosome from accessing the translation initiation site. In a similar manner 
to terminator-anti-terminator switching, ligand binding releases or obscures the RBS and translation is turned 
ON or OFF. 
A third mechanism found in bacteria relies on ligand induced cleavage within the 5’-UTR of the mRNA 105. These 
riboswitches are composed of an aptamer and a ribozyme (also termed aptazyme) and facilitate the 
endonucleolytic degradation by RNase J from the resulting 5’-OH end turning gene expression OFF at the 
translational level 106.  
Figure 2.3 Regulatory mechanisms of 
riboswitches in bacteria.   
Prokaryotes feature various riboswitching 
mechanisms to regulate gene expression 
involving transcription, translation, splicing 
and mRNA stability. 
A Different metabolites (pink) evoke inhibition 
(red insets) or activation (green insets) of 
transcription (left, middle) or translation (right) 
by structural rearrangements of sensor and 
expression platform (grey inset). The 
alternatively folded terminator-anti-terminator 
sequences are highlighted in light blue. 
Shine-Dalgarno (SD) constitutes the RBS 
and is colored dark blue. RNA Pol II (Pol), 
open reading frame (ORF), transcription 
termination complex Rho and the 70S 
ribosome (light purple) are indicated. 2’-dG, 
2’-deoxyguanosine; preQ1, pre- queuosine-
1; Moco/Tuco, molybdenum and tungsten 
cofactors; SAH, S-adenosyl-L-homo- 
cysteine. 
B Glucosamine-6-phosphate (GlnN6P) 
induces the endonucleolytic degradation of 
the target mRNA by RNase J after cleavage 
of the mRNA by the riboswitch. 
C the cyclic di-guanosyl-5’-monophosphate 
(c-di-GMP) riboswitch controls alternative 
self-splicing of the target mRNA and confers 
the fusion of distant RBS parts to a functional 
unit, promoting translation. 
D S-adenosyl-methionine (SAM) serves as 
ligand for transcription termination in cis and 
translation repression in trans.  
Adopted from 103. 
 
 
 
Introduction 
14 
 
The only member currently known, the glmS riboswitch, senses glucosamine-6-phosphate and related 
compounds and thus confers regulation over a wide array of metabolic states (Figure 2.3B) 107. Another rather 
unconventional mechanism is exerted by the cyclic di-guanosyl-5’-monophosphate (c-di-GMP) riboswitch, that 
is essentially involved in self-splicing of group I introns to join to distantly located parts of the RBS, thus acting 
on translation (Figure 2.3C) 108. Typically acting in cis, the described mechanisms were complemented by the 
discovery of a trans-regulating riboswitch sensitive to S-adenosylmethionine (SAM). The SAM riboswitch 
confers cis-regulation over transcription termination of its downstream gene and subsequently functions as a 
small RNA to trans-repress translation of a distant gene (Figure 2.3D) 109.  
In eukaryotes the validated and predominant example for a riboswitching RNA regulatory mechanism controls 
splicing (Figure 2.4). More precisely, the thiamine pyro-phosphate (TPP) riboswitch controls alternative splicing, 
i.e. the rejoining of exons in different combinations after exclusion of the intron. TPP presence above a certain 
threshold triggers the liberation of a previously sequestered splice-site that can now be used to generate a 
different gene product. Depending on the species, the activation of the TPP riboswitch causes the synthesis of 
aberrant peptides (fungi, Figure 2.4A) 110, premature translation termination (algae, Figure 2.4B) 111 or 
destabilized transcripts (plants, Figure 2.4C) 112. 
Figure 2.4 The TPP riboswitch in eukaryotes. 
This riboswitch is heavily involved in (alternative) splicing. TPP 
(pink) presence above a certain threshold triggers the liberation of a 
previously sequestered splice-site that can then be used to generate 
a different gene product. Depending on the species, the activation 
of the TPP riboswitch causes the synthesis of aberrant peptides in 
fungi by inclusion of the micro open reading frame (µORF) and a 
premature stop codon (A), premature translation termination in 
algae by inclusion of a stop codon (B) or destabilized transcripts in 
plants by removal of the poly adenylation signal (yellow rhomb) (C). 
Green circles and arrows illustrate the alternative splice sites. White 
circles represent the splice sites used in absence of TPP. Orange 
rhombs in B and missing in A show the translational stop codon. The 
70S ribosome is colored in light purple. Adopted from 103.  
 
 
 
 
 
 
 
Riboswitches realize their exceptional ability to sense a specific ligand by a highly adapted set of different 
architectures. Practically all major riboswitch classes have been thoroughly investigated and many metabolite-
sensing domains are thus available at atomic resolution. As proposed elsewhere, riboswitches may be classified 
according to their structural principles to accommodate the ligand and confer signal transduction 103,113. Thus, 
the first class is composed of riboswitches constructed from multihelical junctions (Figure 2.5A, B) and the 
second class is engaged in pseudoknot formations (Figure 2.5C). Pseudoknots, or knot-shaped conformations, 
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are usually formed by a stack of two helices connected by short loops that may involve extra elements like 
hairpins. Pseudoknot-governed riboswitches as the SAM-II and fluoride switches appear rather compact in 
structure and pocket the ligand at the interface of the knot-like junction 114,115. 
In contrast, multihelical junctions can be constituted by Y-shaped, long-distance interactions through kissing 
loops that enclose the ligand sensing domain and stabilize the P1 stem that is part of the expression platform 
of the TPP or purine riboswitches (Figure 2.5A) 116,117. Alternatively, long-range, back-folded interactions 
between a loop of a hairpin and a distant helix determine the overall conformation of riboswitches as that of the 
THF riboswitch binding to two molecules THF simultaneously, eventually affecting the folding of the P1 stem 
(Figure 2.5B) 118.   
Figure 2.5 Common riboswitch architectures 
and ligand recognition. 
Folding regimes are classified according to 
participation of multihelical junctions or 
pseudoknots. 
A, B Multihelical junctions can either be Y-shaped 
and contain kissing loop interactions (A) or formed 
by long-range, back-folded interactions (B). The 
ligand is enclosed the junction or incorporated into 
tertiary interactions of long hairpins.  
C pseudoknots, or knot-shaped conformations, are 
usually formed by a stack of two helices connected 
by short loops that may involve extra elements like 
hairpins. Pseudoknot-governed riboswitches as the 
SAM-II and fluoride switches appear rather compact 
in structure and pocket the ligand at the interface of 
the knot-like junction. Ligand binding sites are 
highlighted in pink, long-distance interactions in 
blue. 
D RNA-ligand interactions at molecular resolution. 
Specific hydrogen-bonding, electrostatic and π- π 
stacking interactions as well as cation- or water-
mediated ligand coordination facilitate specific 
recognition of the cognate ligand in concert with 
global shape complementarity. 
Graph adopted from 103. 
 
The modular constitution of binding, transmitting and actuating motifs leads to the recurrence of several motifs 
among different riboswitches and allowed even the inverse phenomenon of different motif configurations that 
recognize the same ligand (SAM-riboswitches) 103,115,119. This underlines the extraordinary ability of RNA to 
encompass virtually any conceivable combination of RNA structure-ligand pairs that is only further broadened 
by the chemistry of these interactions. Metabolites are not identified by a common recognition feature, but rather 
by adapted recognition patterns (Figure 2.5D). A dominant mechanism to ensure ligand compatibility is shape 
complementarity that facilitates the tight encapsulation and correct positioning of the cognate ligand and often 
very closely related compounds and blocks non-cognate ligands by steric hindrance. These ligand pockets are 
equipped with conserved nucleotides forming specific hydrogen bonds or electrostatic interactions to 
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heteroatoms on the edges of the ligand. Planar ligands or ligand moieties are sandwiched between purines in 
π- π stacking interactions. A common feature is the occurrence of mono-or divalent metal ions such as K+ or 
Mg2+ compensating negatively charged functional groups (phosphate, carboxylate or fluoride) or mediating 
direct and water-dependent coordination of RNA-ligand interactions. 
The global mechanism of ligand-RNA interaction is governed by a combination of conformational capture and 
induced fit. The aptamer and expression platform fluctuate between different ligand-free ground states and a 
ligand-bound conformation. The ligand captures only the ligand-bound conformation and induces minor or major 
conformational changes dependent on the riboswitch. Whereas translational riboswitches are typically in 
thermodynamic equilibrium, i.e. ligand binding shifts the equilibrium towards the bound conformation, 
transcriptional riboswitches are never allowed to reach equilibrium as ligand binding triggers a once-in-a-lifetime 
decision on whether the terminator or anti-terminator is formed. The ligand kinetically traps a metastable 
conformation of the aptamer, seizing decision-making on the overall folding instead of the minimum free energy 
(MFE) 65. Both mechanism are exploited in approaches to re-engineer riboswitches according to synthetic 
designs. 
2.3.3 Synthetic riboswitches 
The design and implementation of riboswitches presents a unique opportunity to manipulate any reporter device 
in cis, executing tight temporal and spatial control at low metabolic costs. Their nucleotide composition can be 
configured with ease, facilitating access to a multitude of different convertible RNA architectures triggered by 
virtually any ligand of choice. This short abstract highlights again the important differences between synthetic 
riboswitches and the previously discussed synthetic riboregulators and emphasizes their rich and highly 
functional heritage from their natural precursors. Their property to respond to external stimuli in cis and their 
modular composure constitute the key features that make their engineering amenable to self-contained plug-
and-play approaches. Practically all such studies may be summarized as proof-of-principle experiments, in 
which the feasibility and applicability of the constructed synthetic parts and devices was demonstrated in at first 
trial-and-error style and later enhanced by rational design principles. On the road to true plug-and-play designs 
still many hurdles must be overcome 78,86,87.  
Synthetic riboswitching mechanism implemented in bacteria essentially mimic those of their natural counterparts 
(Figure 2.6). Many studies have capitalized on the seemingly straightforward modification of the mRNA 
transcript. 
Translation repression was foremost achieved by the insertion of the theophylline aptamer flanked by some 
randomized nucleotides to generate an expression platform that allows the alternative hybridization with the 
RBS (Figure 2.6A) 120,121. Addition of theophylline captures the ligand bound conformation, engaging the 
synthetic expression platform in the formation of the aptamer and a hairpin sequestering the RBS. Screening 
for regulatory active riboswitches yielded switches with dynamic ranges of up to 11-fold. These riboswitch were 
placed upstream of the cheZ gene to control migration and chemotaxis E. coli 122. In other follow-up studies the 
broad and robust applicability and portability of these riboswitches to diverse bacterial species was 
demonstrated with regulatory activities of up to 200-fold 123,124. Theophylline-sensitive aptamers were also 
designed to exhibit complementarity to slightly different regulatory mechanisms, such a helix slipping and 
relocations of the SD sequence 125,126.  
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Figure 2.6 Synthetic riboswitching mechanisms in 
prokaryotes.  
A Translation is controlled by the insertion of aptamers with 
synthetic expression platform in the 5’-UTR of a reporter 
gene. In the absence of the ligand the 70S can bind to the 
RBS and start translation. Ligand presence promotes the 
rearrangement of the expression platform by a stabilization 
of the aptamer, the RBS is sequestered and translation 
inhibited. 
B Transcription termination is regulated by two competing 
hairpins, the terminator and anti-terminator. Ligand binding 
triggers the formation of the anti-terminator and 
transcription continues. 
C The introduction of aptazymes (aptamer + ribozyme) 
facilitates ligand dependent control over RBS accessibility. 
Here, ligand addition stabilizes the conformation of the 
aptazyme and thus activates its self-cleavage and the RBS 
is released. Adopted from 78. 
 
 
Riboswitch designs harnessing transcription termination have been provided during the past years (mechanism 
exemplified in (Figure 2.6B). Again, the theophylline aptamer served as a prototype in a de novo design of 
transcriptional ON switches 127. Followed by a hairpin complementary to the aptamer and a poly-U stretch, these 
riboswitches resembled their natural counterparts and could elevate reporter expression by 6-fold upon 
theophylline addition. A true precursor mimicry was designed by the coupling of the in vitro selected theophylline 
and tetracycline aptamers and the natural purine, SAM, FMN and lysine aptamers to three natural expression 
platforms 128,129. Interestingly, the design avoided the insertion of a transmitting module to connect aptamer and 
expression platform allowing the re-engineering of natural riboswitches without extensive screening steps. 
Further re-designs of natural purine riboswitches facilitated ligand specificities orthogonal to the cell and yielded 
translational and transcriptional switches 130.   
Figure 2.6C depicts a rare natural regulatory mechanism that has nonetheless been proven to be very effective 
in synthetic designs. In contrast to synthetic translational OFF switches, the use of aptazymes allows the 
construction of translational ON switches. As mentioned earlier, aptazymes are composed of an aptamer 
domain fused via a communication module to a ribozyme. In bacteria, mainly the theophylline- and TPP-
responsive hammerhead ribozymes (HHR) have been used to control downstream reporter expression 131, 
tRNA abundance 132,133 and 16S rRNA availability 134. Another approach combined the taRNAs known from the 
class of riboregulators with the HHR to yield small RNA triggered mRNA cleavage and a activation of gene 
expression 135.   
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In eukaryotes the focus shifts towards the development of regulatory mechanisms for translation, splicing and 
RNA interference. One of the first mechanisms mimicked translational control in bacteria even before the actual 
riboswitching mechanisms had been discovered. In vitro generated aptamers were set in the 5’-UTR upstream 
of different reporter genes in baker’s yeast and Chinese hamster ovary cells and used to control a downstream 
gene (Figure 2.7A). The aptamer interferes with the scanning of the small 43S pre-initiation complex for the 
start codon. In the absence of the ligand the aptamer is largely unstructured. Presence of the ligand stabilizes 
the aptamer folding and suppresses 43S scanning. The mechanism is discussed in more detail in 4.1.2. The 
ligands, a Hoechst dye 136 and tetramethylrosamine 137, were shown to downregulate gene expression up to 10-
fold. Later, aptamers binding to tetracycline and neomycin were demonstrated to confer similar regulation 138,139. 
As both aptamers are subject to this study and have been extensively characterized in follow-up experiments, 
they are described in chapter 2.3.3.2. A different design was brought to eukaryotes by the concept of trans-
activating RNAs and generated programmable ON and OFF “antiswitches” by use of the theophylline aptamer 
in yeast 17. The ligand triggers the formation of a trans-acting antiswitch flanked by an antisense strand 
complementary to a sequence in the 5’-UTR of a GFP reporter gene. Binding of the antisense strand inhibits 
gene expression.  
Figure 2.7B illustrates the introduction of synthetic control over splicing. In analogy to the TPP riboswitch, the 
theophylline- and tetracycline-binding aptamers have been used to control constitutive and alternative splicing 
by insertion of the aptamers close to either the 5’- or 3’-splice site or the internal branch point in yeast and 
mammalian cells 140–142. 
The regulation of mRNA stability constitutes an efficient possibility to interfere with gene expression. In 
eukaryotes mRNA stability is strongly influenced by the integrity of the poly-A tail. Insertion of aptazymes into 
the 3’-UTR of reporter genes facilitates direct control over mRNA fate by immediate cleavage of the target 
mRNA in absence or presence of the cognate ligand (Figure 2.7C). The communication module between 
aptamer and ribozyme allows the selection of ON and OFF switches, i.e. inhibition or activation of mRNA 
cleavage, respectively. The HHR presents the most frequently used ribozyme and later other ribozymes as the 
HDV 143 or twister ribozymes 144 were tested as well. Ligand sensitivities range from theophylline145,146  and TPP 
144 to tetracycline 24,147,148, neomycin 149 and guanine 143. Since the discovery of RNA interference had 
demonstrated the importance of posttranscriptional regulation in eukaryotes, the underlying mechanism was 
fully elucidated 150. RNA interference (RNAi) is a conserved biological mechanism present in eukaryotes that 
uses small non-coding RNAs to post-transcriptionally modulate gene expression. The two classes of small 
RNAs, short interfering (si) RNAs and micro (mi) RNAs, play a key role in this process. Whereas miRNAs are 
encoded in the genome, transcribed as primary miRNAs by RNA Pol II and processed by the RNases III Drosha 
and Dicer, the siRNA precursors are of exogenous origin and cleaved by Dicer to produce active siRNAs. After 
processing, both 21 to 25 nt RNAs are transferred to the RNA induced silencing complex (RISC) to function as 
a guide targeting mRNAs for either translational repression or mRNA degradation. RNAi is an often used 
mechanism to sequence-specifically knock-down gene expression with synthetic siRNAs. The engineering of 
siRNA precursors (short hairpin, shRNAs) enable the ligand-dependent regulation of their processing. In this 
context the terminal loop structure of an shRNA was replaced with the theophylline-binding aptamer, generating 
a switchable shRNA precursor that facilitated the regulation of GFP expression 151. The developed approach 
was further used to control the level of endogenously expressed human serum albumin in mammalian cells 152. 
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In a different study ligand-dependent synthetic pri-miRNAs were generated by inserting various aptamers into 
the basal segment of the precursor. With this design Drosha processing was successfully targeted and it 
demonstrated the ligand-dependent regulation of GFP expression 153.      
Figure 2.7 Synthetic riboswitching mechanisms in 
eukaryotes. 
A By inhibition of the scanning of the 43S (or 40S, if only 
the small ribosomal subunit is considered) pre-initiation 
complex for the start codon aptamers can regulate gene 
expression in the 5’-UTR of a target gene. Ligand 
addition stabilizes the aptamer folding and blocks 
scanning. 
B Aptamers inserted close to either the 5’- or 3’-splice 
site or the internal branch point influence splicing in yeast 
and mammals by the accessibility of these sites to the 
spliceosome. Here, the intron is retained and prevents 
the fusion of exon1 and exon2. 
C In eukaryotes aptazymes determine mRNA stability in 
the 3’-UTR by ligand-induced cleavage or maintenance 
of the poly-A tail. Here, the ligand stabilizes the active 
conformation of the aptazyme and the poly-A tail is 
cleaved off triggering rapid mRNA degradation. 
D RNA interference.The replacement of the terminal loop 
of the precursor of a small non-coding RNA with a ligand 
(L)-sensing domain (green) results in an engineered, 
ligand-controllable hybrid molecule. In the presence of 
the cognate ligand processing of the modified precursor 
is blocked by the formation of a stable aptamer structure, 
preventing Dicer from substrate cleavage. In the absence 
of ligand the precursor is processed to its mature and 
active variant by Dicer. Adopted from 78. 
 
 
 
          
2.3.3.1 Design and engineering of synthetic riboswitches 
The means by which in vivo active synthetic riboswitches have been generated until today can be narrowed 
down to two fundamental strategies. In general, the sensor domains, i.e. RNA aptamers, are either obtained by 
an in vitro selection process called Systematic Evolution of Ligands by Exponential enrichment (SELEX) or 
simply by using (modified) natural aptamers. Now, to turn them into riboswitches, they must be connected to 
some kind of expression platform. Depending on the organism and regulatory mechanism sought to implement, 
the aptamer, the connecting module and/or the expression platform itself are adapted to exhibit a concerted 
functionality. Following the first strategy, this is done by randomization and extensive screening and selection 
steps for the desired phenotypes. The second strategy has evolved over the recent years and is constituted by 
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rational de novo designs facilitated by major advances in the understanding of RNA folding, riboswitch kinetics 
and thermodynamics and sequence-structure-activity relationships. Among both strategies, several approaches 
were successfully pursued and are further detailed.  
Aptamers for non-natural ligands are selected de novo by SELEX (for a short description on the process see 
chapter 5.1.2.1.1). Although the technology is powerful, only about 60 aptamers have been selected to bind 
small molecules and only a handful of these has found application as sensor domains of riboswitches 77,78. A 
major drawback is associated with the experimental conditions of the selection protocol and the actual goal of 
the selection. Typically, SELEX is performed to obtain aptamers with maximum affinity to their ligands and use 
them solely as sensors. The applied selection pressure leaves little room for RNA sequences that exhibit 
different ligand-free conformations that are highly favored over the ligand-bound conformation that is 
unfortunately the only conformation trapped by the ligand and retained. Thus, the stringency inherent to the 
selection excludes aptamers with potential regulatory properties (this phenomenon is further discussed in 
chapter 4.1.2). Additionally, in vivo features as co-transcriptional folding or the occurrence of RNA-binding 
proteins cannot be simulated or concentrations of crucial cations such as Mg2+ or K+ are present in up to 10-fold 
excess, distorting binding constants. Solving of the latter issue was demonstrated to alleviate the impact of the 
SELEX protocol on the identification of regulatory active aptamers 154. Over the years different SELEX 
approaches have been designed and include in vivo SELEX and efforts to enhance the method as such reducing 
cost, labor, time and failure rate The combination of SELEX with Next-Generation-Sequencing (NGS) 
constitutes a milestone in the improvement of the method as now data on each selection and amplification step 
is accessible, giving insights into enriched and lost sequence and structure motifs (reviewed in 77).  
SELEX-derived aptamers have found application in bacteria, yeast and mammalian cells 33. The aptamer for 
theophylline turned out to very robust, versatile and portable. As indicated in the previous chapter numerous 
riboswitches respond to this ligand.  
Figure 2.8 Aptazymes as riboswitches.  
A The Schistosoma mansonii HHR 
consists of a bulged three-way junction 
and three corresponding stems. Different 
groups attached aptamers to different 
stems. In its tertiary conformation loo-loop 
interactions between stem II and I enable 
the formation of the conserved catalytic 
core (red parts) cleaving off the 5’-stretch 
of stem III (red arrow). B Regulatory 
mechanism of aptazyme cleavage. Placed 
in the 3’-UTR in eukaryotes or 5’-UTR in 
prokaryotes, aptazymes control mRNA 
stability by cleavage of the poly-A tail or 
liberation of the RBS, respectively. Both, 
ON->OFF and OFF->ON switches, have 
been constructed. Adopted from 87. 
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To make broader use of natural or in vitro generated aptamers they are fused to a communication module that 
in turn is connected to a ribozyme serving as expression platform. The resulting aptazyme is thus composed of 
three interdependent modules. To produce a working riboswitch nucleotides of the aptamer, parts of the closing 
stem P1, and the ribozyme, here parts of stem I, II or III of the HHR, are usually randomized. The resulting 
sequence pool is then inserted in the 5’-UTR (prokaryotes) or 3’-UTR (eukaryotes) of a reporter gene and 
subsequent in vivo or in vitro screening and selection steps allow the identification of aptazymes with desired 
phenotypes. The HHR proved to be of exceptional value as all three stems are amenable for a fusion with an 
aptamer, either constraining or promoting the catalytic conformation of the HHR upon ligand binding (Figure 
2.8A). Different screening and selection system have been applied to yield ON and OFF switches for several 
ligands. Still, the only way to obtain a regulatory active aptazyme is to perform many iterative test cycles to find 
a suitable communication module, a resource-consuming endeavor that has not yet been replaced by an in 
silico method computing ligand-free and -bound conformations and predicting the resulting phenotype.                 
A similar cumbersome approach was established to generate the riboswitches for neomycin and tetracycline 
that control reporter expression by blocking ribosome scanning in S. cerevisiae 138,155. Both aptamers were 
obtained by SELEX and only an extensive in vivo screening facilitated their application as riboswitches 
(extensively reviewed and discussed in the following chapter). Both riboswitches as such hold a special position, 
because they do actually not contain a separate expression platform. Their structure is very compact and gene 
expression is modulated by the stability of their global folding and especially that of the closing stem, the “mini-
actuator”. Without ligand both riboswitches adopt structurally loose conformations that enable ribosome 
scanning. The presence of their cognate ligand captures a transient, highly stable conformation that inhibits 
translation. Although no explicit communication module is required here, the need for iterative screening prevails 
as again a ligand-free and –bound conformation must be identified that first promote and then suppress gene 
expression. Applied positive and negative selection pressure can aid in the discovery of a switching window, 
separating ON and OFF states to a maximum feasible level and minimizing the trade-offs between the 
requirement of loose and rigid conformations exhibited by a single RNA architecture 149.  
Recent studies demonstrated that aptamers that had already been implemented in active synthetic or natural 
riboswitches could be fused to natural expression platforms without the need for a communication module 129,156. 
Controlling transcription, these chimeric riboswitches support the hypothesis that the ability to generate 
functional synthetic riboswitches is co-determined by the identity of the aptamer sequence and hence 
unmodified aptamers derived from standard SELEX display poor building blocks. Nonetheless, before the 
chimeric riboswitches could be coupled in a “mix-and-match” design, the natural expression platforms had to 
be decoupled from their original aptamers as natural riboswitches exhibit some overlap between sensor and 
actuator domains. Once decoupled by the introduction of a tried and tested sequence motif, the natural 
expression platforms accepted various aptamers and produced ON and OFF transcriptional switches. This 
approach equipped existing expression platforms with completely different aptamers to obtain new sensor 
domains. 
Another study pursued practically the same goal, namely to confer new ligand specificities to existing expression 
platforms, but with a different engineering effort 130. By chemical derivatization and genetic selection natural 
riboswitches were engineered to respond to derivatives of the formerly cognate ligands. Both approaches, the 
replacement of the complete aptamer and the modification of an existing aptamer addressed an important 
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bottleneck in the generation of novel synthetic riboswitches; the availability of only a limited number of ligands 
orthogonal to the cellular metabolism. Importantly, they circumvented the need to screen and select for 
riboswitching activity by the use of functional riboswitches from the start. Though the approaches were rationally 
designed, true de novo design of riboswitches regulating transcription and translation driven by in silico modeling 
was presented by others. As described, transcriptional control is achieved by the switching between mutually 
exclusive terminator and anti-terminator structures. During the riboswitch synthesis in bacteria the RNA Pol II is 
forced to halt specific sequence motifs. This pausing allows the aptamer to fold, bind the ligand and transmit 
the signal to the expression platform that in turn must have adopted the conformation for termination or anti-
termination. The time-window available to this once-in-a-life-time-decision is dictated by RNA Pol II speed and 
the kinetics of RNA folding and ligand binding. The mechanistic basis for this sequential event have been 
unraveled for numerous natural riboswitches and can thus be applied to build computational models. Accounting 
for thermodynamic and kinetic aspects, the folding paths of synthetic riboswitches composed of the theophylline 
aptamer were calculated 83,127. It was important that the model also considered the inverse folding problem, i.e. 
that any predicted sequence can adopt the conformation of the mutually exclusive structures of terminator or 
anti-terminator. Simulations yielded several transcriptional ON riboswitches in E. coli. During the in vivo testing 
optimizations were only possible by rational evaluation of the genetic context, information the in silico model 
had not provided. Besides context, also structure-stabilizing effects by ligand binding and the formation of 
pseudoknots were not computed. This highlights the vast number of contributing factors that must be considered 
in such in silico design.  
The development of a statistical thermodynamic model in a recent study predicted the sequence-structure-
function relationship for translation-regulating riboswitches 84. Since this regulatory mechanism does 
supposedly predominantly rely on the thermodynamic equilibrium between ON and OFF states, kinetic 
parameters play a comparably negligible role. Based on six different natural and synthetic aptamers this model 
automatically computed designs for 62 riboswitches and demonstrated that computational models built, trained 
and calibrated on thermodynamic data provide facile access to the construction of functional riboswitches.  
2.3.3.2 The neomycin- and tetracycline-binding riboswitches 
The riboswitches for neomycin (Neo) and tetracycline (Tc) applied in S. cerevisiae and are among the best 
studied synthetic riboswitches to date. Both original aptamers were obtained by SELEX 157,158. While the Tc  
aptamer cb32 conferred 6-fold in vivo regulation of a GFP+ reporter gene without further modifications 155, the 
Neo aptamer N1 was not identified before an in vivo screening revealed its riboswitching properties and 
subsequent modifications yielded riboswitch M4 exhibiting 8-fold regulation 138. Both riboswitches confer their 
regulatory activity in the 5’-UTR of the downstream gene. The as 5’-scanning interference described regulatory 
mechanism exploits the mechanism of eukaryotic translation initiation. The 40S small ribosomal subunit 
attaches to the 5’-m7GTP cap inherent to all correctly transcribed eukaryotic mRNAs 159. After binding, 
eukaryotic initiation factors and other cofactors assemble to the 43S scanning-competent pre-initiation complex. 
During scanning for the start codon in 3’-direction the 43S complex eventually encounters the riboswitch inserted 
proximal to the mature start codon (Figure 2.10A). Now, the first key feature exhibited by regulatory active 
aptamers, the occurrence of loose, vastly unstructured ligand-free ground states, determines the ability of the 
43S complex to continue scanning and initiate translation at the start codon. Neo and Tc riboswitch fulfill this 
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criterion as they allow ~40% and ~30% basal gene expression relative to riboswitch-unobstructed gene 
expression (see Figure 4.3A). The second key feature for regulatory activity is inherent to the aptamer structure 
and decides whether ligand addition will have any effect on downstream gene expression. To confer 
riboswitching activity the aptamer must feature a pre-formed ligand-free ground state that can be captured by 
the ligand and thus stabilized. The increased structural stability blocks the advancing 43S complex to a higher 
degree than the loose structure without ligand and represses gene expression. The following text describes the 
detailed mechanistic characteristics of both riboswichtes. 
The originally published neo aptamer R23, though exhibiting low nanomolar (nM) affinity and high selectivity for 
neo, was completely inactive in vivo. Thus, an in vivo screening of the enriched aptamer pool was conducted to 
search for regulatory active aptamers. The screening system is detailed in chapter 5.1.2.1. Briefly, the aptamer 
pool is inserted upstream of a plasmid-borne GFP+ reporter gene and transformed yeast cells are screened for 
neo-dependent GFP+ repression. This way 10 individual sequences were identified with the desired phenotype. 
Subsequent analysis of aptamer N1 revealed that its sequence was not among the aptamer sequences 
previously shown to bind neo, indicating that this aptamer was underrepresented in the enriched SELEX pool. 
Nonetheless, N1 binds in a 1:1 stoichiometry to neo with a dissociation constant of 8 nM and displays equal 
ligand selectivity. Structural probing data unraveled a putative ligand binding pocket and nucleotides mandatory 
for regulatory activity 138. A detailed mechanistic insight into the sequences and structural motifs responsible for 
ligand accommodation and the switching phenotype could be gained by nuclear magnetic resonance (NMR) 
spectroscopy. The regulatory activity is governed by the occurrence of temperature-dependent ligand-free 
ground states that are in in thermodynamic equilibrium. These ground states are constituted by an ensemble of 
open conformations that are entropically favored at ambient temperatures over a compact, highly structured 
conformation that closely resembles the ligand-bound state (Figure 2.9). The inactive aptamer R23 does not 
exhibit a regulatory activity, as it lacks certain structural elements that are a prerequisite to fluctuate between 
loose and stabilized conformations. 
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Figure 2.9 Model of ligand binding and global refolding of the neo riboswitch. The aptamer identified by in vivo screening (N1) exhibits 
riboswitching properties most likely due to stabilization of a ligand-bound conformation by neo, tightly clamping upper and lower helix 
together and promoting energy-releasing interactions of the terminal loop. The free conformation, that is highly favored in the absence of 
neo, fluctuates in a thermodynamic equilibrium with the bound conformation promoted by the switching element 5’-CUU. This interplay 
between loosely structured and subsequent stabilization confers in vivo activity. The aptamer R23 originally identified by SELEX is 
completely inactive as it lacks the necessary structural prerequisites to fluctuate between an open and closed conformation. Gene 
expression is always repressed to the same extent. The hybrid N1(R23) contains the asymmetric bulge including the switching element 
from N1, but the terminal loop of R23. Thus it may display diverse ground states and allow neo-dependent expression control, but since not 
all structural features are met, it is less active than N1. Unstructured parts are shaded light red.    
In the N1 aptamer the folding toward the ligand-bound conformation is restrained by a short 5’-CUU-bulge motif 
that does not participate in ligand-binding, but promotes the separation of the closing stem and the upper mini 
hairpin, resulting in an open conformation. Ligand binding to a transient ligand-“bound” conformation stabilizes 
coaxial stacking of lower and upper helix, forming a long α-helical element that sandwiches neo between 
G5:C23 from the lower helix and G9:C22 from the upper, newly formed helix. While the 5’-CUUmotif, also 
termed the switching element, is bulged out, neo acts as a clamp and not only supports the continuous helix, 
but also promotes U10:U21 wobbling and stabilization of the apical loop by U13:U18 wobbling, stacking 
interactions between U15:A16 and hydrogen bonding between U14:A16 and U14:A17(P). A17 is looped out 
and undergoes hydrophobic interactions with neo (Figure 2.10B, D, E) 160,161. This conformational capture of the 
preformed bound conformation from the conformational ensemble by neo results in the release of enthalpic 
energy that more than compensates the entropic penalty incurred by the transition from the entropically favored 
open, ligand-free conformation to the ligand-bound conformation. The switching element 5’-CUU is a key 
determinant to allow the ground state to be largely unstructured, hence promote translation in absence of neo. 
Presence of neo subsequently shifts the thermodynamic equilibrium of the ground states toward the highly 
structured, ligand-bound conformation that poses a roadblock to the scanning ribosome and ultimately prevents 
translation. As indicated by the ligand-stabilized interactions in the apical loop, this region was demonstrated to 
accommodate improving mutations on the in vivo activity of the M4 riboswitch, upgrading its regulatory 
performance from 8 to 10-fold 162. This increase in performance can be attributed to an enrichment of the 
preformed conformation that is trapped by neo, because the apical loop exhibits pronounced involvement in the 
overall stability of the ligand-bound conformation. 
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Figure 2.10 Mechanistic insights into the neo riboswitch M4. A The riboswitch is placed upstream and start codon-proximal of a GFP 
reporter gene. In the absence of neo, the scanning ribosomal complex is only partly constraint, whereas neo presence increases the 
roadblock and reduces scanning significantly. Ternary complex composed of eIF2, GTP, and Met-tRNAiMet (tern. comp.); eIFs=eukaryotic 
initiation factors. B Secondary structure of the M4 riboswitch. The closing stem is composed of 8 bp and the terminal loop highlighted in 
colored letters. The thermodynamic equilibrium between the open and closed structure is indicated. Nucleotides involved in neo binding 
are boxed. The dashed line represents hydrogen bonding between U14 and A16. C Due to its superior spectral resolution, but nearly 
identical binding profile, ribostamycin is typically used for spectroscopic analyses. D NMR tertiary structure of ribostamycin bound to M4 
(PDB ID: 2KXM). The continuous α-helix is shaded in grey and nucleotides involved in ligand binding are light grey. Nucleotide of the 
terminal loops are color-coded and correspond to B and E. E Single nucleotide resolution of the terminal loop. The loop is closed by the 
non-canonical U13:U18 bp, forming a U-turn that consists of a loop out A17. Relevant hydrogen bonds are highlighted by dashed lines.  
Adopted from 162. 
The neo riboswitch has not only been used in the 5’-scanning mechanism, but was also fused to a HHR yielding 
highly functional aptazymes 149. This further underlines that a riboswitch design is successful, if the aptamer 
domain has been shown to work in such a context. 
The tc riboswitch was equally well characterized by using electron paramagnetic resonance (EPR) and 
fluorescence spectroscopy, since the fluorescence of tc can be used to determine thermodynamic and kinetic 
parameters. The affinity of aptamer and ligand was determined to 0.8 nM in a 1:1 stoichiometric ratio 163. The 
aptamer assumes an h-shaped tertiary conformation, binding tc at the center of an irregular triple helix formed 
by the joining regions J1-2, J2-3 and the loop L3. (Figure 2.11A, C, D). Tc accommodation was demonstrated 
to be governed by a 2-step regimen 164. The aptamer exists in two ligand-free ground states and, similar to the 
binding mode of neo, tc traps one of the two conformations in a first, reversible binding step. Initial association 
of the aptamer-tc complex is mediated by contacts between tc and the nucleotides A13, A58 and A50 that are 
mandatory for a fast binding kinetics and a stable conformation preventing the dissociation of tc (Figure 2.11E) 
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164. Since the conformation to which tc binds is already extensively preformed in the absence of tc at 
physiological Mg2+ concentrations (~0.5-1mM), no major conformational changes occur in the second binding 
step in which the J1-2 caps tc by stacking interaction with A13 and water-Mg2+ -mediated hydrogen bonds of 
nucleotide A50 that had already coordinated tc in the first step (Figure 2.11E) 164–166.    
 
Figure 2.11 The tc riboswitch AN32sh. A, C Secondary structure and crystal structure 167, respectively. Structural motifs are color-coded, 
tc is shown as stick-model and magnesium as green ball. The h-shaped tertiary conformation binding the tc-Mg2+-complex at the center of 
an irregular triple helix formed by the joining regions J1-2, J2-3 and the loop L3 is trapped in a 2-step binding mechanism by tc. B Ball and 
stick model of tc and magnesium emphasizing the coordination of the cation. D The basis of the triple helix if formed by A9, A44 and A55. 
E Nucleotides A13 and A50 are crucial for tc binding and stabilization of the bound conformation of the riboswitch. In absence of tc, 
especially A13 and the loop L3 are further spaced, destabilizing the tertiary conformation. Adopted from 164  
In accordance with the 2-step binding regime, translation can be effectively regulated with the tc aptamer. The 
thermodynamic equilibrium between the two ground states allows ribosome scanning, as tc is required to stably 
maintain the preformed conformation at physiological Mg2+ concentrations and thus to shift the thermodynamic 
equilibrium towards the bound conformation that massively interferes with translation. Hence, the tc riboswitch 
has found numerous applications for conditional gene expression. Approaches range from its introduction to the 
5’-scanning mechanism as monomer, dimer or trimer over its use for controlling pre-mRNA splicing to its fusion 
to HHRs in different set ups. The multiple insertion of tc riboswitches in the 5’-UTR of a GFP+ reporter gene 
even resulted in the amplification of regulatory activity up to 37-fold and was used to control essential genes in 
yeast 168. As part of HHRs the tc aptamer conferred ON and OFF regulation in yeast and mammals 24,147,169. 
Control over pre-mRNA splicing was introduced as a novel means over gene control. Analogous to the 5’-
scanning design the riboswitch was used as such an inserted close to the 5’-splice site. Splice regulation was 
found to depend on aptamer stability and exact positioning and yielded switches with up to 33-fold regulatory 
activity.  
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2.4 RNA synthetic genetic networks 
Information inside cells is transmitted and processed by genetic circuits that allow the simultaneous integration 
of different input signals, typically resulting in a single output. Inputs may come in form of metabolites, 
transcription factors or other environmental factors like ionic strength, light and temperature. The timely and 
sufficient processing of these signals is fundamental to the correct functioning of the metabolic state and thus 
cell viability. Long since it has been known that cell populations, even clonal cell populations, exhibit 
heterogeneous phenotypes with respect to practically all expressed genes. These “noisy”, inhomogeneous 
expression patterns are the result of stochastic fluctuations of the involved molecular components in their level 
and activity 170. On a global scale noise could be quite advantageous to the population or even the overall 
species, as phenotypic variability between single cells fosters a wide range of differentiation strategies and thus 
fast adaption to rapidly changing environmental conditions. On the single-cell level it allows the coordination of 
larger set of genes, because time-variable fluctuations of one component can mask and compensate for 
fluctuations of another (Figure 2.12 upper and middle panel). More precisely, short, burst-like availabilities of a 
transcription factor (mRNA spikes) are buffered by the variable slow degradation rates of the produced protein 
– they are averaged over time. In turn, if the protein was again a transcription factor, this results in the prolonged 
variable activation of another downstream gene. If more of such patterns are overlaid, stable expression 
patterns and a phenomenon called cell memory can occur over cell-cycle timescales.     
 
Figure 2.12 Classification of noise in a short transcriptional cascade. Bursting describes the irregular amplification of mRNA whose 
genetic information is subsequently amplified by many translations rounds, giving rise to sudden increases of the gene product. On the 
protein level these burst decay with variable rates over time, thus averaging protein levels. Time-averaging directly influences information 
propagation since the variably decaying signal intensity create downstream bursts on their own that are higher in frequency but generally 
lower in amplitude. Compared to the initial bursts the transmitted information appears no “smeared” over time.   
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Although recognized as beneficial to wild type populations, synthetic biologists rather view noise as an 
impediment to the predictable functionality of designed genetic circuits. Here noise manifests as intrinsic and 
extrinsic to the studied phenotype. Intrinsic noise refers to variable rate constants of underlying processes such 
as promoter activity, transcription, partly translation and protein and mRNA half-lives of the respective gene. 
Extrinsic noise stems from processes that affect gene expression at large, such as the availability of the general 
and specific transcription and translation machinery. The differentiation between these two can be assessed by 
monitoring the expression of the equally controlled reporter genes. Uncorrelated fluctuations hint toward intrinsic 
noise, whereas correlated fluctuations point toward extrinsic influences. Noise as a cause of malfunctions of 
devices cannot be inferred from bulk measurements as these inherently average any phenotype and thus blend 
out the significant effects of cell-to-cell variations. To study populations with respect to their heterogeneity at the 
single-cell level corresponding techniques must be used. Time-lapse recordings by fluorescence spectroscopy 
in a microfluidic environment have emerged as powerful means to investigate noise phenomena. Flow cytometry 
is equally suited, but allows only snapshots of the population over time, as a specific cell can only be analyzed 
once. Efforts to determine and reduce noise have led to the construction and refinement of various synthetic 
genetic circuits and networks in the past years. Designed to follow Boolean logic, it is generally sought to have 
them process input signals in a digital-like manner (exemplified in Figure 2.13). Logics are named according to 
the desired signal integration. A NOR gate for instance will only yield an output, if none of both input signals are 
present. As described, phenotypic variations bedevil the realization of digital behavior. 
Figure 2.13 Examples of logic gates 
implementing Boolean function. Logic 
function can be represented by symbols 
(here distinctive shape) and 
complementing truth tables that detail the 
output according to the input signal. All 
gates integrate two inputs to a single 
output. Connecting several gates, greater 
circuits can be build that process and 
transmit complex information. Adopted 
from https://i.stack.imgur.com/U92yS.png. 
Nonetheless, the assembly of logic devices to higher order genetic circuits is a prerequisite to establish de novo 
designed metabolic pathways in silico. Hence, it is desirable to have building blocks that may be plugged 
together in a manner that is feasible to compute. RNA regulatory mechanism can be implemented at a low 
sequence load and metabolic burden as they are compact and need only to be transcribed, respectively. 
Proteins in turn consume much of the produced cellular energy by their translation. RNA regulators have proven 
high modularity and portability across species. The may be applied to control virtually any gene expression at 
short timescales if acting in-cis and their precise signal propagation is determined by their fast degradation 
rates, reducing time-averaging and subsequently noise propagation. 
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2.4.1 Synthetic parts characterization 
Before plugging parts to devices and devices to systems, both, parts and devices, need to be thoroughly 
characterized. Since parts characterization could be extended seemingly endlessly, as there are so many 
factors to consider, some physicochemical, thermodynamic and kinetic parameters are routinely determined, 
depending on the part or device. For RNA parts these are (i) structure that is determined by chemical probing, 
x-ray crystallography or other spectroscopic techniques, (ii) ligand interaction that is assessed by binding and 
dissociation rates through spectroscopy and calorimetric assays, (iii) physicochemical properties as ion and 
temperature dependence. The quantification of device performance constitutes a key determinant that follows 
not standard at all. As most studies are conducted for the proof-of-principle, reporter gene assays with 
fluorescent proteins as output are frequently used. Since each part or device is characterized in a specifically 
set up expression system, including instrumentation and environmental factors, absolute comparisons of device 
performances from different studies with respect to their regulatory activity are rather difficult. Therefore relative 
measures of output levels were proposed that quantify the actual reporter relative to an internal control, typically 
another fluorescent protein. Moreover, as context-dependencies influence the characterization, the process 
itself measures the supposedly independent functionality of the studied part rather imprecisely. 
Another important issue is constituted by phenotypic noise. To characterize a device in the context of cell-to-
cell variability single-cell measurements can aid to unravel its reliable performance across a population and 
point out parameters that allow efficient tuning. The time-resolved tracking of the involved molecular 
components is an absolute necessity to resolve transient processes and states. Advances in mRNA and protein 
tagging allow the reconstruction of time traces and the subsequent determination of in vivo kinetic parameters 
like synthesis and degradation rates and the cellular localization of the involved components. Importantly, this 
way RNA-ligand interactions can be mapped spatiotemporally, allowing insights and conclusions about their 
gene regulatory mechanism. 
As RNA devices are further incorporated in increasingly complex synthetic networks, the in-depth studies of 
noise, spatiotemporal response, evolutionary robustness and orthogonality between device and host organism 
will need to be conducted.   
2.4.2 Synthetic RNA logic gates 
Natural RNA-based logic operations have been observed in the context of riboswitch discovery and 
characterization. The glmS riboswitch from B. subtilis processes two inputs, glucosamine-6-phosphate as 
activating ligand, and glucose-6-phosphate as inhibiting ligand, the modulate its activity 107. In B. clausii two 
independent riboswitches sensitive to S-adenosylmethionine or vitamin B12 integrate a NOR logic to control 
expression of the downstream gene. Presence of either ligand leads to transcription termination.  
Synthetic RNA circuits have been constructed from riboswitches, riboregulators and CRISPR-derived parts 76–
78,86. In an early study, aptamers sensitive to theophylline and TPP were set to control translation in the 5’-UTR 
of a reporter gene in bacteria 171. Translation was only active in the presence of both ligands (AND gate) or in 
the absence of both or either ligand (NAND gate). In a follow-up study a transcriptional OFF switch was 
combined with a translational ON switch that both bound to TPP, but with different sensitivities. Thus, acting as 
a band pass filter, only intermediate concentrations of TPP promoted gene expression 172. 
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The introduction of aptazymes enabled the construction of various logics in yeast. Using the HHR as a 
workhorse, aptazymes sensing TPP and theophylline were combined to AND, NOR and ANDNOT gates 173. 
This study nicely demonstrated the incorporation of an amber suppressor tRNA to implement the desired logic. 
Further work on HHRs implemented a series of theophylline and tetracycline-responsive riboswitches by 
realizing novel ribozyme architectures. Deploying stems I and II, ribozymes with aptamers attached to a single 
stem or both stem were generated. The single-stem attachment featured even a “backpack-like” organization 
with one aptamer stacking on top of the other. Ultimately, AND, NOR and NAND gates were assayed for their 
ability to regulate gene expression in the 3’-UTR of the reporter gene, affecting mRNA stability.  
Not only the HHR, but also the twister ribozyme could be engineered to yield AND, NAND, OR, NOR and two 
different ANDNOT gates that are sensitive to TPP and theophylline. Although signal integration resulted only in 
quite moderate output regulation, it impressively demonstrated the modularity and plug-and-play accessibility 
of RNA-derived regulation 144. 
Turning from riboswitches to riboregulators, the previously described toehold switches gained their ligand 
sensitivities from inducible promoters and were used to construct a layered 4-input AND gate 92. The complexity 
of this design in terms of the number of regulatory levels exceeds that of the engineered ribozymes, because 
here four initial, orthogonal inputs controlled the output of two RNAs that were again used as input to regulate 
GFP levels. Despite a dramatic performance decrease relative to the devices of which the 4-input system was 
composed, the signal was sufficiently propagated to yield a 6-fold upregulation of GFP. 
A special highlight in the design of synthetic circuits was the marriage of RNA and protein regulators giving birth 
to sophisticatedly engineered CRISPR tools in yeast. Using catalytically inactive Cas9 as an inducible master 
regulator, scaffold riboregulators (see Figure 2.2C) recruiting transcription activation domains by their aptamer 
component addressed various modified promoters of a metabolic pathway to direct its flux and control the 
output. Less a common logic gate and more a hierarchical, programmable control system, the power of a 
functional RNA-protein-dependent regulation was demonstrated. RNA scaffolds can be sequence-engineered 
to specifically bind to almost any target site. Equipped with basically any aptamer from a pool of aptamers for 
virtually any ligand they can be multiplexed to activate or repress transcription genome wide. Since there is only 
one inducible master regulator, a defined cellular program can be started by a single input. As dCas9 and 
scaffold RNA can be designed to exhibit orthogonality to other dCas9-scaffold RNA pairs, different programs 
could be run at the same time, facilitating the paralleled or time-shifted control over whole cell re-programming 
(Figure 2.14). 
Figure 2.14 Envisioned application of 
CRISPR tools to implement cellular 
programs. Running two orthogonal 
cellular programs (blue and green) in 
parallel that are triggered by two distinct 
inputs A and B is facilitated by the master 
regulators dCas9. A master regulator in 
turn has its own set of molecular slaves 
within one program. The molecular slaves 
address different target themselves. By 
this hierarchical system few input signals      
           can trigger a vast downstream cascade.   
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3 Scope 
The generation of riboswitches with novel ligand selectivity constitutes a major bottleneck in their broader 
application as regulators of conditional gene expression. The aptamer domain can be created against virtually 
any target molecule and therefore it is highly desirable to use them as sensory units for the conditional control 
of gene expression. However, it is assumed that aptamers are a priori not suited to regulate gene expression, 
because the applied in vitro selection strategy is designed to identify RNA sequences exhibiting high affinity to 
their target and not to select for a gene-regulatory activity. At this stage it is key to accomplish the transformation 
from an aptamer sequence to an RNA sequence capable of switching gene expression from an ON state to an 
OFF state – a riboswitch. A previously identified putative quality of in vitro selected aptamers was sought to be 
exploited, featuring the inherent combination of aptamer domain and expression platform in a single compact 
structure to control gene expression in yeast. The basic concept of the system was to interfere with ribosomal 
scanning and the initiation of translation at the start codon by inserting a road block in the 5’-UTR of the 
corresponding mRNA, but leaving mRNA levels undisturbed. This approach should then be extended by 
application of an in vivo screening to identify in vitro generated ciprofloxacin aptamers with riboswitching 
properties.  
Mechanistic insights into riboswitch function are only beginning to foster the understanding of how to convert 
aptamers into riboswitches or how to efficiently improve existing riboswitches. Advancing in silico riboswitch 
design and refinement, dimers of the well-characterized tetracycline riboswitch were anticipated to aid in the 
construction and training of a computational model that would subsequently compute riboswitches exhibiting an 
increased regulatory activity. Besides improvements at the nucleotide level to enhance performance, a thorough 
device characterization at the cellular level is needed to dissect the influence of phenotypic variability on device 
performance. Until today, no standard performance descriptor has been established and thus most devices are 
solely characterized by their ability to switch gene expression based on end point data averaged over a whole 
population. These bulk data cannot account for cell-to-cell variability and no information on the transient shift 
from ON to OFF levels is obtained. Engaging these issues, a novel logic NOR device constructed from the 
neomycin and tetracycline riboswitches was sought to serve as a model to investigate the regulatory 
performance with respect to cell-to-cell variability and the separation of two Boolean states at the single-cell 
level. Transient, single-cell data was supposed to calibrate a hierarchical stochastic model and allow a 
performance mapping of the logic device based on ROC analysis. Using ROC analysis a performance measure 
should be derived that assessed the correct functionality of the gate at the single-cell level – a prerequisite for 
its further adaption to a genetic circuitry. Not being specific for riboswitch devices, this performance indicator 
could then be applied to other logic devices and facilitate their comparable analysis.  
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4 Results & Discussion 
4.1 Project I: Identification of RNA aptamers with riboswitching properties 
4.1.1 Results 
4.1.1.1 A literature-based screen for aptamers with putative riboswitching properties 
In a first approach, RNA aptamers already published by various research groups were selected from 
the literature. It was sought to assess their potential as riboswitches in the aforementioned 5’-UTR 
design without or with only minor modifications by mutations or truncations of the closing stem of each 
aptamer (see chapter 2.3.3.2). Truncations of aptamer sequences taken from natural riboswitches were 
necessary to isolate only the sensing domain and an adjacent closing stem. With the exception of the 
M4-aptamer (ligand: neomycin), the AN32sh-aptamer (tetracycline) and the MG-4 aptamer 
(tetramethylrosamine), none of the other aptamers had been shown to work as riboswitches in yeast 
employing the 5’-UTR design. Aptamers closely matching most of the following specifications were 
chosen for the experiments. (i) Primarily, aptamers were selected according to their novelty to identify 
already published sequences whose gene-regulatory potential has not been investigated yet. These 
aptamers were intended to serve as alternative riboswitches apart from the long since established 
aptamers sensing neomycin, tetracycline and theophylline. (ii) Besides their novelty, sequence length 
was of greater importance since sequences smaller than approximately 70 nt allow for a faster re-design 
to yield enhanced functionality and a determination of the actual ligand-binding domain can be 
performed at lower efforts, if such data are not already available. (iii) The upper threshold for an 
important parameter of aptamer-ligand interaction, the dissociation constant KD, was set to the low µM 
range, because as a general rule a lower KD reduces the effective concentration of the supplemented 
ligand. This in turn diminishes the risk of unspecific side-effects and adverse toxicity issues caused by 
the ligand. (iv) Permeability of most ligands for the yeast cellular membrane is undetermined and 
therefore the highest non-toxic concentration was chosen. This requires a good solubility of the ligand 
in water or water-ethanol mixtures. (v) A last, but not less significant criterion was the costs to purchase 
or synthesize the ligand of interest to make the system eventually available to a broader public. 
Table 4.1 summarizes all aptamers and their ligands tested in this study. Aptamers were clustered into 
different blocks that refer to the substance class of their respective ligand. The length of the cloned 
aptamers is given in nucleotides (nt), molecular weight of the ligand as relative molecular weight (Mr) 
and the dissociation constant (Kd) of the aptamer-ligand complex is displayed in 10-9 mol/L (nM). 
Dimethylindol red and atrazine were supplemented in two different concentrations and the aptamers 
MG-4, TMR1 and TMR2 were tested with the non-cognate ligand rhodamine B. Most aptamers were 
obtained by an in vitro SELEX and hence the original publications are tabulated. Two aptamer domains 
were isolated from naturally occurring riboswitches, the thiM riboswitch from E.coli and the xpt–pbuX 
riboswitch from B. subtitlis. The secondary structures as predicted by RNAfold are listed in Figures 
4.1(#1-22) along annotations specifying the detailed modifications of some aptamers 174,175.  
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# Aptamer Lengt
h  
Ligand MW  Substance 
class 
Kd c(ligand
) 
Reference 
   [nt]   [g/mol]   [nM] [µM] 
 
1 AN32sh 69 Tetracyclin  444 antibiotic 1 250 158 
2 M4 34 Neomycin 615 antibiotic 9 100 138,157 
3 J6sl 27 Tobramycin 468 antibiotic 5/9 100 176 
4 X1sl 26 Tobramycin 468 antibiotic 12 100 176 
5 D1 20 Tobramycin 468 antibiotic 220 100 177 
6 Strepto-
Tag 
45 Streptomycin 582 antibiotic <100
0 
100 178–180 
7 8-1-1 22 Kanamycin B 484 antibiotic 180 100 181 
8 Dano-I 32 Danofloxacin 357 antibiotic 3 100 182 
9 MG-4 38 Malachite green (MG) 365 dye 800 100 137,183,184 
9 MG-4  38 Rhodamine B 
(tetraethylrhodamine) 
479 dye n.d. 100 137,183,184 
10 TMR1 38 Tetramethylrhodamin
e 
343 dye 85 100 154 
10 TMR1 38 Rhodamine B 
(tetraethylrhodamine) 
479 dye n.d. 100 154 
11 TMR2 46 tetramethylrhodamine 343 dye 70 100 154 
11 TMR2 46 Rhodamine B 
(tetraethylrhodamine) 
479 dye n.d. 100 154 
12 TMRV1  28 Tetramethylrhodamin
e 
343 dye n.d. 100 154 
13 TMRV2  30 Tetramethylrhodamin
e 
343 dye n.d. 100 154 
14 13.2  60 DMHBI 300 dye 464 100 185 
15 Apt-1 49 Dimethylindol red 484 dye 87 50;250 186 
16 SRB-2  52 Sulforhodamine B 559 dye 80 100 187 
17 N40 region  49 Atrazine 216 various <200
0 
100;300 188 
18 Aptamer 21  53 HAP (heteroaryl-
dihydropyrimidine) 
360 various 50 100 189 
19 thiM 
riboswitch  
72 TPP (Thiamine 
pyrophosphate) 
424 metabolite 20 500 101 
20 ag.06  54 L-Arginine 174 metabolite 330 10000 190 
21 xpt–pbuX 
riboswitch  
67 Guanine 151 metabolite 5 500 191 
22 mTCT8-4  33 Theophylline 180 metabolite 100 1000 120 
Table 4.1 List of all tested aptamers and their assigned ligands. The denominations were adopted from the original references. 
The indicated aptamer lengths refer to the actually cloned sequence and are illustrated as predicted secondary structure in Figure 
4.1. The molecular weight (MW) of each ligand, their tested concentrations (c (ligand)) and their dissociation constant (Kd) are 
provided. All aptamers are categorized with respect to the substance class of their ligands, reflected by the different shades of 
blue. 
Only small molecules were chosen as ligands, because they are easily handled and administered to the 
growth medium. Proteins or even cellular components constitute other classes of ligands that are either 
impractical to use or their abundance may not be controlled, rendering a switchable gene expression 
impossible. Three major classes could be identified, each featuring aptamers that had already been 
employed as riboswitches or that are naturally occurring riboswitches in bacteria. (i) Antibiotics are 
purchased at a low cost and toxic side effects can be controlled by the appropriate concentration. Their 
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corresponding aptamers are short in sequence and accessible to in silico modeling. Although antibiotics 
do permeate through the cellular membrane of S. cerevisiae, the intracellular concentration is unknown 
and thus, empirically determined concentrations derived from earlier publications on the neomycin- and 
tetracycline- binding riboswitches were adopted 138,155. (ii) Dyes represent an interesting ligand class as 
their uptake inside the cell could either be monitored by phenotype – rhodamines cause the cells to 
become visibly pink – or their concentration may be determined in a cytoplasmic extract. They are widely 
used for fluorescence-based assays and many are easily available by purchase. (iii) Metabolite-sensing 
aptamers were either derived from riboswitches identified in bacteria (TPP, guanine) or stem from a 
SELEX against the respective compound (theophylline, L-arginine). The addition of L-arginine required 
a pH adjustment with hydrochloric acid before the experiment was conducted. The cytoplasmic 
concentration for free guanine could not be found in the literature (Yeast metabolome data base 
(YMDB), http://www.ymdb.ca), but the purine metabolism (KEGG pathway database, 
http://www.genome.jp/kegg/pathway/map/ec00230.html) suggests its rapid conversion to guanosine, 
guanosine monophosphate (GMP), xanthine or deoxyguanosine. Thus no free guanine was expected 
to obscure a putative regulatory activity of the corresponding aptamer. 
Supplied by the purine and vitamin B6 metabolism, the thiamine metabolism generates thiamine 
pyrophosphate (TPP) that in turn is a cofactor for several enzymes involved in numerous metabolic 
pathways (YMDB, http://www.ymdb.ca/compounds/YMDB00381). The intracellular concentration of 
thiamine could not be retrieved. The proteinogenic amino acid L-arginine is endogenously anabolized 
from ornithine in the cytoplasm of S. cerevisiae and catabolized in the context of the urea cycle by 
arginase. Free intracellular concentrations of L-arginine vary greatly depending on the composition of 
the used culturing medium (YMDB, http://www.ymdb.ca/compounds/YMDB00592). Here L-arginine was 
not supplemented to cultures with cells transformed with the corresponding aptamer. The effect on cell 
growth was found to be negligible as L-arginine is readily synthesized from glutamate supplemented at 
1 mM.         
In a first step a toxicity assay was conducted (Table 4.2). As a measure of toxicity the optical density 
(OD600) of the cell suspension was determined in the presence of the respective ligand. Therefore yeast 
cells were transformed with pWHE601 and toxicity was assayed in a growth test. Samples were drawn 
every hour for 8 h and at 24 h. The standard doubling time was determined to ~105 min. Malachite green 
(MG) was found to be too toxic to the cells to use it as a ligand (doubling time ~215 min) and since the 
other original, non-toxic ligand tetramethylrosamine could neither be purchased nor synthesized in time, 
the aptamer was tested with a structurally related fluorophore, rhodamine B. Besides MG, DIR and 
atrazine diminished cell growth to an equal extent at the highest concentration of 250 µM or 300 µM 
supplemented, increasing doubling time to ~130 min, but both were regarded not toxic. Apart from these 
three compounds, no other ligand caused impaired cell growth at the indicated working concentration 
that was also supplemented for the subsequent reporter gene assays (Table 4.1). 
The absorption spectra of all antibiotics, atrazine, HAP and all metabolites revealed no spectral 
interferences with GFP fluorescence emission. The dyes, as expected, either emitted fluorescence 
overlapping with GFP (DMHBI) or absorb light emitted by GFP (all rhodamine derivatives and DIR). 
Nonetheless, this potential quenching effect was regarded a second order problem, since without 
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sufficient basal expression the corresponding aptamer could not be used in any case. In addition, a 
change of the reporter assay to a ß-galactosidase-based system could solve any spectral issues.  
Table 4.2 Growth test to assess toxicity. Yeast cells were 
transformed with vector pWHE601 and cultured in SCD-Ura medium. 
Separate cultures were prepared with all different ligands and grown 
for 24 h. Samples were drawn as indicated, diluted and their optical 
density measured at 800 nm. Ligand concentrations equaled those 
used for reporter gene assays. For further information on pWHE601 
refer to the reporter gene assay and chapter 6.5.1.1. Doubling time was 
calculated by the division of the ln(2) by the growth constant. The 
growth constant was calculated as the slope of the exponential fit of 
the logarithmized OD600 values during exponential growth. Experiments 
were performed in one triplicate. The standard error of the mean was 
below 5% for all triplicates. 
 
 
 
 
 
 
 
 
 
 
 
 
 
Ligand 
Doubling time in 
min 
untreated 100 
Tetracycline 102 
Neomycin 105 
Streptomycin 108 
Kanamycin B 108 
Danofloxacin 108 
Rhodamine B 110 
Sulforhodamine 
B 108 
TMR 107 
DMHBI 108 
HAP 103 
Thiamine 108 
L-arginine 110 
Guanine 106 
Theophylline 108 
DIR 133 at 250 µM 
MG 216 
Atrazine 135 at 300 µM 
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An32sh-aptamer (#1) 
 
X1sl-aptamer (#4) 
 
8-1-1 aptamer (#7) 
 
 
M4-aptamer (#2) 
 
 
D1-aptamer (#5) 
 
Dano I aptamer (#8) 
 
 
J6sl aptamer (#3) 
 
Strepto-Tag aptamer (#6) 
 
 
MG-4 aptamer (#9) 
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TMR1 aptamer (#10) 
 
 
TMRV2 aptamer (#13) 
 
 
SRB-2 aptamer (#16) 
 
 
TMR2 aptamer (#11) 
 
 
13.2 aptamer (#14) 
 
 
N40-region (#17) 
 
 
TMRV1 aptamer (#12) 
 
 
Apt-1 aptamer (#15) 
 
 
Aptamer 21 aptamer (#18) 
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thiM riboswitch aptamer domain (#19) 
 
 
mTCT8-4 aptamer (#22) 
 
 
ag.06 aptamer (#20) 
 
 
xpt–pbuX riboswitch aptamer domain 
(#21) 
 
 
Figures 4.1 Secondary structures of all tested aptamers as predicted by Vienna RNAfold 174. All aptamers are numbered 
according to table 4.1. The secondary structure exhibiting the minimum folding energy (MFE) of all energetically possible 
secondary structures was computed and is illustrated. The color code from violet to red represents the increasing probability of 
each nucleotide to be unpaired or paired, respectively. The following aptamers were modified as described. #04: X1sl aptamer: 
the closing stem was truncated by 4 nt. #08: Dano-I aptamer: the minimal motif of 32 nt was selected. #09: MG-4 aptamer: the 
minimal motif was chosen for experiments. #12: TMRV1 aptamer and #13: TMRV2 aptamer: a redesigned version of TMR1 
aptamer to reduce reporter gene depression by the aptamer in absence of the ligand and to allow for ligand-based gene regulation. 
#14: 13.2 aptamer: the minimal motif shown in the supplementary data was chosen for experiments. #16: SRB-2 aptamer: the 
minimal motif was used for experiments. #17: N40 aptamer: the N40 region was isolated as the atrazine-binding domain of a 
larger riboswitch-forming sequence and thus selected for further studies. The N40 sequence is truncated 5’ by 6 nt to yield a 
reasonable stem length. #18: aptamer 21: this aptamer was taken from data given in the supplement material of the original 
publication, because it showed superior binding affinity to the ligand #3 that was also picked from the supplementary data and 
available through custom synthesis. #19: thiM riboswitch: for the experiments only the aptamer domain of the thiM riboswitch 
was cloned. #20: ag.06 aptamer: the published sequence contained two subsequent closing stems. Stem 1 was deleted and 
stem 2 shortened and modified resulting in a 6 nt closing stem. #21: xpt–pbuX riboswitch: only the aptamer domain of the xpt–
pbuX riboswitch was used and cloned. #22: mTCT8-4 aptamer: the published aptamer was taken and the stem modified according 
to another study 125.  
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All aptamer sequences were ordered as forward (fwd) and reverse (rev) primers that were either directly 
hybridized and ligated with pWHE601* using AgeI and NheI restriction sites or amplified in a PCR using 
fwd and rev primer as mutual templates and subsequently prepared for ligation with the same restriction 
enzymes and linearized vector. Vector pWHE601* 192 was modified from pWHE601 that had been 
introduced and employed in previous studies 138,155. Both vectors bear a GFP+ gene expressed from an 
ADH1 promotor, whereas in pWHE601* the start codon was deleted and had thus to be introduced 
alongside the aptamer sequences in the 5’-UTR of the reporter gene. Vector pWHE601 served as a 
positive control and pWHE601* as a negative control.  After cloning and sequencing, yeast strain 
RS453α was transformed with plasmids harboring the new aptamer sequences in the 5’-UTR of the 
GFP+ reporter gene. Cells were cultured in two independent triplicates for 48 h in absence and presence 
of the ligands assigned to each corresponding aptamer (see Table 4.1) and analyzed in bulk by 
fluorescence spectroscopy (Figure 4.3) 138. Yeast cells expressing the neomycin- and tetracycline-
binding aptamers were used as technical controls, whereas yeast transformed with pWHE601 were 
taken as a positive control expressing GFP+ unimpaired by a 5’-riboswitch. In a preliminary experiment 
the positive control was treated separately with all different ligands to determine unspecific effects on 
the fluorescence output (Figure 4.2). Only DIR caused a drop of fluorescence to 50% relative to the 
untreated positive control, but it was not determined, whether this was due to quenching or other 
unspecific side effects. Interestingly, no other red dye was found to quench or otherwise diminish GFP 
fluorescence. 
 
Figure 4.2 Ligand influence on GFP+ expression from pWHE601. Non-specific effects on gene expression were tested by 
supplementation of each ligand to the growth medium of yeast cells bearing pWHE601. GFP+ expression of each culture 
supplemented with a different ligand is presented relative to an untreated culture. The negative control pWHE601* was equally 
treated and used to subtract background fluorescence. Cells were cultured in two independent triplicates for 48h and measured 
in bulk by fluorescence spectroscopy on a Fluorolog instrument after normalization to cell growth and subtraction of fluorescence 
background.  
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The results of the reporter assay divided all aptamers into three groups. Those strongly suppressing 
GFP+ expression in absence of their ligands, those with no effect on translation and those interfering 
moderately with gene expression. Strong suppression, that is, low to very low basal expression was 
observed for J6sl (tobramycin), the Strepto-tag (streptomycin), MG-4 (malachite green), TMR1, TMR2, 
TMRV2 (all tetramethylrhodamine), 13.2 (DMHBI), Apt-1 (DIR), SRB-2 (sulforhodamine B), Aptamer 21 
(HAP), thiM-aptamer (TPP), ag.06 (L-arginine) and xpt-pubX aptamer (guanine). No or only slight 
suppression could be seen for X1sl, D1 (both tobramycin), 8-1-1 (kanamycin B) and Dano-I 
(danofloxacin). TMRV1 (tetramethylrhodamine), N40-region (atrazine) and mTCT8-4 (theophylline) 
repressed gene expression ranging from 50% to 16%. Addition of the assigned ligands resulted in no 
further decrease of gene expression for barely any of the newly introduced aptamer sequences. X1sl 
(tobramycin) and mTCT8-4 (theophylline) conferred slight regulatory activity with switching factors of 
about 1.5-fold and did so with moderate to high basal expression levels. To make use of them as 
riboswitches though, they would need to be extensively improved to reach switching factors greater than 
5-fold.  
In many cases, reduced basal gene expression may be correlated with increasing length and stability of 
the closing stem as predicted by RNAfold (Figure 4.1#6, 14). This was especially pronounced for 
aptamer 13.2 (DMHBI, #14) and the Strepto-tag (streptomycin, #6) that both feature comparably long 
closing stems. Vice versa, the gain of basal expression by a reduction of the closing stem’s length and 
stability was showcased by the transition from the J6sl- to X1sl- and ultimately to the D1-aptamer all 
binding tobramycin as well as the rational truncation of the TMR aptamers (tetramethylrhodamine). Short 
closing stems in combination with more elaborate global architectures found with the SRB-2, N-40 or 
AN32sh aptamers, promote intermediate basal expression profiles. It should be noted, however, that all 
these relations are rather a rule of thumb and may not be applied to all aptamers, especially since their 
tertiary interactions are mostly unknown, but contribute significantly to the final 5’-roadblock opposing 
the scanning movement of the 43S complex and their ability to confer in vivo regulation as will be 
discussed later.   
Almost all ligands were tested at a single concentration with the exception of atrazine and DIR that were 
also supplemented in lower concentrations, at 100 µM and 50 µM, since they had previously been found 
to reduce the growth rate of yeast cells (Table 4.2). The results proved to be no different compared to 
the originally used concentrations (data not shown). The technical controls M4 (neomycin) and AN32sh 
(tetracycline) showed the expected reduction of gene expression, ensuring correct sample processing 
and culturing conditions. The aptamers J6sl and X1sl had been tested by Dr. Julia Weigand in previous 
experiments and the reporter assay was repeated in this study.  
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Figure 4.3 GFP reporter gene assay. The assay results are grouped by substance class of the ligand. A Antibiotics, B dyes and 
C metabolites and other small molecules. GFP+ expression of each culture supplemented with a different ligand is presented 
relative to the positive control supplemented with the same ligand. The negative control pWHE601* was equally treated and used 
to subtract background fluorescence. Cells were cultured in two independent triplicates for 48h and measured in bulk by 
fluorescence spectroscopy on a Fluorolog instrument after normalization to cell growth and subtraction of fluorescence 
background. 
4.1.1.2 In vivo screening for Ciprofloxacin-binding riboswitches 
In a second approach, an in vivo screening for the identification of ciprofloxacin (CFX)-binding 
riboswitches was conducted. As described in chapter 5.1.2.1, RNA aptamer pools from SELEX rounds 
6 (R6) and 9 (R9) were cloned in front of the GFP+ reporter gene using homologous recombination up- 
and downstream of the established AgeI and NheI restriction sites present in pWHE601* 192. Dr. Florian 
Groher designed the initial pool according to Paige et al. 185 and generated the SELEX protocol. The 
SELEX itself was performed by Dr. Cristina Bofill-Bosch. Two separate reactions with respect to the two 
different pools were performed and used to transform yeast strain RS453α.  Cells were spread on agar 
plates that were subsequently assayed for fluorescence phenotypes by fluorescence microscopy. From 
about 1300 picked colonies 57% originated from R6 and 43% from R9. 
 
Figure 4.4 In vivo screening for CFX binding riboswitches. A The 5’-scanning interference constitutes the regulatory 
mechanism deployed for the in vivo screening. Briefly, in absence of CFX the 43S complex in not or partially hindered by the 
aptamer structure. Presence of the ligand stabilizes the aptamer and interferes with ribosomal scanning to a greater extent, 
repressing translation of GFP+. PADH1 and TADH1 drive and terminate transcription, respectively. B The in vitro selection for CFX-
binding RNA sequences yields moderately and highly enriched RNA pools. The pools are inserted upstream of the GFP+ reporter 
gene. Subsequent screening steps in 96-well format in absence and presence of CFX are performed to identify CFX aptamers 
with riboswitching properties that are then further characterized.  
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During the first screening round cells were selected with respect to their basal expression (BE) and 
switching factor (SF). As indicated by the highlighted subset in Figure 4.5A, only cells with a BE greater 
than 5% and SFs greater 1.1 were further processed. It is evident that over 95% of all assayed cells did 
not exhibit a switching behavior, but all levels of basal gene expression could be found, accumulating 
from 10% to 50% with respect to both SELEX rounds (Figure 4.5). The share of relative gene expression 
and switching factors among all different colonies for both SELEX rounds is presented in Figure 4.5B, 
C.  
 
 
Figure 4.5 Results of the first screening round. A shows the distribution of 1300 phenotypes from R6 (red) and R9 (blue) 
previously identified by fluorescence spectroscopy and assayed in 96-well format in absence and presence of 100 µM CFX. All 
phenotypes were classified with respect to basal expression and switching factors. Basal expression was calculated relative to 
GFP fluorescence exhibited by the equally treated positive control. Background fluorescence was subtracted but the fluorescence 
output was not normalized to cell growth. The inset depicts the candidates selected for the next screening round. The boxplots B 
and C illustrate the statistic distribution of all phenotypes identified from R6 (red) and R9 (blue) with respect to basal expression 
(B) and switching factors (C). The whiskers represent the upper and lower 25% of the population, whereas the mean is symbolized 
by a circle and the median by the horizontal line within the box that itself harbors 50% of the population.  
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The data suggested a lower overall BE for R9, but simultaneously higher SFs. This supports the fact 
that less colonies from R9 were identified by fluorescence microscopy compared to R6, because a more 
enriched SELEX pool harbors a higher concentration of aptamers with a presumably stronger structure 
depressing basal gene expression. Furthermore this finding is mirrored by the distribution of the 2% 
sequences sufficing the selection criteria and that were therefore subjected to the next screening round 
(inset Figure 4.5A). The values of these criteria were chosen based on the overall assay results and will 
be discussed later. Before the second screening was conducted, 32 colonies had been spread for single 
clones and thus, 4 clones of each regulatory active colony identified in the first round were analyzed 
(refer to 5.1.2.1 for more details). The results are shown in Figure 4.6. The graph displays 48% of a total 
of 128 screened clones – 52% emitted fluorescence on background level and were discarded. Although 
each four clones were derived from one colony, basal expressions and switching factors may split up 
as is observed for clones 2A, B, C and D or even 6H. Clones 2A-D vary mainly in their basal expression, 
whereas 6H was the only clone from colony 6 that continued to exhibit a switching phenotype. 117 out 
of 128 clones lost this phenotype through the propagation from first to second screening and in total, 4 
out of 32 colonies from the first screening passed the second screening. Again, all clones after the 
singularization and 2nd screening were selected based on basal expression and switching factor levels. 
 
Figure 4.6 Second round of the in vivo screening. The distribution of 61 clones derived from selected candidates from the first 
screening and assayed in 96-well format in absence and presence of 100 µM CFX is shown. All phenotypes were classified with 
respect to basal expression and switching factors. Basal expression was calculated relative to GFP fluorescence exhibited by the 
equally treated positive control. Background fluorescence was subtracted and fluorescence output normalized to cell growth. 
Colored clones were subjected to further processing and analysis specified in Figure 4.7 
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Figure 4.7 Analysis of candidates from the second screening. The GFP reporter assay was conducted after the plasmids had 
been propagated through E.coli and retransformed into yeast. Cells were grown in 1.5 ml cultures in 24-well plates in two 
independent triplicates in absence and presence of 100 µM CFX for 24 h and analyzed in bulk with a Fluorolog instrument. The 
neomycin-sensitive riboswitch M4 and clone 12A were used as controls and treated equally. Relative fluorescence output was 
calculated as described for Figure 4.6. The color code is adopted from Figure 4.6. 
The plasmids of all 11 remaining clones were isolated, propagated through E.coli to ensure single 
plasmid uptake and isolation, and retransformed into yeast cells that were assayed by fluorescence 
spectroscopy on a Fluorolog instrument (Figure 4.7). The M4-aptamer (neomycin) was used as a 
technical control to ensure correct culturing and processing of the cells. Clone 12A contains an aptamer 
sequence unresponsive to CFX, but with a moderate basal expression of 36%. It was chosen here and 
in later experiments to confirm that even very low switching factors of less than 2 imply a CFX-induced 
switching phenotype in this assay. Clones 2A and 2C lost their ability to confer CFX-dependent gene 
downregulation, whereas all other clones kept it, although with diminished basal expression. This 
reduction can be traced back to the altered experimental set up with different culturing conditions, 
background levels and instrumental equipment. The disappearance of switching factors is a common 
phenomenon after propagation of the isolated plasmids through E.coli, underlining the ability of yeast 
cells to take up more than one plasmid.  
All clones were sequenced and interestingly clones 2B, 2D and 4A, B, C, D turned out to harbor the 
same aptamer sequence. Clones 6H, 10A/D and 12A differed in their sequence identity. To confirm the 
phenotypes now measured with the new experimental set up, the analysis for clones 2B, 4C, 6H 10A 
and 12A was repeated and found to match the previous results. The predicted secondary structures of 
the unique sequences 2B, 6H, 10A and 12A are displayed in Figure 4.8. Sequence 2B features a very 
long terminal hairpin with two symmetrical bulges. Sequence 6H adopts a very similar conformation, but 
features two asymmetrical bulges in the terminal hairpin. Both structures share a motif resembling a 
three-way junction. Sequence 10A features again a three-way motif and an internal loop followed by the 
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short terminal hairpin. However, overall base pairing probabilities are very low and the actual 
conformation might be completely different.  
 
Figure 4.8 Secondary structures of the unique sequences 2B, 6H, 10A and 12A as predicted by RNAfold. A 2B, B 6H, C 
10A, D 12A. The displayed sequences contain the flanking primer sites and thus represent the full length construct cloned for the 
in vivo screening. The 5’-end of each sequence is always displayed on the left hand side. Base pairing probabilities are encoded 
by the heat map showing the probability of being paired or unpaired on a scale from 0 (low) to 1 (high).  
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The regulatory inactive sequence 12A assumes a split conformation with respect to the 3’- and 5’-end 
which might explain its conferred phenotype. 
Accounting for the sequence identities, only clones 2B, 6H and 10A were further processed and 
subjected to extensive truncations of the 5’- and 3’-ends. Truncations aimed at the reduction of 
sequence length and thus to shed presumably unnecessary sequence load. Furthermore, functional 
truncations increase the accessibility of a sequence to more intricate modifications towards a better 
performing riboswitch. The ultimate 20 nt of the 5’- and 3’-ends of the randomized inserts containing the 
aptamer sequence are constituted by the primer binding sites used to amplify the pool during SELEX 
and to attach overhangs for the homologous recombination of the aptamer pools with the vector 
pWHE601* in yeast. These sequences are principally dispensable, although they might play a role in 
ligand binding by partially forming the ligand binding pocket. Truncations were performed by the 
successive reduction of 10 nt blocks from the 5’- and 3’ends in 3 steps, yielding nine different 
combinations of truncated sequences – 3 evenly matched cutbacks and 6 with either a 3’- or a 5’- 
unmatched overlap of 10 to 20 nt (Figure 4.9). Thus, truncations (partially) removed the flanking primer 
sites and cut into the randomized region composing the putative riboswitch sequence. 
 
# 3’-end 5’-end 
1 -10 nt -10 nt 
2 -20 nt -20 nt 
3 -30 nt -30 nt 
4 -10 nt -20 nt 
5 -10 nt -30 nt 
6 -20 nt -10 nt 
7 -20 nt -30 nt 
8 -30 nt -10 nt 
9 -30 nt -20 nt 
 
 
 
 
Figure 4.9 GFP reporter assay of truncated sequences from clones 2B, 10A and 6H. A The table shows the conducted 
truncations of the 3’- and 5’ ends that are consecutively numbered and match the numbering of the relative fluorescence output 
plotted in B. Cells were grown in 1.5 ml cultures in 24-well plates in two independent triplicates in absence and presence of 100 
µM CFX for 24 h and analyzed in bulk with a Fluorolog instrument. Basal expression was calculated relative to GFP fluorescence 
exhibited by the equally treated positive control. Background fluorescence was subtracted and fluorescence output normalized to 
cell growth. The neomycin-sensitive riboswitch M4 was used as controls and treated equally. 
After the GFP reporter assay had been performed it became evident that, although truncations resulted 
in greatly varied basal expressions, the switching phenotype had vanished. As truncations had been 
rather extensive, parts of the ligand binding site could have been destroyed. Unfortunately, no 
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information could be deduced on basal expression as a function of the preceding 5’-UTR length or the 
calculated stability of the closing stem, as no correlation between these parameters is apparent.   
In an effort to elicit at least some information from the sequences with regard to the ligand binding core 
and an improvement of the switching profile, clone 10A was further investigated as it exhibits the best 
switching factor of 1.8-fold and forms a defined closing stem. At first, the dose dependence of the 
putative riboswitch on increasing concentrations of CFX was tested to further unravel the riboswitching 
profile of this sequence. Clone 12A was again used as a control to warrant the dose responsiveness of 
clone 10A, since 12A was not expected to confer downregulation of GFP+ in the presence of increasing 
concentrations CFX (Figure 4.10). The experiment verified sequence 10A as a riboswitch sensitive to 
CFX with a half-maximal inhibitory CFX concentration of 50 µM and capable to decrease gene 
expression about 2.3-fold in presence of 500-1000 µM CFX. Even in presence of 1000 µM CFX 
sequence 12A showed no measurably effect on gene expression.  
 
Figure 4.10 Dose-dependence of sequence 10A on c(CFX). The dose-dependency of sequence 10A on increasing 
concentrations of CFX was assessed. Sequence 12A was used as a control. Cells were grown in 1.5 ml cultures in 24-well plates 
in two independent triplicates in absence and presence of increasing concentrations of CFX for 24 h and analyzed in bulk with a 
Fluorolog instrument. Basal expression was calculated relative to GFP fluorescence exhibited by the equally treated positive 
control. Background fluorescence was subtracted and fluorescence output normalized to cell growth. The neomycin-sensitive 
riboswitch M4 was used as a control and treated equally. 
Truncation experiments were focused either on the conservation of the 11 nt closing stem or the 
introduction of low-impact modifications, because it was unknown to what extent the ligand binding site, 
that was thought to reside at the core of the bulged three-way junction, extended into this stem region. 
Constructs 10A(-)10_0 and 10A(-)20_0 were truncated 10 and 20 nt from the 5’-end whereas the 3’-end 
was kept unaltered (Figure 4.11A, B). This way the complete 11 nt closing stem was conserved and 
only the flapping 5’-end reduced. Constructs 10A(-)30_0 and 10A(-)30_4 were cut 30 nt from the 5’-end 
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and the latter additional 4 nt from the 3’-end, resulting in a closing stem of 7 nt with a 4 nt 3’-flap or an 
even hybridization terminus (Figure 4.11C, D). 
 
 
Figure 4.11 Predicted secondary structures of the truncated versions of sequence 10A by Vienna RNAfold. A Construct 
10A(-)10_0, B construct 10A(-)20_0, C construct 10A(-)30_0 and D construct 10A(-)30_4. The 5’-end of each sequence is always 
displayed on the left hand side. Base pairing probabilities are encoded by the heat map showing the probability of being paired or 
unpaired on a scale from 0 (low) to 1 (high).       
The switching phenotype could be maintained for the first three constructs with varying basal 
expressions (Figure 4.12). Although the sequence load was reduced, basal expression was diminished 
by the 10 nt and 20 nt truncations from the 5’-end. Nonetheless, this is in accordance with an enhanced 
probability for closing stem formation by the reduction of the 5’-end that in turn had undergone only weak 
intra-strand interactions before the truncation and thereby lowered the hybridization efficiency of the 
actual closing stem. Only the 30 nt truncation restored or elevated GFP+ expressions relative to 
construct 10A in the absence of CFX. Again, this coincided with a reduced probability for stem formation 
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by a truncation of the closing stem length from 11 to 7 nt. Since the switching phenotype was abrogated 
by only a minor 4 nt truncation of the 3’-end, the closing stem might play a role in the formation of the 
binding pocket. It was not elucidated, whether this was due to the stem structure itself or tertiary 
interactions of the stem with other secondary structures of the three-way junction. Further, the extent to 
which the upstream 5’-UTR affects truncation steps and thus closing stem integrity is unknown. In 
summary, the experiments highlighted the occurrence of an improved switching factor of 2.1-fold found 
for the 20 nt truncation and underline the difficulty of rational design operations without sufficient data 
on the ligand binding site and global folding constraints imposed by up- and downstream framing 
sequences and truncations. 
  
Figure 4.12 Truncation experiments of sequence 10A. A small set of defined truncations of sequence 10A were assessed in 
the GFP+ reporter gene assay. Cells were grown in 1.5 ml cultures in 24-well plates in two independent triplicates in absence and 
presence of 100 µM CFX for 24 h and analyzed in bulk with a Fluorolog instrument. Basal expression was calculated relative to 
GFP fluorescence exhibited by the equally treated positive control. Background fluorescence was subtracted and fluorescence 
output normalized to cell growth. The neomycin-sensitive riboswitch M4 was used as a control and treated equally. 
4.1.2 Discussion 
The eukaryotic translation machinery is controlled by a variety of mechanisms and stimuli. Importantly 
for the in vivo screening system, local mRNA organization, structure and stability play key roles to 
facilitate ribosome assembly and translation initiation. The basic concept of this system is to interfere 
with ribosomal scanning and the initiation of translation at the start codon by inserting a road block in 
the 5’-UTR of the mRNA.  To do so, select aptamers were cloned into the 5’-UTR of the GFP+ reporter 
gene and assayed for their ability to regulate gene expression in a ligand-dependent fashion. Despite a 
few contrary reports, none of the tested aptamers was found to act as a riboswitch in the employed set 
up 136,137. Because it was sought to determine the potential of readily available and fully evolved 
aptamers to act as riboswitches, the experiments were performed in a trial and error style, without a 
detailed adaption of the aptamer sequences to the genetic context. This is in accordance with the two 
previously mentioned publications by Werstuck & Green and Grate & Wilson 136,137. In these studies the 
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authors explored the same putative in vivo property of aptamers and successfully used the MG-4 
aptamer to control the yeast cell cycle. However, only a morphological phenotype was assayed and 
western blotting was performed to support the phenotypic appearance. Basal expression levels were 
not presented, although a 10-fold-change of the Clb2 protein after addition of the MG-analog 
tetramethylrosamine was calculated by chemoluminescence levels after western blotting. These results 
underline the need for uniform reporter assays to directly compare two studies. In this study the MG-4 
aptamer depressed GFP+ expression to 3% leaving only marginal room for a switching activity, even if 
the cognate ligand tetramethylrosamine had been supplied and it is not clear at what expression levels 
the original aptamer-ligand pair operated.  
Instead, it is very likely that a major issue in the generation of 5’-UTR riboswitches was encountered 
here. Originating from presumably maximally enriched SELEX rounds, all aptamers were selected for 
the highest possible affinity towards their cognate ligand. Thus, an aptamer with high affinity for its target 
is very likely strongly pre-structured and may therefore interfere extensively with basal gene expression 
rendering it inactive for transformation into a riboswitch. The link between high affinity and extensive 
pre-structuring is given by the selection pressure inherent to the SELEX approach. Only those aptamers 
may be subjected to the next selection round that could withstand the stringent conditions under which 
selection was performed. This means, the closer the actual folding resembles the perfect folded aptamer 
the higher the affinity for the target. Accordingly, they strongly interfere with gene expression leaving no 
room for a further regulation. On the other hand, aptamers with very little effect on basal gene 
expression, X1sl and D1 (both tobramycin), 8-1-1 (kanamycin B) and Dano-I (danofloxacin),  do not 
necessarily exhibit low affinity towards their ligand, but are rather small or too weakly structured to pose 
an obstacle to the 43S scanning complex. Moreover, most SELEX protocol contain unphysiological 
concentrations of Mg2+, enhancing aptamer-ligand interactions and the overall folding. The dependence 
of the SELEX on the Mg2+ concentration was shown to impact low-affinity binders to a greater extent 
and that high-affinity binders could also be generated with physiological Mg2+ concentrations 193.   
Generally, the ability of an aptamer to either undergo extensive structural rearrangements upon ligand 
binding or to display an ensemble of different ligand-free ground state conformations in thermodynamic 
equilibrium, are prerequisites to confer ligand-dependent regulation of gene expression. One of these 
conformations is then captured by the ligand and stabilized. Several experiments in the past have shown 
that the ligand exclusively binds to an already pre-folded structure, typically energetically disfavored and 
short-lived, inducing only minor conformational rearrangements 160,161,163,164,166. This conformational 
capture mechanism is mandatory for in vivo activity as it allows for the ligand-free ground states to be 
largely unstructured, hence to promote ribosome scanning, and on the other hand to spontaneously 
fluctuate into the folded conformation which is specifically bound and trapped by the ligand, hence to 
prevent ribosome scanning. For the neomycin- dependent aptamer a switching element could be 
identified that destabilizes the ligand-free ground state, weakening the global fold of the riboswitch and 
resulting only in a moderate reduction of basal gene expression 160. In turn, addition of the ligand shifts 
the thermodynamic equilibrium towards the entropically disfavored, folded conformation which is 
captured by the ligand. The complex is stable due to the beneficial release of enthalpic energy 
compensating the entropic penalty. Therefore the neomycin-sensitive riboswitch gains its in vivo activity 
from the fact that the ligand-free conformations are loose and rather unstructured and above all highly 
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populated in comparison to the folded conformation that can only steadily exist when captured by the 
ligand. This ensures relatively high gene expression values without ligand and a decrease of gene 
expression upon ligand addition. 
The in vivo activity of the tetracycline-dependent riboswitch is governed by a transiently folded loose 
tertiary structure with high ligand affinity that is captured by the ligand as well. Since the ligand-free 
conformations fluctuate on biological relevant time- scales and do mostly not exhibit affinity to 
tetracycline, basal gene expression values are greater than 20%. A transiently occurring tertiary 
structure serves as a scaffold for ligand docking, resulting in only minor conformational changes towards 
the ligand-bound conformation that impairs expression from the controlled gene 163,164,166. Although 
some of the aptamers selected for this study exhibit conformational rearrangements from ligand-free to 
ligand-bound state, they did not exhibit a riboswitching phenotype within the 5’-scanning mechanism 
178,184,194.  
Aptamer domains pried off a natural riboswitch might not work, because the natural design requires an 
expression platform that receives the aptamer-mediated signal for a regulatory activity. Recent studies 
have highlighted the feasibility of a substitution of natural aptamers for other natural or synthetic 
aptamers that were known to exhibit a regulatory phenotype. Connected to the expression platform of 
the original aptamer, the regulatory property of the riboswitch as such could be preserved 128,129. 
Additionally, it has been shown in several studies that aptamers derived from natural riboswitches can 
be fused to different expression platforms by an empirically designed communication module 134,143,144. 
The artificial hybrid made from aptamer and mostly a ribozyme displays high regulatory activity in pro- 
and eukaryotic organisms, but operates by a completely different mechanism than the 5’-UTR design. 
Considering both examples, the aptamers are basically suited to be incorporated into engineered 
riboswitches, but needed to be completely re-designed with regard to their structure to function in the 
pursued 5’-UTR design. The mTCT8-4 aptamer binding to theophylline represents such a proven super-
versatile and portable RNA structure that even conferred weak in vivo activity in this study. The aptamer 
itself is SELEX-derived and has, besides other applications, been used in bacteria to control the access 
to the ribosome binding site (RBS) by coupling to a short expression platform 121,125,195. The design 
principal is similar to the 5’-UTR design, but runs in a quite different environment. It was included in this 
study to investigate whether its flexible nature would allow a direct transferability to the 5’-scanning 
mechanism. Much for the same reasons, the aptamer domain N40 of the atrazine-sensing riboswitch 
was chosen. Unfortunately, the publication was retracted shortly after this study had been performed 
and it is unknown, whether the atrazine aptamer domain actually belongs to the group of aptamers with 
a regulatory profile. 
In conclusion, high affinity aptamers from an in vitro selection or isolated from an existing riboswitch, be 
it natural or engineered, might not directly be used as a 5’-UTR riboswitch in yeast. In the light of a 
conformational capture mechanism, any aptamer sought to be used as a 5’-UTR riboswitch must feature 
two or more ligand-free ground states in thermodynamic equilibrium, whereupon the favored 
conformation must be weakly structured to allow for sufficient basal expression. The ligand will then 
selectively trap a more strongly structured conformation and thus gene expression is decreased. The 
greater the difference between the ligand-free and ligand-bound conformations the better the regulatory 
in vivo activity expressed as switching factor. Moreover it has been found that variations of the closing 
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stem were sufficient to adjust basal expression and switching factors 138. Albeit this could suggest the 
adaption of an aptamer’s closing stem as a guideline to transform these RNA structures into 5’-UTR 
riboswitches, modifications of the closing stem are not enough. The strategy to convert an aptamer into 
a riboswitch is governed by trade-offs between the presence of a loosely pre-structured RNA and the 
ability to efficiently fold into a stable global architecture. Hence, it must allow a sufficient sequence space 
to accommodate structural motifs that facilitate an energetic separation of the ligand accessible 
conformation from the ground states, such as the switching motif identified in the neomycin riboswitch 
160,161.  
The in vivo screening for CFX-sensitive riboswitches thus contained two different SELEX pools to suffice 
these criteria. A moderately (R6) and a highly (R9) enriched pool are generally needed, because only 
from a broad spectrum of sequences candidates can be identified that satisfy the selection criteria of 
medium to high basal expression and simultaneously exhibit the conformational space required to 
reduce it. Sequence space itself is a product of the pool diversity which is given by the length of the 
randomized region, but drastically diminished as the enrichment of binding aptamers proceeds 196, and 
the transformation efficiency in yeast. Initially, cells were selected for their GFP fluorescence by 
microscopy to ensure (i) correctly recombined plasmids and (ii) the occurrence of aptamer sequences 
that incorporated no premature out-of-frame start codons and whose global architecture promoted 
scanning of the 43S complex for the original start codon. Aptamer pools enriched over many rounds are 
normally extensively pre-structured and lose their competence to fluctuate between loose and ridged 
conformations eventually resulting in low basal gene expression and no switching activity. With 57% of 
the selected colonies stemming from R6 both SELEX rounds impacted basal expression levels to an 
almost equal extent. Accounting for the results after the first screening, regulatory active colonies 
however, were found to originate rather from R9, as a regulatory activity generally follows lower basal 
expression levels, since they supposedly imply sufficiently pre-structured aptamer sequences. 
The values for basal expression and switching factors were determined based on the overall assay 
results. As such, the thresholds set for both aptamer properties were mainly dictated by the experimental 
set up. Theoretically, the basal expression cannot be smaller than 1, because expression without ligand 
is divided by expression with ligand and the latter is supposed to be reduced. Nonetheless, these values 
are inherently connected to the expression levels of the positive controls and the background. If these 
values are influenced by CFX in the assay and this is not correspondingly mirrored by the aptamer-
containing cells, values lower than 1 may be obtained. In addition, the first screening round was not 
corrected for cell growth, because the original set up required to culture the cells statically. As this was 
seen to have a negative impact on the assay itself, the second screening was performed with cells 
cultured in a platform shaker and expression  levels were corrected for the OD600. The influence of these 
factors was also reflected by the cells transformed with the neomycin riboswitch. Normally exhibiting 
switching factors between 8- and 10-fold, the assay produced factors of only ~3-fold. The lower threshold 
for basal expression was set to 5%. This values still allows to detect a regulatory activity as it was several 
fold higher than background fluorescence.      
After the second screening all plasmids were isolated and propagated through E.coli to ensure that 
yeast cells were only transformed with a single plasmid. The ability of yeast cells to simultaneously 
maintain more than one plasmid may result in the occurrence of two or more different aptamers during 
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homologous recombination and thus corrupting assay results. Therefore some clones lost their 
regulatory phenotype after that “purification” step. Because only one E.coli colony had been processed, 
only one of the possible multiple plasmids was propagated. At this point, aptamers displaying in vivo 
activity might have been lost.  
Truncations of the regulatory active clones 2B, 6H and 10A yielded a variety of different basal 
expressions, but abrogated their switching phenotype completely. Since it is unknown which nucleotides 
form the ligand binding pocket and how secondary and tertiary interactions contribute to the overall 
folding, the extensive truncations performed to remove presumably unnecessary sequence load had 
most probably destroyed crucial interactions conferring regulatory activity. For the same reasons no 
correlation between the stability and length of the closing stems and basal expression levels could be 
deduced. Contrarily, more detailed, low-impact modifications of the aptamer sequence of clone 10A 
allowed such a correlation and a better switching factor could be gained; but, as described above, only 
at the cost of a lower basal expression. Further investigations of that sequence led to the discovery of a 
dose-dependent switching phenotype supporting the identification of a CFX-sensitive riboswitch. 
Although unearthed from 1300 fluorescent colonies, aptamer 10A exhibited only a 2-fold reduction of 
gene expression that is of no use to conditionally control a gene of interest. Foremost, a detailed analysis 
of the ligand binding core would aid to improve the sequence length and enable modifications enlarging 
the “switching window” limited by basal and ligand-repressed gene expression. Recently, such an in 
vivo selection system was established in baker’s yeast 149. Here and in a similar approach, riboswitch 
identification was achieved by applying positive and negative selective pressure to generate a functional 
window in which the riboswitch is supposed to operate 171,197. Such tailored gene expression profiles 
may not only be yielded by selection pressure, but can also be obtained through sole selection from the 
whole population by FACS-based approaches 198.  
The presented in vivo screening system would undoubtedly benefit from the introduction of an automatic 
and unbiased pre-selection to avoid the screening and processing of phenotypes that suffice either only 
the criterion for basal expression or exhibit switching factors that are unfit to be used, because they 
operate in the lower 5%-range of gene expression. 
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4.2 Project II: Tetracycline-Dimers: A massive approach towards the in silico prediction of 
riboswitch performance 
A major milestone in eukaryotic riboswitch design would be the construction and calibration of an in 
silico model from rich in vivo data to assess sequence-structure-activity relationships (SSAR). In this 
study two tetracycline-binding riboswitches were set in tandem to control the expression of a GFP+ 
reporter gene by the 5’-scanning interference to ultimately feed a computational model with the gathered 
in vivo data. It was known from preliminary experiments that variations of the closing stem of the start 
codon proximal riboswitch (3’-Tc) yield a sufficient range of different basal expressions (BE) and 
switching factors (SF) to calibrate the model. A tandem construct was chosen, because in later 
experiments it was also sought to determine the influence of the spacer unit between both riboswitches 
on their SSAR, as a context-dependent performance constitutes another major issue with the application 
of riboswitches. Besides, it was previously demonstrated that Tc-dimers or even trimers dramatically 
enhance the regulatory performance compared to the monomer 168. The model was built and calibrated 
by Sven Jager from the group of Prof. Hamacher. 
4.2.1 Results 
4.2.1.1 Parameter identification for the design of a first set of tandem tc-riboswitches to train 
the model 
The constructed GFP reporter system is depicted in Figure 4.13A. The two tetracycline-binding (tc) 
riboswitches are placed start-codon proximal in the 5’-UTR of the GFP+ reporter gene. Both riboswitches 
are spaced to a total of 27+2 nt including nine CAA-spacer units. The CAA-spacer units generally 
constitute an unstructured insulation module to allow the riboswitches to fold independently. As a starting 
experiment to assess parameters relevant to design a large set of different tandem constructs the 
possible range of BE and SF was probed. While the 5’-Tc was kept constant, the closing stem of the 3’-
Tc was randomly mutated with stem lengths varying between 6 and 11 nt. These eight new constructs 
(GFP15-GFP22) were tested alongside two constructs (GFP3, 7) previously designed by Dr. Julia 
Weigand and Lara Gorini (group of Prof. Suess) in a GFP reporter gene assay. 
Thus, three independent triplicates of yeast cultures each transformed with a single construct were 
cultured in absence and presence of 250 µM tetracycline (tc) for 24h in 24-well pates and their 
fluorescence determined. Vectors pHWE601* and pWHE601 were used as negative and positive 
controls, respectively, and treated equally (Figure 4.13B). As a general rule, longer stems result in lower 
BE and higher SFs. Based on these results lower and upper limits for P1 stem length and free energy 
of the 3’-Tc were determined, since only the closing stem of this riboswitch was to be modified. The 
minimum free energy (MFE) of all 3’-Tcs was calculated by RNAfold 174,175. 
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Figure 4.13 Tc-dimer design and GFP reporter assay. A Tc-dimers were constructed from the tc-binding riboswitch AN32sh 
155, spaced by 29 nt and placed start codon proximal in the 5’-UTR of the GFP+ reporter gene. The closing stem variations of the 
3’-Tc refer to the design of a first set of 96 different 3’-Tcs. Addition of tc represses gene expression as shown in B and according 
to the 5’-scanning interference. Ten different Tc-dimers with respect to the 3’-Tc were assayed for GFP fluorescence. The length 
of the P1 stems is indicated. Yeast cells were transformed with plasmids bearing the different Tc-dimers and cultured in 1.5 ml 
24-well plates in absence and presence of 250 µM tc for 24 h. Expression was measured in bulk normalized to cell growth, 
corrected for background fluorescence and calculated relative to the positive control pWHE601 that was equally treated.  
A first set of 96 different tandem constructs was designed considering the following criteria for the 3’-Tc. 
(i) The stem length should be between 6 nt and 10 nt and (ii) the MFE between -20 and -30 kcal/mol to 
yield fluorescence outputs in the range of ~20% to ~70% BE as observed in Figure 4.13B. Lower or 
higher BEs were disregarded, because this either leads to riboswitches operating at a very low 
expression levels and a further reduction of gene expression is impractical (<20%) or to riboswitches 
that cannot efficiently respond to tc presence as their BE is too high (>60%) to allow the occurrence of 
a sufficiently pre-formed conformation. Additionally, it was deduced from the experiments pictured in 
Figure 4.13B, that MFEs between -20 and -30 kcal/mol would yield functional riboswitches. Ultimately, 
this meant for the design space that five blocks with regard to stem lengths of 6 nt to 10 nt were pre-set 
and the ~20 sequences within each block exhibited MFEs between -20 and -30 kcal/mol. Sequences 
were generated by a randomization algorithm (developed by Sven Jager), trimmed to compute a high 
sequence entropy (nucleotide composition within a given sequence, here the P1 stem) and clustering 
diversity between the five blocks (inter, Levenstein distance) and the within the block (intra, Hemming 
distance). Predicted sequences were then subjected to a folding test, checking for folding constraints of 
the secondary structure of the tandem constructs flanked by 40 nt upstream and 150 nt downstream 
(see example in Figure 4.14).  
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Figure 4.14 Secondary structure of a Tc-dimer flanked by 40 nt 
upstream and 150 nt downstream. The folding algorithm used by 
RNAfold was used to predict this secondary structure. 
 
 
 
 
 
 
 
 
Moreover, only closing stems devoid of the triplet ATG were selected to circumvent issues with pre-
mature translation initiation. Constructs were ordered as two primer sets, one forward and one reverse, 
and PCR amplified from the hybridized core of the 3’-Tc. Fwd and rev primers introduced the restriction 
sites AgeI and NheI that were used to ligate the constructs with vector GFP3 cut with the identical 
enzymes. After passage through E.coli and sequencing, yeast strain RS453α was transformed with 
plasmids bearing a single construct and the negative and positive controls. Cells were cultured as 
indicated for the experiments shown in Figure 4.13B and assayed by flow cytometry, making use of an 
integrated auto sampler. Each construct was analyzed in two independent duplicates and the results 
are shown in Figure 4.15A. 
 
Figure 4.15 Classification of 100 Tc-dimers. A Tc-dimers were classified according to basal expression and switching factors. 
Yeast cells were transformed with plasmids bearing the different Tc-dimers and cultured in 1.5 ml 24-well plates in absence and 
presence of 250 µM tc for 24 h. Expression was measured by flow cytometry and calculated relative to the positive control 
pWHE601 (basal expression). The switching factors were calculated as the ratio of relative gene expression in absence and 
presence of tc. The Experiments were performed in two independent duplicates. B  MFE structure of the best performing riboswitch 
from the first set as calculated by RNAfold. 
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In Figure 4.15A the performance of 100 constructs is plotted according to BE and SF. Values for BE and 
SF range mainly between 20% and 70% (averaging at 34%) and 5-fold to 15-fold (averaging at 6.4-fold), 
respectively. Some constructs display no regulatory phenotype, whereas one construct exhibits a ~23-
fold switching at ~25% BE. This construct is shown in Figure 4.15B. It features a 8 nt closing stem, a 
MFE of -24.4 kcal/mol and a GC content of 75%. The results support the overall design of the first set, 
providing a wide range of BEs and SFs to train the model. Moreover, already before the training with in 
vivo data, the model had predominantly generated sequences sufficing the criterion set for BE levels. 
To assess putative correlations between the SF and the P1 parameters melting temperature (Tm), MFE, 
stem length, GC-content (GC%) and folding time, the parameter values were calculated and plotted 
against the SFs of each construct (Figure 4.16A-E). The structure prediction heuristic employed by 
RNAfold was used to compute the MFE (Figure 4.16C). No correlation was found for stem length, as 
basically all SFs were yielded with all different stem length (Figure 4.16D). The GC-content, contributing 
to stem stability and thus to Tm and MFE, showed a weak correlation to the SF, but a tendency for higher 
GC% to allow a broader range of SFs; also the highest SF of ~23-fold (Figure 4.16A). MFE and Tm, two 
closely related parameters showed the same correlation to SFs as basal expression levels, namely that 
higher SF are obtained with lower MFE and thus lower basal expression. Though the correlation was 
also weak, it confirmed the tendency observed for GC%. The importance of each parameter for 
riboswitch performance is summarized in Figure 4.16E.     
 
Figure 4.16 Influence of various inherent folding parameters on switching factors. The different graphs show the SF plotted 
against the GC% (A), the melting temperature Tm (B), the MFE as computed by RNAfold (C), and the stem length (D). E rates all 
parameters according to their importance for the SF.    
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4.2.1.2 Design of a second set of Tc-dimers 
Considering the low correlation between SF and BE (data not shown) and the calculated parameters, 
the model is not a simple linear equation, but must rather account for all parameters to compute a 
different relationship. A random forest was now trained with the generated in vivo data to compute a 
better connection between all parameters and SF and BE. The random forest describes the analysis of 
many thousands of decision trees interrogating the parameter set and reconciling the parameter values 
with their corresponding BE and SF. In such way the values of all parameters are linked by their mutual 
BE and SF. Essentially, this represents the training of the random forest that was based on the 
empirically in vivo determined dependence of SF and BE on the in silico calculated parameters. The 
random forest was then used to classify random sequences sufficing the criteria of BE > 20% and SF > 
8 and all other criteria proposed for the first data set. To reduce solution space it was important that BEs 
and SFs spanned a wide range of different values. Ultimately, a second set of 96 different 3’-Tcs was 
generated. Only sequences exhibiting predicted BEs > 20% and SFs > 8 were selected, cloned, 
subjected to the described reporter assay and analyzed.  
Figure 4.17 Comparison of 
riboswitch performance as obtained 
by randomized mutagenesis of the 
P1 stem or computed using a 
random forest. Different Tc-dimers 
are plotted with respect to BE and SF. 
Results from the first set generated by 
randomized mutagenesis of the P1 
stem are shown in the upper panel. 
The results from the second set based 
on the trained random forest are 
depicted in the lower panel. 
Experimental procedures and 
calculations were performed as 
described for Figure 4.15. 
 
 
 
 
 
 
Results of the experiments of the second dimer set are displayed in the lower panel of Figure 4.17. 
These results partly mirrored the first data recording, but also showed that the model can reproduce the 
sequence-activity relationships that it had learned from the first recording. Moreover, non-regulating 
sequences were almost completely erased and the abundance of switches with desired switching factors 
increased to a mean SF of 8.3-fold compared to the previously obtained mean SF of 6.4-fold and an 
average BE of 56%. 
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The relationship between BE and SF became now more apparent than in the first set. Higher BEs, due 
to a higher MFE and thus highly destabilized ground states, correlate with lower SFs. Vice versa, high 
SFs are only obtained with BEs < ~30%. In total, the model was able to improve the correlation between 
BE, SF and the parameter set. Unfortunately, there is still a significant abundance of Tc-dimers 
exhibiting forbidden values of BE (> 60%) and SF (< 5-fold), suggesting ample room for a refinement of 
the model. 
4.2.2 Discussion 
The redesign of functional natural or artificial riboswitches towards higher basal gene expression and 
better switching factors still poses a fundamental challenge. Many approaches are based on 
permutation, selection and screening, following base pairing and simple secondary structure folding 
rules and considering structural data from advanced spectroscopy like NMR or fluorescence 
spectroscopy. While these approaches have led to the construction of several riboswitches, the design-
built-test cycle is generally cumbersome and resource-intensive 33,48,77,86. Recently, several rational 
design principles were proposed for the construction of riboswitches in bacteria. Capitalizing on the 
availability of many resources on structure, regulatory mechanisms and advancing computational 
modeling capacities, they demonstrated the applicability of in silico designs for facilitating in vivo activity. 
While the substitution of natural aptamer domains 129,156 or the mutation of natural binding sites 130 to 
generate different ligand specificities are promising approaches to retain existing regulatory activity, two 
other approaches on the de novo construction of transcriptional 83,127 and translational 84 riboswitches 
are similar to the scope of this study. The regulatory mechanism of transcriptional riboswitches was 
thought to rely mostly on kinetic aspects like folding traps of the terminator structure, but it was shown 
that also the stability, a thermodynamic property, of the terminator hairpin inflicted major pressure on its 
performance. Moreover, it was demonstrated that dimers or trimers of the used theophylline riboswitch 
enhanced performance in a linear dose-dependent manner. Before the conduction of the presented 
study, similar behavior had also been reported for dimers and trimers composed of the tc-binding 
riboswitch in yeast 168. In the present study the serial dimer arrangement led again to improved 
regulatory activity as compared to the monomer. Additionally, since the dimer is spaced by a defined 
number of nucleotides, this arrangement also allows the assessment of context dependencies in terms 
of spacer identity in future experiments.    
Returning to the modeling of the transcriptional riboswitches, it was important that the model would also 
consider the inverse folding problem, i.e. that any predicted sequence can adopt the conformation of 
the mutually exclusive structures of terminator or anti-terminator. In the present study BE and SF 
account for the interplay between ON and OFF states. While it was sought to obtain riboswitches with 
loose ligand-free ground states, thus permitting ribosome scanning and represented by a high (> 20%) 
BE, the corresponding SF would reveal whether the ligand-free ground states had also comprised a 
short-lived, entropically unfavored pre-formed conformation that, if bound by tc, would reduce gene 
expression. It was subsequently discovered that BE and SF were antiproportional, i.e. high BEs (rare 
occurrence of pre-formed conformations or weakly pre-structured conformations) incurred lower SFs. 
The sequence exhibiting the best performance after analysis of the first set confirmed this hypothesis 
as it features a low MFE and high GC content for the 3’-Tc. The model was thus trained with the 
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empirically derived in vivo data to discern a possible correlation between BE, SF and several 
thermodynamic and kinetic parameters. After the first set had been analyzed no correlation was evident 
and so the second set was based on model predictions obtained through training and not correlation. In 
part this mirrors the experimental procedure of the transcriptional riboswitch design as it was reported 
that during the in vivo testing optimizations were only possible by rational evaluations of the genetic 
context, information the in silico model had not provided. Besides context, also structure-stabilizing 
effects by ligand binding and the formation of pseudoknots were not computed.  
The development of a statistical thermodynamic model in a recent study predicted the sequence-
structure-function relationship for translation-regulating riboswitches in E. coli 84. The model was built 
under the assumption of thermodynamic equilibrium between the ribosome, mRNA and ligand. 
Additionally, aptamer structure, affinity, mRNA sequence context and macromolecular crowding were 
considered. Interestingly, the model did not compute changes of mRNA stability, although it accounted 
for the switching free energy. The latter is exactly the parameter the SF describes in the present study 
and seems as such suited for model building and training. Sequence context was included as a design 
parameter and was used to test whether it would result in misfolded riboswitches rather than whether it 
would exhibit performance constraints. The influence of ribosome binding energetics on riboswitch 
performance with respect to ligand-free and ligand-bound conformers was not regarded. As the 5’-
scanning mechanism relies crucially on mRNA-ribosome interactions, such parameters should be 
incorporated into the model.  
Co-transcriptional folding seems to be another parameter that could improve in silico modeling of 
translational riboswitches. As a kinetic parameter it was thought to dominate the regulatory mechanism 
of transcriptional riboswitches. Both studies on tc riboswitches in yeast 139 and the discussed design of 
translational riboswitches in E. coli 84 have found a higher regulatory activity when the ligand was 
supplied before or co-transcriptionally compared to after transcription had been induced. 
Supplementation before transcription yielded the highest activity. This may be explained by the 
occupancy of the mRNA with translating ribosomes, which is especially pronounced in bacteria, as 
translation itself occurs co-transcriptionally. Once subjected to the translation machinery, the 
spatiotemporal chances of structural rearrangements are distinctly limited, compromising the regulatory 
activity. If included in the model, these data could set boundaries to riboswitch performance, an upper 
threshold of efficiency that cannot be overcome due to factors extrinsic to the SSAR. 
Other limitations could be inherent to the system, such as whether high BE and high SF could ever be 
reached. At the moment the model is trained and can compute a classification with respect to both 
parameters. More data could result in a regression, e.g. by regression trees obtained by machine 
learning, yielding explicit BEs and SFs and the model could then be used to simulate the maximum in 
vivo accessible performance space. Another drawback is the current inability to sufficiently consider 
pseudoknots due to limitations of the computing time and insufficient validation of the developed 
algorithms. This is especially important in the case of the tc riboswitch that displays an H-type 
pseudoknot-like tertiary interaction between the interhelical junction of J1-2 and the loop L3 (see Figure 
2.11).   
Turning towards benefits, the developed method exhibits high portability to other biological systems. 
This feature can be attributed to the universal approach itself. First, some element, motif or sequence 
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must be identified that is susceptible to randomization for machine learning. Next, rationales must be 
inferred from preliminary experiments, pointing towards logic, outer boundaries of the randomization 
and to confirm a direct dependence of the sought re-design on the investigated parameters. Then the 
generated data is subjected to train a random forest and improve the model. The model is subsequently 
used to classify random motifs, elements or sequences according the desired solution space. At last, 
another data set is generated and the first feedback loop closed. The more iterative cycles are performed 
the more accurate the model will evolve and may eventually even be calibrated on rich in vivo data to 
correctly compute output parameter.  
4.3 Project III: ROC’n’Ribo: Characterizing a riboswitching expression system by modeling 
single-cell data 
4.3.1 Results 
RNA-engineered systems offer simple and versatile control over gene expression in many organisms. 
In particular, the design and implementation of riboswitches presents a unique opportunity to manipulate 
any reporter device in cis, executing tight temporal and spatial control at low metabolic costs. Assembled 
to higher order genetic circuits, such riboswitch-regulated devices may efficiently process logical 
operations. The following study presents an approach that facilitates the comprehensive single-cell 
characterization of a novel RNA-controlled devices constructed from the neomycin- and tetracycline-
sensitive riboswitches and implemented in S. cerevisiae. By coupling two synthetic riboswitches that 
both block translation initiation by the same mechanism, representing a NOR operation, it was initially 
sought to improve the dynamic range between ON and OFF state of reporter gene expression (Figure 
4.18). With its orthogonal ligands however, the devices could also realize single-input NOT operations. 
After a preliminary fluorescent reporter assay to assess the general gate performance, one gate was 
subjected to more extensive analyses (Figures 4.18B and 4.19). 
4.3.1.1 Construction of repressor gates operating by NOT and NOR logic 
Initially, tandem devices composed of the neomycin- (aptamer M4)138 and tetracycline- (aptamer cb32-
ANsh)155 binding riboswitches were constructed and inserted in the 5’-UTR of the GFP+ reporter gene 
expressed from pWHE601* by the ADH1 promoter and terminator (Figure 4.18A) 199. The resulting 
dimers capable to transduce only NOT logic are represented by two copies of the M4 (termed NeoNeo) 
or AN32sh riboswitch (TcTc), respectively (devices not shown). The two NOR gates, 5’-NeoTc and 5’-
TcNeo may either be operated with both ligands (NOR gate) or with a single ligand, then constituting 
NOT gates. The two riboswitches were separated by multiple CAAA-spacer units to minimize global 
folding constraints between the two RNA architectures 192. This strategy has also been used in other 
studies, since CAA(A) repeats do not form any secondary structures and may thus be seen solely as an 
insulation module. As both riboswitches operate by the conformational capture mechanism, it is crucial 
for their functionality to facilitate free fluctuations between their ground-state conformations 200. To 
assess gate functionality in absence and presence of the repressors fluorescence of the S. cerevisiae 
strain RS453α transformed with the reporter devices was recorded in a standard bulk measurement 
after 24 h (Figure 4.18B and 4.19).  
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Figure 4.18 Overview of the NOR gate design and its regulatory activity. A gates were constructed from the neomycin-binding 
riboswitch M4 and the tetracycline-binding riboswitch AN32sh. Both riboswitches are spaced by 29 nt and placed start codon 
proximal in the 5’-UTR of the GFP+ reporter gene. PADH1 and TADH1  are used for transcription and a proposed yeast Kozak 
sequence (A at -3 and G at +4 relative to the translation start site) marks translation initiation 201,202. Motifs involved in the formation 
of the ligand binding pocket are highlighted in color and nucleotides involved in ligand binding or binding site formation are boxed 
in the 2D structure or specified in the 3D structure (compare Figures 2.10 and 2.11). Adopted from 203 and further modified. B 
Addition of either ligand leads to a decrease of gene expression due to an interference with 43S ribosomal scanning. Logic 
operations are illustrated by a scheme of the constructed gate. A single-input corresponds to a NOT logic that can be expanded 
to a NOR logic upon addition of the orthogonal ligand. Cells transformed with the gate were cultured in the absence and presence 
of neomycin and/or tetracycline and analyzed by fluorescence spectrometry in a bulk measurement after 24 h. Output fluorescence 
was normalized to cell growth, background corrected and is displayed relative to a positive control that is not riboswitch-controlled 
but otherwise treated equally. Experiments were performed in three independent triplicates and repeated twice. 
The performance of a single riboswitch was enhanced by adding the same riboswitch in tandem. The 
Neo-riboswitch left 60% basal expression that was depressed to 10% by the addition of neomycin, 
whereas the 5’-NeoNeo device operated on 30% basal expression and exhibited an enhanced switching 
factor of 9-fold. Similar results were found for the tetracycline devices. Again, two copies of the riboswitch 
increased switching ratios from 5-fold to 10-fold, but almost at the same basal expression level of 55% 
as compared to the single copy with 50%. 
Coupling of the orthogonal riboswitch to either of the single copies resulted in two distinctly different 
outcomes. The 5’-TcNeo gate was sensitive to tetracycline, reducing basal expression from 55% to 5%, 
but showed no response to the addition of neomycin. Additionally, the effect on gene expression exerted 
by both ligands was reduced to a 7-fold switching as compared to tetracycline alone with 11-fold.  
The 5’-Neo-Tc gate showed sensitivity to both ligands when administered singularly, in which addition 
of neomycin and tetracycline decreased gene expression 5-fold and 3-fold, respectively. 
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Supplementation of both ligands resulted in a concerted response with a switching factor of 18-fold. 
Moreover, this gate displayed a dose-dependent reduction of its switching behavior on decreasing 
repressor concentrations. On a first level, the device could thus be used to only moderately inhibit gene 
expression, whereas its application as a NOR gate led to a multiplied decrease of residual reporter 
expression to about 2%, yielding an increased level of regulation. 
From these data it can be concluded that the 5’-riboswitch contributes more to the switching efficiency 
than its 3’- orthogonal counterpart. This supports the mechanism of gene regulation pursued here – 
inhibition of ribosome scanning in 3’-direction. Whether neomycin or tetracycline constitutes the stronger 
repressor cannot be determined as the single riboswitches perform comparably. In addition, a NOR 
operation might only be achieved using the 5’-NeoTc gate, as the inverse version 5’-TcNeo showed no 
regulation at the addition of neomycin. Especially the switching profile of the 5’-TcNeo gate hints at 
structural interferences between the two parts that have not been resolved yet. 
Figure 4.19 GFP reporter assay of all 
constructed gates. To assess the effect of different 
combinations of the Neo and Tc riboswitches the 
depicted variants were analyzed by fluorescence 
spectroscopy in a bulk measurement after 24 h. 
Cells were cultured in the absence and presence of 
neomycin (neo) and/or tetracycline (tc) at the 
indicated concentrations. Output fluorescence was 
corrected for background fluorescence, normalized 
to cell growth and is displayed relative to the positive 
control that is not riboswitch-controlled but otherwise 
treated equally. SFs are indicated. A dose 
dependence experiment was performed with the 5’-
NeoTc riboswitch, investigating the dependence of 
switching efficiency on ligand concentration. 
Experiments were performed in triplicates of at least 
two independent biological samples. 
Accounting for its sequential switching phenotype processing a NOR operation efficiently, the 5’NeoTc 
gate was further characterized at the single-cell level. To determine the phenotypic distribution with 
respect to the fluorescence output, flow cytometry experiments with steady-state cultures were 
conducted (Figure 4.20). Population analysis of the constitutively expressed 5’-NeoTc gate highlighted 
the broad phenotype arising in the fluorescence profile of cells harboring 2µ-replicated plasmids. 
Extraction of the mean fluorescence values allowed rebuilding the previously calculated basal 
expression and switching factors (compare Figure 4.18B).  
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Figure 4.20 Single-cell analysis of the constitutively expressed 5’-NeoTc gate. The histogram shows the normalized 
abundance of each GFP fluorescence level for the unrepressed and repressed populations of the 5’-NeoTc gate analyzed by flow 
cytometry after 24 h. 10,000 events were recorded per population. The x-axis is plotted biexponentially. The different repressed 
states are indicated by color: unrepressed (lime green), repressed by neo (blue), tc (orange), neo and tc (black).  The presented 
data is an average replicate of at least three independent replicates. Samples were prepared as described in Figure 4.19.  
Besides the high cell-to-cell variability conferred by 2µ plasmids, they impose an increased metabolic 
burden on the host cell, especially when equipped with strong promoters that drive the overexpression 
of reporter genes 44,204. Genetic circuits of any complexity constructed from several 2µ plasmids will 
therefore exhibit severe noise propagation and ultimately broad distributions of phenotypes, rendering 
performance on the single-cell level rather poor 205. In concert with bulk measurements at the steady 
state level from outgrown cultures of the constitutively expressed GFP+, the expression system as a 
whole was not suited to assess the transient dynamics of the 5’NeoTc device and to facilitate an 
increased functionality at the single-cell level. 
4.3.1.2 Introduction of the GEV system for inducible transcriptional regulation 
The expression system was prepared for kinetic analysis by adopting the GEV system developed for 
rapid, tunable and single-gene specific conditional gene expression in yeast 206. GEV is a chimeric 
transcription factor composed of a VP16 transcription activation domain, a Gal4 DNA binding site and, 
most importantly, a ß-estradiol-receptive domain. The transcription factor itself is constitutively 
expressed from an ARS/CEN plasmid using the TEF1 promoter and CYC1 terminator. Additionally, the 
RFP derivative mCherry is C-terminally coupled. Transcription of PGAL1-controlled genes is switched on 
by supplementation of nanomolar concentrations of β-estradiol (βE). A scheme of the complete inducible 
system encoded on two different plasmids is illustrated in Figure 4.21.  
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Figure 4.21 Scheme of the inducible expression system. A The GEV transcription factor is composed of a Gal4 DNA-binding 
domain, the human estrogen receptor and a transcription activation domain VP16. In absence of ß-estradiol GEV is bound to 
HSP90 in the cytoplasm. The presence of ß-estradiol activates GEV and a GEV-dimer locates into the nucleus and induces gene 
expression of the GAL family. Adopted from 206. B The complete system is encoded on two plasmids. GEV is C-terminally coupled 
to mCherry and its expression is driven by the constitutive TEF1 promoter. Supplementation with ß-estradiol activates GEV and 
induces transcription of the 5’-NeoTc gate controlling GFP+ expression. Different Boolean states can be realized by repressor 
addition.  
The promoter of the original plasmid containing the 5’NeoTc device was substituted for PGAL1 to 
introduce the binding site for GEV, resulting in an extension of the 5’-UTR from 43 nt to 75 nt upstream 
of the beginning of the 5’-NeoTc gate (compare Figure 4.18A). The positive control pWHE601 was 
modified accordingly (pWHE601-PGAL1). In a first test, it was sought to measure the induction rate 
alongside the OD600 to determine cellular growth. Cellular growth was measured, because it was known 
from the original and further studies that GEV expression driven by a strong promoter like PTEF1 would 
reduce cell growth in presence of βE due to off-target gene activation or repression 206,207. Hence, a 
titration experiment was conducted to check the influence of increasing concentrations of ß-estradiol on 
the growth rate. In a parallel approach, PTEF1 was replaced by the weak PSTE5 to verify that a decreased 
expression rate of GEV would leave cell growth undisturbed in presence of βE. Fluorescence and OD600 
of yeast cells transformed with pWHE601- PGAL1 and either the GEV-PSTE5 or GEV-PTEF1 plasmid in 
absence and presence of increasing concentrations of βE were recorded after 24 h. Figure 4.22 
highlights the defective growth of yeast cells in presence of βE at concentrations greater than 10 nM, if 
GEV expression was driven by PTEF1. PSTE5 -driven expression of GEV had no impact on cellular growth 
at any of the tested concentrations of βE, but the maximum fluorescence values reached at each titrated 
concentration were generally shifted to higher concentration for the PSTE5 system. The PTEF1 system is 
thus more sensitive to lower concentrations of βE. On the downside, owing to the comparably high 
fluorescence of uninduced cells, the PTEF1 system exhibits much lower induction efficiencies of 28-fold 
to 35-fold-fold as compared to the over 200-fold in the PSTE5 -based system at 100 and 500 nM βE. To 
circumvent any adverse effects on cell growth and accounting for its superior induction efficiency, the 
PSTE5 system was selected to conduct further analyses. 
 Results & Discussion 
67 
 
 
Figure 4.22 Induction test of the positive control. Yeast cells transformed with plasmids expressing GEV by either STE5 or 
TEF1 promoter and pWHE601 were cultured in absence or presence of increasing concentrations of βE for 24 h and assayed in 
bulk for GFP fluorescence output and cell growth. Fluorescence output was normalized to cell growth, corrected for background 
fluorescence and is plotted in counts per second as computed by the software of the Fluorolog instrument. Optical density was 
determined at 600 nm using diluted samples.  
In a subsequent GFP+ reporter gene assay the 5’-NeoTc gate was tested as part of the now inducible 
expression system. Alongside PSTE5 -driven GEV expression another supposedly weak promoter, PMRP7, 
was assayed for its aptitude to serve as an alternative promoter. PMRP7 had been used previously in a 
similar approach to circumvent the growth deficiencies imposed by PTEF1 and was found to exhibit very 
low leakiness in absence of βE, but to provide ample expression to reach high induction in presence of 
βE 207.  Figure 4.23A shows the relative fluorescence output of the 5’-NeoTc gate in absence and 
presence of the repressors neomycin and tetracycline as compared to GFP+ expression from pWHE601 
(positive control), induced by 500 nM βE in concert with either PSTE5 -GEV or pMRP7-GEV. Fluorescence 
data obtained from bulk measurements was recorded after 24h from outgrown cultures. Both expression 
systems operated equally with respect to basal gene expressions of 20% and switching factors exerted 
by the 5’NeoTc gate. Additionally, expression levels in absence of the repressors were in the same 
range as provided by the constitutively expressed 5’-NeoTc gate. Repression by neomycin alone and 
both ligands was more pronounced for the inducible system with switching factors of ~12- fold and ~50-
fold, respectively. The tetracycline induced repression is found at the same level with a ~3-fold off-
switching in both, the constitutively and induced set up. Noteworthy, the expression of the 5’-NeoTc 
gate, if induced by PSTE5 -GEV, was basically zero after addition of both repressors and thus, no 
reasonable switching factor could be calculated. Such differences in the calculated switching factors 
were a result of the underlying background levels. The higher the background that was subtracted, the 
greater its influence on low (repressed) expression levels. Here, the inducible system exhibited higher 
background fluorescence compared to the previous constitutively expressed system driven by PADH1. 
The background was constituted by the negative control pWHE601* that features GFP+, but no stat 
codon and no 5’-riboswitch.  
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Figure 4.23 GFP reporter assay of the 5’-NeoTc gate and induction test of the 5’-NeoTc gate and pWHE601. A Yeast cells 
transformed with plasmids expressing GEV by either STE5 or MRP7 promoter and the 5’-NeoTc gate were cultured in absence 
or presence of indicated repressor concentrations and induced by 500 nM βE for 24 h and assayed in bulk for GFP fluorescence 
output. Fluorescence output was normalized to cell growth, corrected for background fluorescence and is plotted relative to 
pWHE601. B the induction of pWHE601 and the 5’-NeoTc gate by variable GEV levels was tested. Induction factors were 
calculated from cultures used in A. A and B share the same legend. Experiments were performed in two independent triplicates. 
Figure 4.23B emphasizes the influence of both promoters, PSTE5 and PMRP7, on the induction efficiency 
of the 5’-NeoTc gate and pWHE601. The absolute fluorescence output was normalized to cell growth 
and corrected for background fluorescence with and without βE to clearly discern the differences 
between the two promoters. The PSTE5 -driven system provides 3- to 4-fold higher GFP+ expression 
levels for pWHE601 (180-fold) and for the 5’-NeoTc gate (240-fold). Residual fluorescence measured 
for all uninduced cells containing pWHE601 is less than 1% relative to the induced state, whereas it is 
even further reduced for the 5’-NeoTc gate owing to generally decreased basal expressions in presence 
of a 5’-riboswitch. In this direct comparison to an already tested promoter, the PSTE5 performed even 
better and confirmed the previous results. 
4.3.1.3 Genomic integrations 
After the successful adoption of the GEV system, the 5’-NeoTc gate as well as positive and negative 
controls were integrated into the ade2 locus situated on yeast chromosome XV. A genomic integration 
was thought to reduce phenotypic heterogeneity and by that to improve the switching performance with 
respect to a better separation of the individual (un)repressed populations. The CRISPRS/Cas9-based 
system CASEMBLR was employed to facilitate genomic integration 45. This system allows for the 
marker-free integration of any insert DNA into a locus of choice and is highly effective. The only 
constraint is posed by the design of the small gRNA targeting the locus of choice, as it must meet the 
criteria necessary for target DNA recognition and processing by the Cas9 endonuclease. Most 
importantly the target site must be unique to the yeast genome to avoid off-target integrations or DNA 
damage leading to genome instability. In this study all integration sites were selected based on already 
tried and verified target loci 45. The 5’-NeoTc gate was amplified from its plasmid backbone pWHE601* 
as a single integration cassette of ~1700 nt flanked up- and downstream by 100 nt DNA stretches 
homologous to the ade2 locus as pictured in Figure 6.12. Thus, yeast strain RS453α was transformed 
with the linear dsDNA integration cassette and plasmids encoding Cas9 endonuclease and the gRNA 
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targeting the Ade2 locus. Correct integrations were identified by yeast colony PCR or a PCR on 
previously isolated genomic DNA from various colonies. Once the phenotype had been confirmed in a 
preliminary reporter gene assay, integrations were verified by sequencing of the integration cassette 
and the up- and downstream flanking regions.  
The single-cell analysis was initially performed by flow cytometry. Yeast cells containing a 
chromosomally integrated 5’-NeoTc gate were transformed with the GEV-PSTE5 plasmid and 
subsequently cultured for 24 h in absence and presence of 500 nM βE and the repressors to perform a 
steady state measurement from an outgrown culture providing first insights into the phenotypic 
distribution. Figure 4.24 shows the GFP fluorescence of gated (see chapter 5.1.2.2.4 for gating protocol) 
populations in an overlay histogram. Plots were normalized to unit area displaying event counts for each 
fluorescence value (channel) relative to all events within the gate, allowing for a direct comparison of all 
histograms. Additionally, fluorescence channels were plotted biexponentially, revealing events beyond 
zero and hence avoiding a cut-off at zero. Besides, low fluorescent values are highly compressed on 
the “linear” log-scale, facilitating a compact presentation without long leads or tails for populations 
between 0 and 1000.   
   
Figure 4.24 Single-cell analysis of the inducible 5’-NeoTc gate. The histogram shows the normalized abundance of each GFP 
fluorescence level for the unrepressed and repressed populations of the 5’-NeoTc gate analyzed by flow cytometry. 10,000 events 
were recorded per population that was sampled from cultures grown in 24-well plates for 24 h in absence and presence of indicated 
repressor concentrations and 500nM βE. The x-axis is plotted biexponentially. The presented data is an average replicate of at 
least three independent replicates. Extracted mean fluorescence values from the histograms are shown in the column plot. The 
switching factors are given in x-fold for each repressor. Fluorescence was calculated relative to the positive control pWHE601 that 
was also analyzed by flow cytometry. 
Uninduced cells and induced cells expressing the 5’-NeoTc gate are shaded light grey and lime green, 
respectively, and mark the range of 120-fold induction of GFP+ expression that may be reached with 
this inducible expression system. Notably, populations of fully induced (lime green) and fully repressed 
(black) cells are completely baseline-separated, demonstrating an efficient processing of the NOR 
operation at the single-cell level. The neomycin repressed population (light blue) overlaps slightly with 
the fully induced, whereas, reflecting its poor switching factor, the tetracycline repressed population 
(orange) superimposes the fully induced population to a larger extent. Thus, switching factors and 
phenotypic distributions are major parameters contributing to the correct and efficient functionality of the 
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5’-NeoTc gate at the single-cell level. Expression of GEV was monitored by mCherry fluorescence and 
found to exhibit the same level and phenotypic distribution among all investigated conditions and 
populations. 
Figure 4.24 shows also the extracted mean fluorescence values plotted relative to the chromosomally 
integrated positive control pHWE601. With 76%, basal expression far exceeded that displayed by the 
plasmid-borne system. Surprisingly, switching factors were comparable across substantially unlike 
expression systems (plasmid-borne and chromosomal expression of the NOR gate) and experimental 
set ups (fluorescence spectroscopy from bulk and flow cytometry), mainly owing to different background 
levels and basal expressions. A bulk measurement of the integrated 5’-NeoTc gate confirmed that the 
major difference observed with respect to basal expression and switching factors was due to the 
reduction of gene copy number by genomic integration, since the bulk measurement recorded on a 
Fluorolog instrument mirrored the results obtained by flow cytometry.  
Now, that the performance of the inducible 5’-NeoTc gate had been improved at the single-cell level by 
a reduction of its gene copy number, the transient dynamics of the fluorescence phenotypes after 
induction and repression were sought to be assessed. As a start, exponentially growing yeast cells 
bearing the integrated 5’-NeoTc gate and the GEV-PSTE5 plasmid were repressed at different time points 
(-1h, 0h, +1h, +2h) relative to the addition of 500 nM βE to measure whether the timing of repression 
had any influence on gate performance. Samples were drawn during a time course of 7 h after induction 
and analyzed by flow cytometry. The analysis revealed that the transient induction driven by PSTE5 
exhibited only a 3-fold increase of fluorescence after 2 h that was far too low to clearly discern induced 
from uninduced populations. The plasmid-borne expression of the 5’-NeoTc gate yielded a 10-fold 
induction of GFP+ expression after 2h, suggesting that higher copy numbers of GFP+ could partially 
compensate very low GEV availability. To overcome this problem, the PTEF1-driven expression of GEV 
was considered and evaluated again. It was hypothesized that with such a strong promoter and a GEV 
activation by 10 nM βE being sufficient to reach maximum expression levels and avoid impaired cell 
growth, the transient characterization of the integrated 5’-NeoTc gate would be feasible, because very 
high levels of GEV would overcompensate the occurrence of only a single GFP+ copy due to a 
permanent occupancy of the PGAL1. 
4.3.1.4 Transient characterization of the 5’-NeoTc gate 
Yeast cells bearing the integrated 5’-NeoTc gate were transformed with the GEV-PTEF1 plasmid and 
processed as described for the abandoned GEV-PSTE5 approach. Figure 4.25A-D show the mean 
fluorescence of samples drawn over 7 h of continuous culturing induced by 10 nM βE, supplemented 
with neomycin and/or tetracycline and measured by flow cytometry. Onset of GFP expression was fast 
enough to clearly discern induced cells from uninduced cells after 1 h by an 8-fold increase of the mean 
fluorescence value (Figure 4.25A, 4A). By 2 h, the induced populations shifted to a near complete 
baseline separation from background fluorescence (13-fold induction) and showed an almost linear 
increase of fluorescence over the time course of the experiment (Figure 4.25A). The device featured a 
high repression efficiency for the dual-input, as indicated by the -1 h and 0 h experiments, where only a 
2-fold increase of the mean fluorescence over background level was observed for 7 h. Importantly, onset 
kinetics of the repression cascade triggered by ligand addition showed an immediate effect on gene 
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expression within the first hour after ligand addition, irrespective of the time point after induction (Figure 
4.25D). Thus, the device processed a NOR operation within a short time scale, enabling low-delay 
repressive operations for genetic circuit design. 
 
Figure 4.25 Gate characterization on the single cell level. A-D Fluorescence means over time for unrepressed cells A and cell 
repressed with 100 M neomycin B, 250 M tetracycline C and both ligands D. E-H show the corresponding coefficients of variation 
(CV) summarizing the width of the cell population. Trajectories are color-coded to show different times of repression; 1 h of 
repression before induction (red), simultaneous repression and induction (dark blue), repression after 1 h of induction (yellow) and 
repression after 2 h (light blue). 10 nM ß-estradiol were used for all experiments. Samples were drawn every hour for 7 h from 
cultures grown in 12-well plates. Data was averaged over three technical replicates as indicated by the error bars and is 
representative for three independent replicates. Fluorescence background was not subtracted. 
The single-input data suggests different repression kinetics for the neomycin- and tetracycline-inputs, 
respectively (Figures 4.25B, C). The device exhibited a progressive decrease of repression efficiency 
for the tetracycline-input, reflecting a fast onset followed by a gradual reduction of repression with 
advancing induction (Figure 4.25C). The differences in the onset of repression for both ligands are best 
seen by comparing the slopes of the graph between 1 h and 2 h for the +1 h experiments and between 
2 h and 3 h for the +2 h experiments. For the single-input these slopes are parallel with respect to the 
different time points of repression. This is also observed for the dual-input experiments and hints towards 
a timing-independent application of the device as stated above (Figures 4.25B-D). The comparison of 
these slopes for the two single-inputs reveals the 4-fold faster onset that was achieved with tetracycline. 
Interestingly, the onsets (slopes) of the +1 h and +2 h experiments were very similar for the tetracycline-
input (750 arbitrary units/h (arb. units/h)) and the dual-input (800 arb. units/h). This points towards a 
predominant role of the tetracycline-sensitive riboswitch in the fast repression kinetics of the NOR gate 
that were complemented by the more efficient repression by neomycin in the long run (see Figure 12 for 
comparison). Figures 4.25E to H show the coefficients of variation (CV) for all experimental setups to 
account for cell-to-cell variability. Although the CVs changed overall less than 2-fold, the CVs decrease 
upon induction indicates a stabilizing effect on phenotypic heterogeneity. This effect correlates mainly 
with the disappearance of all background fluorescence that could be traced back to autofluorescence of 
the cells and ß-estradiol independent GEV activity broadening the phenotypic distribution of uninduced 
cells, but vanishing upon induction among all other induced cells, ultimately reducing the CV.  
In Figure 4.26A the population dynamics exemplified by the dual-input repression for the +2 h 
experiment are illustrated. In accordance to the CV analysis, cell-to-cell variability was reduced by 
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induction, turning cells towards an ON-state at varying time scales reflected in a smooth population shift. 
Repression at +2 h caused the population shift to halt as further translation was blocked efficiently by 
the 5’-NeoTc gate. Although flow cytometry is a powerful technique to analyze a bulk culture at the 
single-cell level, it does not allow a single cell to be tracked over time to determine the characteristics of 
a transient response on the single-cell level. To link the snapshot data of a population recorded by flow 
cytometry to its single-cell transient dynamics the 5’-NeoTc gate was analyzed in a +2 h experiment on 
a microfluidic chip by time-lapse fluorescence microscopy by Jascha Diemer (Prof. Koeppl) (Figure 
4.26B).  
 
Figure 4.26 Qualitative population dynamics of the 5’-NeoTc gate. A Histogram of time-lapse cytometry data from a +2 h 
experiment. Uninduced cells (black) show a broader distribution than cells induced at 0 h (green) and cells induced at 0 h and 
repressed at +2 h (gray). B The picture series shows a representative cell trapped on the microfluidic chip and recorded over time 
by fluorescence microscopy. Scale bar 5 µm. C Density plots of segmented single-cell traces. Random examples for individual 
traces are highlighted in orange. Induction with 10 nM ß-estradiol, repression with 100 µM neomycin and/or 250 µM tetracycline. 
Color becomes darker the more cell traces approaching the median. For cytometry samples were drawn every hour for 7 h from 
cultures grown in 12-well plates. Plotted data are representative for at least three independent replicates. From the same inoculum 
cells were taken to conduct microfluidic measurements and analyzed data is representative for at least three independent 
replicates. Fluorescence background was not subtracted in both experimental setups. 
Single cells harvested from an actively growing culture were trapped on the chip, cultured in presence 
of 10 nM βE and the repressors (100 µM neomycin and/or 250 µM tetracycline) and their emitted 
fluorescence was recorded every 0.2 h for 6 h. In addition to the density profile, single-cell traces were 
randomly picked to demonstrate their coherently developing phenotypes over time (Fig. 4.26C). That is, 
a highly expressing cell emits a stronger fluorescence signal after several hours of repression than a 
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lowly expressing cell, thus their dynamic fluorescent phenotypes develop coherently. In total, the live-
cell imaging data provided further backing for the considered time-lapse flow cytometry dataset.  
Having identified that the repression kinetics and efficiencies are independent of the preceding induction 
period, gate performance at different induction levels was assessed and its dose dependence on 
different repressor concentrations determined (Figure 4.27). Exponentially growing yeast cultures were 
sampled at indicated time points (dots), whereas an in silico model calibrated on these data by Leo 
Bronstein (Prof. Koeppl) reproduced the full time-resolved response of the 5’-NeoTc device (lines). 
Induction with progressively increasing levels of ß-estradiol led to a proportional increase of the GFP 
signal. All concentrations of neomycin and tetracycline were titrated in preliminary experiments to 
determine the optimal concentrations for model calibration. The two highest concentrations of neomycin 
(50µM and 100 µM) and tetracycline (50 µM and 250 µM) were used to determine the saturation level 
of full repression.  
 
Figure 4.27 Matrix of dose-response profiles at varying induction levels. NeoTc gate induced with A 2.5 nM ß-estradiol, B 5 
nM ß-estradiol and C 10 nM ß-estradiol and repressed with indicated ligand concentrations after 2 h induction. Fluorescence 
output was recorded by flow cytometry. Mean fluorescence values (dots) are plotted over the time course of the experiment from 
samples drawn at the indicated time points. The calibrated computational model reproduces the full time-resolved response of the 
device (lines) for all gate induction levels and for all combinations of repressor concentrations. Cultures were grown in 12-well 
plates. Plotted data is representative for at least five independent replicates. Fluorescence background was not subtracted. 
The gate featured an equal repression onset and efficiency for all three induction levels indicated by the 
slopes within the hour of repression and the expression levels after 7 h relative to the time point of 
repressor addition. Consistent with the precedent results, these experiment series highlighted the high 
repression efficiency after addition of both ligands. For 100 µM neomycin and 250 µM tetracycline 
translation was fully blocked and the observed signal decay is congruent with the half-life of the reporter 
GFP. By supplementing different repressor concentrations the full dose-response profile of the gate 
could be mapped out and its performance was computed with respect to the three inductor 
concentrations as presented in the following sections. 
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4.3.1.5 Performance characterization 
As of now, data analysis was rather focused on a qualitative description of the performance of the 5’-
NeoTc gate at the single-cell level. Cell-to-cell variability is directly observed in histograms as the width 
of the population on the x-axis plotted as fluorescence output. Overlaps of populations with different 
Boolean states upon repressor addition indicate a malfunction of the logic gate at the single-cell level, 
since for correct functionality and high performance not only a separation of the mean, as in bulk 
measurements typically expressed by the switching factor, but rather a separation of the complete 
population is sought (Figure 4.28). Hence, driven by the need to quantitatively characterize the 
performance of the 5’-NeoTc gate, a new measure, the ROC curve, describing receiver-operator-
characteristics and accounting for cell-to-cell variability was introduced (Figure 4.29A, B). The principal 
idea is summarized in Figure 4.28. Two overlapping populations in two different Boolean states are 
divided by an arbitrarily chosen threshold determining false and true positive as well as false and true 
negative cells (Figure 4.28A). For instance, cells of the repressed population (lime green) that are 
beyond the threshold to the right (orange) are false positive cells, because they show an ON state 
instead of the supposed OFF state. These subpopulations decrease the performance of a logic gate at 
the single-cell level.  
Figure 4.28 Illustrating performance characterization using the ROC curve. A Empirical distributions for the ON state (right) 
and the OFF state (left) of a gate across a cell population. Generally, both distributions are divided into two parts by a choice of 
decision threshold. Corresponding to each, there are cells in the OFF state producing output levels above (false positive rate, 
orange) and cells in the ON state correctly producing output levels above that threshold (true positive rate, yellow). B The curves 
represent the continuous evolution of the areas under the ROC curve (AUCs) over time. The accuracy of the gate is thus computed 
as the achieved asymptotic AUC, whereas the speed of the gate is determined by the time it takes until its AUC reaches half-
maximum. C Different gate designs can be located in the two-dimensional performance space, where trade-offs for a given gate 
architecture define fundamental performance constraints that cannot be overcome for that architecture (gray-shaded area). 
The lower the threshold in Figure 4.28A is set the more true positives are derived, but on cost of the 
appearance of more false positives. Plainly spoken, if the red line (threshold) shifts left more yellow cells 
appear to be true positives, but also the orange area (false positives) increases. The ROC curve displays 
the evolution of the true positive rate over decreasing threshold levels, i.e. increasing rates of false 
positives (Figure 4.29A, B). The ideal classifier, or here the 5’-NeoTc gate, would produce a ROC curve 
that runs in parallel with the ordinate at a rate of zero of the false positives and keeps a value of 1 for 
the true positive rates regardless of increasing false positive rates. A random classifier in turn, always 
shows a 1:1 output, i.e. if the false negative rate increases by 0.1 the true positive rate increases also 
by 0.1. To gain a measure of the evolution of the true positive rate at any threshold value, the area under 
the ROC curve (AUC) is computed. An ideal classifier exhibits an AUC of 1 and all other AUCs are 
calculated relative to the ideal classifier (Figure 4.29C). Thus the AUC accounts for the total overlap of 
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two populations, in which one is in the OFF state and one in the ON state. From a log-normal distribution, 
as can be approximated for the populations measured by flow cytometry here, the AUC can simply be 
regarded as the difference of the means divided by the square root of the sum of the variances of two 
populations. In that way the AUC accounts for the separation of the mean values, the actual switching 
factors, and more importantly for the width of each population, i.e. its cell-to-cell variability.   
Figures 4.29A, B show the resulting performance of the gate for specific repressor concentrations and 
for a combination of the repressors for different induction levels over the course of a 7 h experiment. 
Correspondingly, Figure 4.29C depicts the time course of AUC during the course of induction. The ROC 
and AUC characterization was solely done on the experimental data. Figure 4.29C indicates that gate 
performance within the observed time interval is independent of the gate induction levels that were 
considered, suggesting that the AUC characterizes the gate as such and is not affected by its expression 
level. 
 
Figure 4.29 ROC analysis of flow cytometry data. A ROC curve evolution over time for full induction (10 nM ß-estradiol) and 
maximum repression (100 µM neomycin and 250 µM tetracycline) initiated after 2 h of induction. B ROC curves at different 
concentrations of repressors (added after 2 h), induced with 10 nM ß-estradiol and measured after 5 h. In A and B, the dotted 
diagonal line shows the performance of a hypothetical, completely random (i.e., dysfunctional) gate. C Increase of AUC relative 
to its value at the time of repressor addition (100 µM neomycin and 250 µM tetracycline, 2 h after induction) over time for different 
inducer concentrations. 
The slope of the AUC accordingly provides a measure of how fast the gate becomes functional; in 
particular the slope or speed is defined as the inverse time it takes to reach half-maximum performance. 
Based on this observation two orthogonal features of the gate that describe (i) the accuracy of the gate 
and (ii) the speed or responsiveness of the gate were extracted. Every gate design can then be mapped 
into a two-dimensional performance space as indicated in Figure 4.28B, C. For a given gate design only 
a certain region of the performance space will be accessible through parameter variations (e.g. rate 
constants) and some parameterization thereof will lead to an optimization of that gate design. 
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4.3.1.6 In silico completion of device characterization 
Although the short and transient experimental characterization of the gate did not provide a full account 
of the gate’s behavior, it was directly geared toward providing minimal, yet informative data for 
translation of the system to the in silico domain. Having a computational model that accurately predicts 
the repression dynamics and its cell-to-cell variability, the model was now used to complete the device 
characterization in silico. In particular, it was employed to map out the dose-response curve of the 
repressor and the dose-response surface of the NOR gate at arbitrary time points and especially at 
steady state phase. In such a way, the device’s output over the time course of simulated prolonged 
exponential growth was emulated; data that were beyond the experimentally feasible time window. 
Figure 10 shows the dose-response of the NOR gate at 7 h (Fig. 4.30A) and at steady state (Fig. 4.30B) 
for different induction levels of the gate. The experimental data at 7 h aligned remarkably well with model 
predictions. As it was previously observed, different induction levels do not influence the performance 
of the gate and thus computed dose-response surfaces superimpose each other, only distanced by the 
respective induction strength. The model predicted a residual fluorescence output for maximum 
repressed cells at the higher induction levels of 5 nM (3-fold) and 10 nM βE (6-fold) relative to the starting 
level of uninduced cells at ~500 arb. units, suggesting the continuous translation of a small number of 
mRNAs escaping any repressor interaction. Additionally, total fluorescence induced by 10 nM βE was 
expected to increase by 1.5 - 2-fold, comparable to the induction levels reached with the PSTE5 system 
after 24 h.   
 
Figure 4.30 Dose-response surfaces at various induction levels of the gate, showing the dependence of gate output on the 
concentrations of repressors. The system was measured until 7 h after induction. The model, calibrated from the measured data, 
interpolates the missing parts of the dose-response surface. A Measured data at 7 h (colored diamonds) and interpolated dose-
response surface. B the unobserved dose-response after 24 h is predicted using the model since this time point was beyond the 
possible sampling interval that requires prolonged exponential growth. 
From the steady state predictions different NOT gate configurations (single input) were located in the 
proposed two-dimensional performance space of accuracy and speed. Figure 4.31 shows the 
coordinates of the NOT/NOR gate at various repressor concentrations in the two dimensional 
 Results & Discussion 
77 
 
performance space. It is evident that addition of higher repressor concentrations lead to a faster 
response of the gate and a better separation of the two Boolean states with respect to cell-to-cell 
variations and the fold-change between them. The performance space mapped here can then be used 
to characterize the gate design as shown in Fig. 4.28C, by simply setting a core coordinate for the gate 
design itself and defining an area around it determined by the tested repressor concentrations to 
visualize the performance constraints that cannot be overcome by the design of the 5’-NeoTc gate. 
 
Figure 4.31 NOT gate performance characterized 
through position in the performance space for various 
combinations of repressor concentrations. Inducer 
concentration was 10 nM ß-estradiol. Repressors were 
added at stationarity of the system. 
 
 
 
 
 
 
 
The reporter measurements presented in Figure 4.25 and 4.27 imply differences in the repression 
kinetics of Tc and Neo and a closer look at the concurrent events for the case of a double-repression 
would be desirable. However, due to the stability and hence low-pass filtering of the reporter, 
quantifications based solely on the experimental data were unfeasible. The model-based reconstruction 
provided mRNA estimates at their comparably faster time-scales, allowing a better dissection of the 
temporal sequence of events at the onset of repression after 2 h induction. By this only newly transcribed 
mRNAs in the presence of repressors are captured and used to calibrate the model. Figure 4.32 shows 
the evolution of occupancies for the different mRNA subpopulations (i.e. free, single-bound, double-
bound) at the onset of repression. In accordance to protein levels (Figures 4.25 and 4.27), free mRNA 
abundances decrease faster in presence of tetracycline as compared to neomycin (Figure 4.32A, B). 
Increase of double-bound mRNAs is slowed by transient occupancy of the mRNA with tetracycline alone 
as neomycin exhibits relatively slow association kinetics (Figure 4.32C). For the same reason, no single-
bound mRNAs by neomycin are found in the presence of tetracycline. The overall abundance of mRNAs 
encoding the NeoTc gate may be assumed to be unaffected by the integration of the two riboswitches 
near the start codon as has been shown in earlier studies 137,139.  
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Figure 4.32 Relative abundance of mRNA subpopulations after addition of repressors at +2 h. A 100 nM neomycin. B 250 
nM tetracycline. C 100 nM neomycin and 250 nM tetracycline. Due to the faster binding kinetics of tetracycline, the majority of 
mRNA molecules binds tetracycline immediately after addition. Subsequently, the balance progressively shifts to double-bound 
mRNA due to the slower binding kinetics of neomycin. 
The model also allowed the investigation of the noise in GFP expression which is left after removing the 
effect of cell size. Hence, an in silico homogenization was performed. The resulting distributions are 
shown in Figure 4.33 for several combinations of inducer and repressor concentrations. It indicates that 
a considerable variability due to stochastic gene expression remains after such homogenization that is 
inherent to the system and cannot be decreased by a further reduction of gene copy number for instance.  
 
Figure 4.33 Predicted GFP abundance for fixed cell size after 7 h of induction. A No repressors. B 100 µM neomycin. C 250 
µM tetracycline. D 100 µM neomycin + 250 µM tetracycline. Repressors were added after 2 h induction with 10 nM ß-estradiol. 
4.3.1.7 Computer-aided redesign  
Having general performance measures in place, it was sought to assess whether performance could be 
further improved by a redesign of the inducible expression system, for instance by changing specific 
reaction rate constants that are amenable to experimental modification. As the width of the distribution 
and in particular the distributional overlap between the Boolean states are critical to achieve high AUC 
it was specifically investigated, whether reduction of extrinsic noise resulted in improved gate 
performance. Although ARS/CEN plasmids were used for the expression of GEV that should be ideally 
maintained as a single copy within the cell, recorded data and previous publications suggest that cells 
do not always carry just a single plasmid, but multiple 52. In particular, Figure 4.34A provides evidence 
for a considerable population of cells carrying two and three plasmids. This plasmid heterogeneity leads 
to a broadened distribution of the GEV transcription factor.  
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Figure 4.34 Influence of GEV variability on gate performance. GEV vs. forward scatter for plasmid-based GEV A and for 
chromosomally integrated GEV B. For the plasmid-based case, at least two subpopulations are clearly discernable. The distance 
on the mCherry-axis between the red lines corresponds to doubling or tripling of GEV abundance, which is the simplest assumption 
for the behavior when 2 or 3 plasmid copies are present in a cell. For chromosomally integrated GEV, only the subpopulation 
corresponding to a single copy of the plasmid remains. C AUC increase over time for plasmid-based and for integrated GEV for 
induction at 2.5 nM ß-estradiol and repression with 100 µM neomycin and 250 µM tetracycline. The differences between these 
two are within the margin of error. Data for plasmid-borne GEV expression are derived from cultures processed in Fig. 4.27. Data 
for integrated GEV expression were obtained equally. 
 
Generally, through noise propagation a broadened GEV distribution will give rise to a broadened 
distribution of the gate output, and hence, deteriorating the gate’s performance. Using the model, the 
sensitivity of the gate’s AUC with respect to changes in GEV heterogeneity was queried. Practically, the 
AUC was computed for different standard deviations of GEV heterogeneity in the model and it was found 
that variability in GEV abundance had little effect on the AUC and hence did not contribute much to the 
output variability. Thus, the model suggested that redesigns targeting a reduction of GEV variability 
through, for instance, a chromosomal integration of GEV, would not yield a performance increase. To 
test this prediction, the plasmid-derived GEV expression cassette was inserted into the His3 locus using 
CASEMBLR and the above single-cell device characterization was repeated. Figure 4.34B shows the 
reduction in GEV heterogeneity after integration. In terms of performance the device behaved the same 
under the same conditions (Figure 4.34C). Thus, the integration of GEV and thereby the reduction of its 
noisy expression had no influence on the AUC increase of the gate. On top of the AUC analysis the 
model also provided an explanation for this counterintuitive insensitivity of gate performance with respect 
to GEV variability. A plain saturating effect through GEV at the promoter would be incompatible with the 
observed gradual dose dependency of gate output with respect to different induction levels (e.g. Figure 
4.30) and the model indeed determined that the insensitivity arises because ß-estradiol is the limiting 
factor, while GEV is in excess for a very broad range of values, exceeding the threshold needed for 
maximum GFP+ expression even with a single gene copy. 
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4.3.2 Discussion 
The natural design goal for logic-based devices is to require correct functionality of the gate at the single-
cell level and not just at the bulk level. The x-fold-change at the bulk level is a poor descriptor of the 
gate performance, because cell-to-cell variability in the device’s behavior is not considered, although it 
plays a key role for efficient operation at the single-cell level. Hence, apart from the fold-change between 
the Boolean states, the overlap between the single-cell distributions associated with this two states is 
crucial. Importantly, time course measurements of device behavior during induction and repression 
provide insight into the kinetics of the device, such as the time interval it requires until it equilibrates to 
a new expression profile. Characterizing the device kinetics on the single-cell level moreover, allows to 
capture the heterogeneity in the onset of a response to the inducer and repressor directly visible in live 
cell imaging and at least discernable in flow cytometry data through transient fluctuations of the 
measured distributions. Resolving the transient dynamics of a device is also important for building and 
calibrating computational models for it as the characterization at steady state provide only insufficient 
data. Considering the requirements for logic gates and the ideal assessment of their performance, the 
ROC analysis of transient single-cell data was introduced as a new measure for gate performance 
accounting for both, the x-fold change and the distributional overlap of (un)repressed populations 
bearing an RNA-based logic gate. Initially, four different logic gates constructed from the tetracycline- 
and neomycin-binding riboswitches had been constructed, but only one, the 5’-NeoTc gate, was further 
analyzed and yielded the data for ROC analysis and model calibration. Among two exclusive NOT gates, 
the 5’-NeoTc gate was the only one of two NOR gates that exhibited the phenotypic behavior expected 
from a NOR operation. The output of its inverse counterpart, the 5’-TcNeo gate, suggested extensive 
malfunction possibly due to yet unresolved structural interferences. Further analysis of the transient 
performance of the 5’-NeoTc gate at the single-cell level by flow cytometry and time-lapse fluorescence 
microscopy using a microfluidic chip unraveled its fast and efficient repression kinetics. The absolute 
output processed by the gate could be fine-tuned with different inducer concentrations, whereas signal 
processing itself exhibited high robustness and hence the performance of the gate was found to be 
independent of the induction level. 
Besides the designed NOR gate composed of riboswitches, recent work on the construction of RNA-
based logic gates in bacteria has shown the versatility and aptitude of RNA-based regulation for the 
development of small genetic circuits 92,144. The RNA toehold switches generated by Collins and co-
workers feature high orthogonality in E.coli and have been yielded by a combination of in silico 
computation and rational design. Felletti et al. have engineered the twister ribozyme in E.coli to sense 
different ligands mainly by permutation experiments guided by rational design principles from previous 
works 131–133,149,208. The performance of any logic gate presented in these two studies appeared to be 
generally lower compared to the single-input counterparts, underlining the need for connectable RNA 
parts without compromised functionality, i.e. performing better than the single parts of which they are 
composed. In an attempt to rank the performance of their logic gates, Felletti et al. employed a metric 
derived from probability binning developed to analyze single-cell data that was recorded by flow 
cytometry 209. The method uses a statistic parameter T(Χ) that provides a measure of the probability by 
which two populations, e.g. the unrepressed and a repressed, are different and is also capable of ranking 
different populations with respect to their difference. An empirical threshold has to be determined beyond 
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which populations are regarded as different. Although being rather similar to the ROC analysis, ROC 
analysis is independent of a threshold to summarize the performance of a given logic gate. Moreover, if 
transient fold-changes are recorded, the ROC analysis can be used to compute the speed with which 
the gate reaches its maximum accuracy. A particular gate design can subsequently be mapped into a 
whole design space determined by accuracy and speed allowing direct comparisons to other designs 
and their performance to elucidate the best possible design for a given operation (Fig. 6B, C). These 
analyses are beyond what is feasible with the approach of probability binning. Collins and co-workers 
did not consider phenotypic noise at all to calculate switching factors and did so solely by extraction of 
the mean fluorescence from the corresponding histograms. Besides, the discussed studies used steady 
state measurements that only allowed to assess the equilibrium of all involved rate constants, and hence 
all transient information needed to dissect transitions from one Boolean state into another was lost.  
In the present study the model built and calibrated on the transient single-cell data was not only 
employed to perform ROC analysis, but also to determine the gate’s full dose response profile at steady 
state. In such a way, the device’s output over the time course of simulated prolonged exponential growth 
was emulated; data that were beyond the experimentally feasible time window as these growth phase 
may only be maintained up to about 8 h in synthetic complement medium supplemented with all 
necessary nutrients. To solve this issue of limited exponential growth an alternative approach, the 
EnPresso® growth systems, had been developed by BioSilta. Generally applied to extend exponential 
growth for higher protein yields of a continuous fed-batch culture of the yeast Pichia pastoris, the so 
called EnBase® technology could also be transferred to reach prolonged exponential growth for a 
reporter gene assay. The main idea is a controlled release of glucose to the medium by an enzymatic 
degradation (called the glucose-releasing agent, GRA) of long polysaccharide chains. The growth rate 
may be regulated by the concentration of the GRA. S. cerevisiae has been cultivated without problems, 
but growth protocols must be developed by the user (personal communication with Antje Neubauer, 
BioSilta). In particular, the GRA must be titrated to adapt its concentration to the timing of the overall 
experiment. Polysaccharide (administered as tablet) and GRA may be supplemented to the medium at 
any time. Additionally, cultures must be well aerated and the complete experimental set up would have 
to be changed from 3ml culture in 12-well plates to 2ml culture in 24 deep-well plates to allow for 
vigorous, high-amplitude shaking in a different incubator.  
With the simulated dose-response surface of the 5’-NeoTc gate, the model predicted a residual 
fluorescence output for maximum repressed cells at the higher induction levels of 3-fold (5 nM βE) and 
6-fold (10 nM βE) relative to the starting level of uninduced cells at ~500 AU, suggesting the continuous 
translation of a small number of mRNAs escaping any repressor interaction, consistent with steady state 
measurement of outgrown cultures. Considering the mechanism by which the 5’-NeoTc gate inhibits 
gene expression, it may be hypothesized that mRNA already transcribed in the absence of any repressor 
is densely occupied by ribonucleoprotein particles (RNP) and especially 43S pre-initiation complexes 
actively scanning the 5’-UTR for the start codon. As a consequence the mRNA is not accessible for the 
repressors and additionally the riboswitch structure is continuously compromised and unable to form the 
entropically disfavored conformation that can be captured by the ligand. On the contrary, the -1 h 
experiment illustrated in Figure 4.25 and a previous study suggest that a pre-incubation with repressors 
leads to a lower residual gene expression after repression. This is presumably because neomycin and 
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tetracycline have already permeated through cell membrane and nucleus, encountering the newly 
transcribed mRNA before it is exposed to RNPs and the ribosomal pre-initiation complex 139. Transient 
data of the +1h and +2h experiments shown in Figures 4.25 and 4.26 further support this mechanism, 
since the increase of GFP fluorescence is stopped within the hour of ligand addition, leaving only already 
transcribed mRNAs to be translated. A further decrease of fluorescence over time can be attributed to 
a progressive degradation of already translated GFP in concert with a gradual capture of 5’-NeoTc gates 
in their ligand binding conformation by the repressors, thus inhibiting gene expression. 
The model was further used for a computational redesign of the complete expression system, exploring 
the influence of extrinsic noise on the distributional overlap of the different Boolean states. The GEV 
transcription factor presented an easy to monitor extrinsic noise factor as it is coupled to mCherry whose 
fluorescence is proportional to the concentration of GEV. The theory of noise propagation suggested 
that variability of GEV would result in increased variability of GFP. Interestingly, the model computed 
the counterintuitive alternative, a negligible influence of GEV variability on the phenotypic heterogeneity 
of GFP. The plasmid-borne copy number of GEV was subsequently reduced from 1-3 copies to a single 
copy by a genomic integration into the His3 locus. Indeed, reduction of GEV variability did not influence 
the AUC analysis (Fig. 14). This finding is plausible, if the gating protocol providing the data for model 
building and calibration is considered.  After the gating of a single-cell population, this population is 
displayed in a bivariate plot composed of both fluorescence channels. Figure 4.35 shows bivariate plots 
for an induced population bearing the integrated 5’-NeoTc gate and plasmid-borne GEV expression after 
7 h. The circled subpopulation in plot A (that may itself by divided in at least two subpopulations) is 
subject to gating and will be used to build and calibrate the model, because all cells of that population 
exhibit a positive correlation between GFP (FL1-510) and mCherry (FL4-610). The other subpopulation 
is composed of cells that do not express GEV-mCherry and thus no GFP. Plot B shows a bivariate of 
mCherry and the forward scatter (FCS-A). Acknowledging the FSC as a measure for cell size, the plot 
correlates mCherry fluorescence to cell size. At least two subpopulations are clearly discernable that 
have the same FSC values, but differ in their fluorescence signal. A similar plot has been shown in 
Figure 34. Now, it can be verified in plot C, a bivariate overlay of the gated populations from A (red) and 
B (light blue), that the two subpopulations from B are identical with the two subpopulations discernable 
in the gated population of plot A. This in turn confirms the prediction of the model, because “stacked” 
subpopulations from plot B will also “stack” in plot A, thus only broadening the mCherry signal, but not 
GFP fluorescence. A main contributor to the width of a histogram is consequently identified as cell size. 
A reduction of GEV variability by reducing its gene copy number leads to a single subpopulation, for that 
matter the circled population in plot B, that, if plotted against GFP will not change the GFP signal and 
thus phenotypic noise cannot be reduced (compare Figure 4.34). It seems likely that a threshold for the 
concentration of GEV exists, that, once reached, provides enough GEV to fully induce GFP, irrespective 
of how much the threshold was exceeded.  
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Figure 4.35 Population analysis of cells expressing GEV from plasmid. A The whole population as recorded by flow cytometry 
in a bivariate plot of mCherry (FL4) and GFP (FL1) fluorescence. The drawn gate marks the red subpopulation displayed in C. B 
The same population as displayed in A, but plotted as mCherry (FL4) fluorescence and forward scatter area signal (FSC-A). The 
gate denotes the light blue subpopulation in C. C An overlap of both gates from A and B in a bivariate plot of mCherry (FL4) and 
GFP (FL1) fluorescence. Data is exemplary and originates from cultures processed in Fig. 4.25. 
In conclusion, a reduction of extrinsic noise did not lead to an increase of the actual gate performance 
as also all repressed populations were not affected by fluctuating GEV level. This suggests that noise 
propagation is not so much of an issue in this constructed expression system. A closer look at the data 
and a comparison with data recorded from the integrated GEV factor however, reveal a fundamental 
benefit at last. As immediately apparent from the bivariate plots in Figure 4.36 with data generated 
according to Figure 4.35, GFP+ expression driven by the integrated GEV factor results in a single 
compact population. No subpopulation exist that does not exhibit mCherry and thus no GFP 
fluorescence. The FL4:FSC-A plot confirms the occurrence of a single gene copy of GEV. Although cell-
to-cell variability of the GFP phenotype remains unchanged compared to Figure 4.35, the whole 
population as such is solely composed of cells exhibiting a uniform expression pattern. If GFP was 
replaced by a transcription factor, signal transduction would not be corrupted by non-responding cells – 
an inevitable event that, in contrast to the in silico domain, cannot be corrected in vivo. Since the model 
was built and calibrated from the gated data mimicking the GFP phenotype gained by a GEV integration, 
no improvement upon GEV integration was predicted. 
Another benefit that arose with GEV integration was the 3-fold reduction of background fluorescence 
emitted by uninduced cells, increasing the induction-fold accordingly. The model also uncovered another 
extrinsic parameter that would improve the induction-fold of the system. The GAL1 promoter is not 
saturated with activated GEV, since a dose dependency of gate output with respect to different induction 
levels was observed (e.g. Figure 4.30). The model determined that ß-estradiol is the limiting factor of 
maximum GFP expression, a feature that would have remained hidden as it was experimentally not 
accessible due to growth deficiencies in the presence of higher βE level. Considering a volume of 100 
fL per yeast cell (cell radius 3µm) and 10 nM βE, the approximate intracellular number of βE, if all βE 
was available as ligand for GEV, is 600. This number is surely to be reduced by the amount of βE 
remaining at or within the bilayered cell membrane, associated to lipids as its logP in an n-octanol:water 
mixture is 4, exhibiting the same hydrophobicity as polyaromatic hydrocarbons 210. Increasing quantities 
of βE could thus promote a higher transcription rate. 
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Figure 4.36 Population analysis of cells expressing GEV from the HIS3 locus. In analogy to Fig. X, A shows the whole 
population as recorded by flow cytometry in a bivariate plot of mCherry (FL4) and GFP (FL1) fluorescence. B The same population 
as displayed in A, but plotted as mCherry (FL4) fluorescence and forward scatter area signal (FSC-A). Data was obtained from 
cultures presented in Fig. 14. 
The GEV system had been further developed over the years to completely eliminate off-target induction 
of other pGAL1-driven genes, abolishing any defect on cell growth 57,58. This was achieved by the fusion 
of engineered artificial transcription factors (AF) containing zinc-finger DNA-binding domains with the 
human estrogen receptor and the VP16 activation domain, both former constituents of the GEV factor. 
Thus, the system could still operated with βE, but induced only specifically modified GAL1 promoters. 
The possibility to multiplex the response to βE by the simultaneous induction of multiple promoters with 
a single AF or the employment of different and orthogonal AF-promoter pairs opens the door to a new 
level of transcriptional control over gene expression. In concert with the here and elsewhere developed 
RNA-based logic gates, the specific characterization of such RNA devices with respect to extrinsic noise 
contributing to signal transduction and amplification could be assessed. As both components of the 
system, the inducing and the inducible, are fast-acting and highly efficient, a transient analysis on 
biologically relevant time scales is straightforward. In combination with the EnBase® technology even 
very long time lapse measurements could be conducted without the need to account for distorting 
metabolic adaptions of the growing yeast cells. As the results of the reduction of gene copy numbers 
implied a “cleansing” of non-responding cells from the total population, the adoption of this finding will 
further diminish losses during signal propagation. Consequently, other variable extrinsic factors like the 
abundance of components of the transcription and translation machinery and their impact on the 
performance of an artificially engineered genetic circuit can be studied unobscured from malfunctions 
inherent to the expression system. Additionally, intrinsic noise stemming from variable synthesis and 
degradation rates inherent to the studied device can be elucidated more easily by modifications and 
redesigns, now that they are entangled from excessive systemic errors. Albeit not presented in the 
results chapter, a second 5’-NeoTc gate with RFP as a reporter, but otherwise isogenic to the already 
integrated 5’-NeoTc gate, was also chromosomally integrated. This dual-color set up of equal gates was 
designed to better dissect extrinsic noise from intrinsic noise. Preliminary experiments revealed that 
GFP and RFP signals correlated well at steady state, suggesting minor influences of intrinsic noise, but 
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rather a mutual dependence on extrinsic parameters as discussed. A preliminary transient 
characterization showed that GFP levels increased on faster timescales, but the phenotypic variabilities 
of GFP and RFP behaved equally. For one, this supports the finding of the steady state measurement. 
Secondly, since gene expression strongly depends on the local chromatin structure, the GFP device 
could respond faster due to issues with accessibility of the locus. A flipped integration, i.e. 5’-NeoTc-
GFP moved from ade2 to his3 and 5’-NeoTc-RFP from his3 to ade2 was not yet conducted, but would 
shed some light on the matter. 
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5 Methods 
5.1 General protocols for molecular cloning 
5.1.1 PCR 
PCR was used to (i) amplify a defined sequence from a vector or other double-stranded oligonucleotide 
sequence with or without novel 5’-flanking parts and to (ii) confirm the correct ligation of a vector and 
insert after subsequent transformation into E.coli. To work-up the PCR (i) a column purification or (ii) a 
gel-purification or (iii) an alcohol precipitation was performed. 
To amplify a distinct part of a vector or oligonucleotide primers were designed to meet the criteria listed 
in Table 5.1 and, if necessary, 5’-flanked with a new oligonucleotide sequence. Typically, these 
amplicons comprised two 5’-flanking restriction sites allowing ligation with a complementarily cut plasmid 
or up to 50 nt stretches homologous to the target vector in a Gibson cloning or yeast homologous 
recombination. 
The applied general protocols are summarized below. 
Table 5.1 Criteria for primer design 
# Parameter value 
1 GC in % range 50 – 60 
2 Tm in °C range 55 – 70 
3 Thyb in °C 55 
4 Stability 5‘ vs 3‘ in kcals >0 
5 3‘-Dimer matches in nt <4  
6 3‘-GC clamp ≥1 ultimate or penultimate 3‘-nucleotide 
These criteria were set manually in Clone Manager. Other pre-set criteria were adopted from the 
software. 
Table 5.2 PCR mix 
Concentration Reagent Volume [µl] Final Concentration 
100% H2O 31.9 - 
5x  
100%  
Q5-Buffer 
DMSO 
10 
1.5 
1x 
3% 
10 mM dNTPs 1 200 µM 
20 ng/µl 
100 µM 
100 µM 
2 U/µl 
Vector 
Primer-fw 
Primer-rev 
Q5 Polymerase 
0.5 
0.3 
0.3 
0.5 
2 ng/µl 
600 nM 
600 nM 
1 U 
 Endvolume 50  
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Table 5.3 Thermocycler program 
# Step Duration [s] Temperature [°C] 
1 Initial Denaturation 30 98 
2 Denaturation 10 98 
3 Hybridisation 15-60 58-72       35 cycles 
4 Extension 2 s/100 nt 72 
5 Final Extension 180 72 
6 Cool-down ∞ 8 
Temperatures for primer hybridization and durations for primer extension were adjusted to target length 
and primer-template hybridization temperatures. 
5.1.2 Colony-PCR 
By means of Colony-PCR, several bacterial clones were screened by amplification of a distinct 
sequence targeted by an appropriate set of primers. The reaction mix was visualized on an agarose gel. 
Appearance of the desired band on the gel implied the insertion or deletion of a particular sequence of 
the vector used.     
A bacterial colony was picked with a sterile toothpick from an LB-agarose plate and suspended in 20-
50 µl H2O for colonies with a diameter <1 mm. 1 µl was taken for PCR. 
Table 5.4 Reaction mix 
Concentration Reagent Volume [µl] Final Concentration 
100% H2O 6.8 - 
10x  Taq-Buffer 1 1x 
10 mM dNTPs 0.2 200 µM 
10 µM 
10 µM 
5 U/µl 
- 
Primer-fwd 
Primer-rev 
Taq-Polymerase 
Bacterial colony 
0.4 
0.4 
0.2 
1 
400 nM 
400 nM 
1 U 
- 
 Endvolume 10  
 
Table 5.5 Thermocycler program 
# Step Duration [s] Temperature [°C] 
1 Initial Denaturation 600 95 
2 Denaturation 10 95 
3 Annealing 30 48       24 cycles 
4 Extension 6 s/100 nt 72 
5 Cool-down ∞ 4 
Extension time is varied according to target sequence. 
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5.1.3 Oligonucleotide Hybridization and 5’-Phosphorylation 
To clone short oligonucleotides (<80nt) without a template for PCR the complementary single strands 
were ordered either pre-cut to match the restriction site of the target vector or blunt to serve as a template 
for PCR. The double-stranded products were 5’-phosphorylated, if further subjected to a sticky end 
ligation. The protocol is displayed in table X.   
Table 5.6 Reaction mix hy 
Concentration Reagent Vol [µl] Final concentration 
10x T4-Polynucleotide Kinase Buffer 5 1x 
100 µM 
100 µM 
10 mM 
Oligo fwd 
Oligo rev 
ATP 
1.5 
1.5 
5 
1.5 pmol/50 µl 
1.5 pmol/50 µl 
1 mM 
10 U/µl T4-Polynucleotide Kinase (T4-
PNK) 
1 0.2 U/µl 
100% H2O ad 50  
The mix without T4-PNK was incubated 2 min at 98 °C and then cooled at 0.1 °C/s to 25 °C. T4-PNK 
was added, the reaction mixed and incubated for 1 h at 37 °C. Phosphorylated double-stranded 
oligonucleotides were used without further purification for ligation or as template in a PCR.  
5.1.4 Fill-in reaction 
To ligate a linear vector with incompatible sticky ends, blunt ends were created by a fill-in reaction at 12 
°C for 15 min. The reaction was stopped by adding EDTA to a final concentration of 10 mM and 
incubation at 75 °C for 20 min. To shift the equilibrium of 5’→3’-polymerisation versus 3’→5’-
exconucleolytic degradation towards the fill-in, low temperature, low enzyme concentration and high 
dNTP concentration was chosen.  
Table 5.7 Reaction mix 
Concentration Reagent Vol [µl] Final concentration 
10x 
1mg/ml 
NEB4 
BSA 
5 
5 
1x 
100 µg/ml 
- 
2 mM 
Linear vector 
dNTPs 
500 ng 
2.5 
- 
100 mM 
3 U/µl T4-DNA Polymerase 0.3 0.02 U/µl 
100% H2O ad 50  
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5.1.5 Restriction digest 
Type IIM(165) - DpnI digest 
After PCR the template vector was digested at 37°C for 1h with Dpn I, a type IIM restriction enzyme, 
with cleavage specificity to (hemi-) methylated DNA. The PCR product remained undigested and was 
isolated by column purification, gel extraction or alcohol precipitation. 1 µl 20U/µl Dpn I was added 
directly to the PCR mix and simultaneously removed by PCR purification. 
Type IIP(165) (orthodox) 
Plasmids and inserts that were subject to ligation were incubated for 1 h or up to 24h at 37°C with two 
restriction enzymes type IIP. A digested vector was purified by gel extraction. PCR products were 
purified by column purification or alcohol precipitation. The enzymes were inactivated at 80°C for 20 min 
or excluded in the purification step. The general reaction volume was 50 µl. 
Table 5.8 Reaction mix 
Concentration Reagent Vol [µl] Final concentration 
10x CutSmart Buffer or as indicated 5 1x 
- 
- 
Vector or 
Insert 
2-5 µg 
Purified 
PCR 
reaction 
 
20 U/µl Restriction enzyme 1-2 0.4-0.8 U/µl 
100% H2O ad 50  
5.1.6 Gibson cloning reaction 
Gibson cloning was employed to fuse one or more inserts with a target vector taking advantage of the 
introduced 40 nt homology between inserts and vector by a previous PCR. A 20 µl Gibson reaction 
contained 0.02-0.5 pmol DNA fragments in a total of 5 µl that were mixed with 15 µl home-made Gibson 
master mix (Ref openwetware) and incubated at 50 °C for 1 h. PCR fragments and linearized vector were 
purified as described. A downscale of the 5x ISO mix and Gibson master mix was prepared. After 
incubation the mix was purified by BuOH precipitation and dissolved in 10 µl water. 1.5 µl were taken to 
transform electro-competent Top10 cells. 
Table 5.9 Gibson master mix 
Concentration Reagent Vol [µl] Final concentration 
5x ISO buffer 320 1x 
10 U/µl T5 Exonuclease 0.64 0.004 U/µl 
2 U/µl Phusion Polymerase 20 0.025 U/µl 
40 U/µl Taq Ligase 160 0.1 U/µl 
100% H2O ad 1600  
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Typically, 300 µl Gibson master mix were prepared and stored at -20 °C. Up to 10 freeze-thaw cycles 
are possible. Here, up to 4 cycles were tested without a compromised activity. 5x ISO mix was stored 
at -20 °C in 500 µl aliquots. 
5.1.7 Ligation 
The fusion of an insert and a vector backbone cut with identical restriction enzymes was carried out at 
RT for 45 min. The ratio vector : insert was chosen with respect to insert size and resulted in typical 
ratios of 1:3 – 1:5. Always 25 ng Vector were used for ligation. The reaction was purified by BuOH 
precipitation and dissolved in 10 µl water. 1.5 µl were taken for transformation of electro-competent 
Top10 cells. 
Table 5.10 Reaction mix 
Concentration Reagent Vol [µl] 
10x T4-DNA Ligation Buffer 2 
- 
- 
Linear vector 
Insert 
25 ng 
q.s. 
400 U/µl T4-DNA Ligase 1 
100% H2O ad 20 
5.1.8 Transformation of chemo-competent E.coli in 96-well format 
Cells were thawed on ice. 100 µl cells were added to the ligation mix and incubated 1 h on ice. Cells 
were heat-shocked at 42°C for 45s in a PCR cycler. Cells were then incubated 10 min on ice. 
Subsequently, the mixture was pipetted in 1 ml LB in 1.5 ml reaction tubes and incubated at 37°C for 1 
h in a 37°C incubator. Reaction tubes were inverted occasionally using the racks as sandwich cover. 
Cells were concentrated by centrifugation at 8000 rpm for 15 s und plated on LB plates containing 100 
µg/ml ampicillin. Plates were incubated at 37 °C overnight. 
5.1.9 Transformation of electro-competent E.coli 
50 µl of electro-competent E. coli Top 10 cells were thawed on ice, mixed with 1.5 µl purified ligation or 
Gibson mix, transferred to a sterile electroporation cuvette pre-chilled on ice and electro-shocked at 
1800 V for 5ms. 450 µl sterile SOC-medium at 37 °C were added and plated on an LB-agarose dish 
supplemented with 100 µg/ml ampicillin under aseptic conditions before incubation at 37 °C overnight. 
5.1.10 General protocol for yeast homologous recombination 
To facilitate a ligation reaction exploiting the highly efficient DNA repair mechanisms in yeast a purified 
and linearized vector and one or more inserts were transformed into yeast. Inserts and vector bear a 
total of 40 nt sequence homology at the junction of two parts to facilitate an efficient recombination 
event. The molar ratio insert : vector was set to 1 : 5 – 1 : 10. 
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5.1.11 Transformation of competent yeast cells 
The Frozen Yeast EZ II Transformation Kit from Zymo Research was chosen to conduct all yeast 
transformations. The procedure was carried out according to the manufacturer’s instructions. 
5.1.12 Agarose gel electrophoresis 
For DNA extraction and analysis high quality agarose was utilized. After casting gels with agarose 
concentrations ranging from 1% to 3%, samples were mixed with agarose-loading buffer and pipetted 
into pre-formed gel slots alongside an adequate molecular length marker. Gels were run in 1x TAE 
buffer at 6 V/cm for 35 – 60 min. Next, gels were stained with 0.5 µg/ml ethidium bromide in water for 1 
– 5 min. DNA was visualized with 254 nm light for analytical purposes and 366 nm for extraction. 
Afterwards the gel was digested and the DNA extracted using the Qiagen Gel extraction Kit. 
5.1.13 DNA isolation – Mini preparation from Top 10 cells 
All plasmids were isolated with the Qiagen Plasmid MiniPrep Kit. Usually, pDNA was eluted in 55 µl and 
stored at -20 °C for further use.  
5.1.14 DNA isolation – Mini preparation from yeast  
The following steps were taken from a user-developed protocol published by Qiagen. All steps were 
performed at RT. 4 ml saturated yeast culture were harvested by centrifugation at 13000 rpm for 1 min. 
Cells were resuspended in 250 µl P1 Buffer. 150 µl glass beads (diameter 0.25 – 0.5 mm) were added 
and vortexed for 5 min. Glass beads were allowed to settle, the supernatant was transferred to another 
reaction tube. 350 µl N3 Buffer were supplemented and incubated for 5 min. From here the standard 
protocol for a plasmid mini preparation according to the Qiagen Plasmid Mini Prep Kit was followed. The 
DNA was eluted in 20 µl and 2 µl were taken for subsequent transformation of Top 10 cells. 
5.1.15 DNA isolation – genomic DNA preparation from yeast (Bust’n’grab) 
In general gDNA was extracted by 2 heat-freeze cycles. First 1-2 ml saturated yeast culture were 
harvested by centrifugation at 13000 rpm for 1 min. Cells were resuspended in 200 µl STET Buffer in 
PCR reaction tubes and subjected to two rounds of freezing at -80 °C and heating at 98 °C. The 
supernatant was extracted with 1 Vol. phenol/chloroform/isoamyl alcohol (25:24:1). The aqueous phase 
was again extracted with 1 Vol. chloroform. DNA was precipitated by isopropanol and dissolved in 100 
µl water. The concentration was measured and the samples stored at -20 °C. For a subsequent PCR 
reaction 1ng/µl PCR reaction were taken. 
5.1.16 DNA quantification 
The Nanodrop ND-1000 was used to measure the concentration of 2 µl DNA solution at 260 nm 
employing Lambert-Beer’s law assuming only marginal contamination by RNA and/or genomic DNA. 
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5.1.17 DNA purification – Ethanol, isopropanol and butanol 
1. EtOH: 1/10 vol. 3 M sodium acetate was added to the DNA solution and mixed. 2 – 3 vol. ethanol 
were added and mixed. The mixture was incubated at 4 °C for 15 – 20 h, centrifuged at 4 °C at 
13000 rpm for 30 min and washed one time with 70% ethanol followed by centrifugation for 15 
min again at 13000 rpm and 4 °C. DNA was dried at RT for 20 min, resolved in H2O and kept at 
-20 °C. 
2. 2-Propanol: see EtOH protocol. Instead of 2 – 3 vol. EtOH 1 vol. isopropanol was used. 
3. 1-Butanol: 10 vol. BuOH were added and thoroughly mixed. The precipitate was collected by 
immediate centrifugation at 13000 rpm for 10 min. A 70% EtOH wash was performed prior to 
dissolving the DNA pellet in water. 
5.1.18 Sequence analysis 
To confirm sequence integrity and successful cloning single clones were picked from a LB-agarose 
plates supplemented with 100 µg/ml ampicillin and incubated in LB-medium containing ampicillin at 100 
µg/ml for about 15h. After mini preparation, pDNA was analyzed by Seqlab laboratories, Goettingen.  
5.1.19 Preparation of chemo-competent E.coli 
The desired strain, typically Top10, was taken from the frozen stock and streaked out on an LB plate to 
yield single colonies. 4 ml LB were inoculated with a single colony and incubated at 37 °C, 150 rpm for 
16 h. 300 ml pre-warmed LB medium were inoculated to an OD600 of 0.1 – 0.2 and grown to an OD600 of 
0.6 – 0.8. Cells were cooled to 4°C on ice and harvested by centrifugation with 8000 rpm for 20 min at 
4°C. Cells were washed with ice-cold 150 ml 0.1 M CaCl2 and resuspended in 25 ml 0.1 M CaCl2. Sterile 
glycerol was used to adjust the cell suspension to 15% glycerol. 1ml aliquots were frozen at -80°C. 
5.1.20 Preparation of electro-competent E.coli 
The desired strain, typically Top10, was taken from the frozen stock and streaked out on an LB plate to 
yield single colonies. 4 ml LB were inoculated with a single colony and incubated at 37 °C, 150 rpm for 
16 h. 300 ml pre-warmed LB medium were inoculated to an OD600 of 0.1 – 0.2 and grown to an OD600 of 
0.6 – 0.8. Cells were cooled to 4°C on ice and harvested by centrifugation with 8000 rpm for 20 min at 
4°C. Cells were washed with ice-cold 150 ml 10% glycerol (v/v) twice. Cells were resuspended in 10% 
glycerol, 100 µl aliquots were prepared and frozen at -80°C. 
5.1.21 Preparation of chemo-competent yeast 
The Frozen Yeast EZ II Transformation Kit from Zymo Research was chosen to prepare competent 
yeast cells. The procedure was carried out according to the manufacturer’s instructions. 
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5.1.22 Yeast glycerol stocks 
4 ml YPD or SCD full medium were inoculated with a single yeast colony and cultured for 20h. Sterile 
glycerol was added to a final concentration of 15% in a total of 1 ml. This aliquot was incubated at 30 
°C for 30 min and finally stored at -80 °C. 
5.2 Adapted protocols for molecular cloning and reporter gene analysis 
5.2.1 In vivo Screening of RNA aptamers in S. cerevisiae 
5.2.1.1 SELEX – pool design and selection strategy 
SELEX – Systematic Evolution of Ligands by Exponential enrichment, is a process used to identify RNA 
or DNA sequences competent to bind ligands of choice 211 . A SELEX was not conducted in this study 
and therefore the general procedure for an RNA SELEX is described briefly. A randomized pool of DNA 
is generated by DNA synthesis. The pool is transcribed to RNA and incubated with the desired ligand. 
The ligand is coupled to a solid state, a column, or to a bead suspended in solution. By incubation and 
several washing steps unspecific binders are discarded and all sequences bound to the ligand are 
eluted. A reverse-transcription yields DNA that is amplified by a PCR and the cycle concludes. Up to 10 
or more cycles may be performed to narrow the pool down to the best binders.  
Here, it must be pointed out that for the design of the initial pool a rather long randomized region of 50-
90 nt was considered that is optimal for the identification of small molecule-binding aptamers 211,212. 
Long nucleotide stretches exhibit a greater structural flexibility and may probe the limited binding sites 
on a small molecule more efficiently 154. To bias the evolution of RNA sequences towards a stable 
folding, structural elements as hairpins can be considered in the pool design 213,214. This strategy 
however, as it compromises structural flexibility, had not proven to be beneficial to obtain small molecule 
binding aptamers that exhibit riboswitching properties. The number of selection rounds depends on the 
target molecule, but typically 5-10 rounds of enrichment are performed yielding pools with moderate 
(µM) to high (nM) affinity binding profiles.  
5.2.1.2 RNA-library cloning for in vivo screening 
The SELEX approach from 2.1 yielded RNA aptamer pools from different rounds of selection differing 
in their enrichment of sequences that exhibit binding towards the target molecule. Here, two pools were 
used, the pool from round 9 with presumably strong aptamer target interaction and the pool from round 
6 with average binding properties. Copy DNA pools from rounds 6 and 9 were PCR-amplified with a 
forward (fwd) and reverse (rev) primer. These primers attach 5’-overhangs that are homologous to the 
5’ UTR upstream of the green fluorescent reporter gene (gfp) and 3’-overhangs to a 5’ part of the coding 
sequence of the reporter gene itself (for details see Figure 5.1). After PCR amplification of the selected 
pools with the correct primers the PCR product was used without further purification, nonetheless the 
correct length of the product was confirmed by gel electrophoresis. 
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Figure 5.1 SELEX pool cloning by homologous recombination in yeast. The cloning site of vector pWHE601* upstream of 
the GFP+ reporter gene is depicted. Upper panel: The two proposed TSS of the ADH1 promoter are indicated by arrows and the 
ultimate 3’-sequence of the promoter is underlined. The AgeI and NheI restriction sites are highlighted in bold and itacalized. The 
GFP+ reporter gene is emphasized in green, including the NheI restriction site. The vector is linearized using both restriction sites. 
The SELEX pool is amplified with primers (orange arrows) attaching overhangs (black extension of orange arrows) homologous 
to the sequence stretch upstream of AgeI and downstream of NheI. The rev primer introduces the Kozak-Start sequence (green 
line).   
The expression of GFP from the 2µ yeast shuttle vector pWHE601 is constitutively driven by a PADH1 
promoter with a 5’ UTR of 34 to 44 nt since two transcription start sites are described 155. The template 
vector, termed pWHE601*, used in this study is a derivative of the aforementioned pWHE601 where the 
start codon has been deleted (also known as I.BB – lab internal communication). For homologous 
recombination it was prepared by cutting with two restriction enzymes that produce incompatible ends 
– Nhe I and Age I. The restriction sites reside immediately upstream of the reporter gene to promote an 
efficient recombination event between promoter sequence and gfp gene 155. The start codon including 
the yeast Kozak sequence 5’-AAA-start-G-3’ was introduced with the 5’ overhang of the rev primer 201,202. 
This ensures that only yeast cells that have undergone an accurate homologous recombination will be 
selected for the in vivo screening step as incorrect recombined plasmids or survivors of the restriction 
digest cannot code for the fluorescent reporter and therefore remain colorless. That said, to minimize 
transformation of uncut plasmids, a gel extraction of the cut plasmids after the restriction digest was 
performed. 
Overall, one transformation mix for a homologous recombination contains around 100 fmol gel purified 
vector, a 10:1 molar excess of the PCR-amplified inserts and competent yeast cells according to the 
protocol used. Transformation was carried out according to the protocol of the Frozen Yeast 
Transformation Kit II from Zymo Research or a lithium acetate-based method 215. The transformation 
mix was plated on up to 40 petri dishes with a diameter of 9.2 cm. This assured a moderate colony 
density that simplified the selection of clones for the in vivo screening. Agar plates were composed of 
minimal medium (0.2% [w/v] yeast nitrogen base, 0.55% [w/v] ammonium sulfate, 2% [w/v] glucose, 12 
µg/mL adenine, MEM amino acid mix). The transformed yeast cells were cultured for 3-4 days at 28-
30°C.       
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5.2.1.3 Selection – Fluorescence Microscopy 
The selection step was accomplished employing a standard stereo microscope (M50, Leica 
Microsystems) equipped with a setup to visualize the fluorescence of interest. Petri dishes were scanned 
by eye for fluorescent colonies. Controls have to be transformed alongside the pool to determine the 
minimal and maximal fluorescence. The negative control accords to the vector backbone pWHE601* 
unable to express GFP and the positive control, pWHE601, constitutively expressing GFP from the same 
backbone vector, but containing a start codon and Kozak sequence. In addition it is helpful to have an 
already working riboswitch available to get an idea which fluorescence levels are to be expected 
approximately. Fluorescent colonies were marked with a pen on the bottom of the petri dish and later 
picked into a 96-well plate as described the next section. Colonies were select spanning the whole 
spectrum of fluorescence intensities. Only those colonies displaying no or a very weak fluorescence 
were omitted. 
5.2.1.4 In vivo Screening  
The screening step was carried out in transparent 96-well plates using the Tecan plate reader Infinite 
M200 Pro. Colonies chosen from plate in 2.3 were incubated as pre-culture in 200 µl minimal medium 
for 16-20 h at 30°C using 96-well format, U-bottom, on a plate shaker Titramax 1000 (Heidolph 
instruments). The pre-culture was then transferred to fresh medium and grown for additional 24 h in the 
absence and presence of the target molecule. 20 µl are drawn each time to inoculate 2 triplicates for 
each independently grown colony. The first triplicate is cultured in absence of the ligand, the second 
triplicate in presence of the target molecule. These cultures are used to determine whether addition of 
the ligand reduces fluorescence levels and thereby indicates the presence of a working riboswitch 
transcribed by the corresponding yeast cells. 
Fluorescence was measured from the top at an emission wavelength of 510 nm after excitation at 482 
nm at an optical density (OD600) of 0.6-0.9 in 96-well flat-bottom plates. Cultures were diluted accordingly 
in PBS and have to be shaken up shortly prior to analysis. In addition to fluorescence, the OD600 was 
recorded in parallel to normalize the fluorescence signal for cell growth. Yeast cells transformed with 
the positive and negative control as well as a working riboswitch were included in each plate and 
measured alongside the picked colonies. The determined fluorescence signal was normalized to an 
OD600 of 1, the fluorescence of the negative control was subtracted and the signal is displayed as relative 
fluorescence with the positive control set to 100% signal intensity. The riboswitch control was used to 
check whether a systematic error had occurred, since the fluorescence values including the dynamic 
change of fluorescence of cells expressing this construct was known. 
Cells in wells displaying a dynamic change of the fluorescent signal were spread out on agar plates and 
singularized. This separation step (singularization) after the first screening round was important, 
because sometimes a partitioned fluorescence distribution within a given colony was observed that is 
due to an uptake of multiple plasmids at once. Four individual colonies from one original candidate were 
incubated and subjected to a second round of screening as described above. 
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Typically, only few colonies were identified to show a change in fluorescence signal intensity upon ligand 
addition. The dynamic range of the signal change was rather low and a threshold needed to be set 
above which candidates were chosen. Once candidates had been verified in the second screening 
round, the plasmids were isolated and transformed into E. coli. Isolated plasmids should then be 
retransformed into yeast and measured to confirm their switching activity. Ultimately, the plasmids were 
sequenced. 
5.2.1.5 Fluorescence spectroscopy reporter assay  
In general, reporter plasmids containing a fluorescent reporter protein with or without a preceding 
riboswitch in the 5’-UTR were transformed into yeast and gene expression was measured by 
fluorescence spectroscopy on a Fluorolog FL3-22 instrument from Horiba. All experiments were 
performed in two biological triplicates. Yeast cultures were grown to saturation in 4ml SCD minimal 
medium at 30 °C and used to inoculate a fresh culture in a 1:100 dilution. These cultures were grown in 
1.5 ml SCD minimal medium in 24-well plates for 24 h in absence and presence of the cognate ligand. 
A positive and negative control were treated equally and used to calculate basal expression and 
switching performance of the reporter constructs. Initially, 500 µl culture were harvested by 
centrifugation at 13000 rpm for 30 s and resuspended in 1 ml PBS. 500 µl were transferred to 1.5 ml 
PBS in a 2 ml four-way cuvette to yield a 1:8 dilution of the original optical density about 6 at 600 nm of. 
This suspension was also taken to measure the OD600. GFP was excited at 482 nm and fluorescence 
was measured from 500 nm to 520 nm. Fluorescence values at 510 nm were taken for calculations. 
Since a plateau in the emission spectrum emerges from 508 nm to 512 nm, errors are kept at a minimum. 
Entrance and exit slits were set to allow a width of 2 nm for the path of light. Dark current was 
automatically subtracted and fluorescence recorded in counts per second. To calculate the basal 
expression of yeast cells expressing a riboswitch in the 5’-UTR, all fluorescence values were corrected 
for cell growth, background fluorescence emitted by the negative control was subtracted and the 
fluorescence values of the constructs were divided by the fluorescence values of the positive control. 
This protocol was followed for samples treated with and without ligand, such that by the division of 
untreated by treated conditions an x-fold reduction of gene expression could be determined. 
5.2.1.6 In silico rational design 
The secondary structure of the identified sequences was simulated deploying online tools such as the 
Vienna RNA package 174. Based on these predictions it was now necessary to track down the minimal 
motif that is essential for ligand binding and in vivo activity. This was done by carefully evaluating the in 
silico generated structural data and a sequence alignments from truncated versions 138,216. For the 
design of primers that will truncate the sequence step by step it was found to be critical to start with 
short steps of about 5 nt, as it is completely unknown where the binding site and the structural 
information for in vivo activity are located. Truncated sequences were cloned using standard cloning 
techniques. After cloning, the plasmids were sequenced and the regulatory effect was measured after 
transformation into yeast. 
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5.2.2 Characterization of a riboswitching expression system 
PADH1-driven device: A modified version of the plasmid pWHE601 was used as the backbone vector to 
clone the riboswitch parts downstream of the ADH1 promoter, generating the NOR and NOT devices 
shown in Figures 4.18 and 6.9. Plasmids were transformed into the electrocompetent E. coli strain 
TOP10 grown in LB medium supplemented with 100 µg/ml ampicillin. 
PGAL1-driven device: The plasmid pSP212-PTEF1-GLC-TCYC1 expresses the GEV transcription factor that 
is C-terminally coupled to mCherry and was transformed into competent yeast containing the NeoTc 
device integrated into the ade2 locus.  
5.2.2.1 Genome manipulations 
Genotype RS453α  matα ade2-1 trp1-1 can1-100 leu2-3 his3-1 ura3-52  
Genotype CEN.PK111-27B matα leu2-3 trp1-1 
Genomic integrations were performed by the CRISPR/Cas9-based method CASEMBLR 45. The yeast 
shuttle plasmids p414-PTEF1-Cas9-TCYC1 (plasmid #83946)217 and p426-pSNR52-gRNA.CAN1.Y-TSUP4 
(plasmid #43803)72 were ordered from addgene.org. p414 (Trp-) expresses the Cas9 endonuclease and 
p426 (URA marker) harbors the gRNA expression cassette that was transferred to p425 (Leu-) as the 
URA3 locus presented a putative integration site and the CEN.PK111-27B strain is Ura+. Gibson 
assembly was used to simultaneously ligate the gRNA expression cassette amplified in one part from 
p426 (broken in two by a Cla I restriction site) with one of the three gRNAs targeting the ade2, his3 and 
ura3 loci and the linearized p425 plasmid, excluding the original gRNA. Initially, as described in the 
publication from Jakoucinas et al., yeast strain CEN.PK 111-27B was used for integrations into the ade2 
locus, resulting in null mutants accumulating a red pigment that absorbs green fluorescence light. 
Experiments with GFP as a reporter protein were thus found to be impracticable. The strain was 
therefore switched to RS453α that, too, is a null mutant with respect to the ade2 gene, but passaged 
long enough to have a white phenotype due to mutations of enzymes in the upstream de novo 
biosynthesis of purine nucleotides, thus preventing the occurrence of a red pigment. For integrations 
into the his3 and ura3 loci strain RS453α was taken as well. DNA parts for integration were assembled 
by PCR, purified, and EtOH precipitated to increase their concentration. Parts featured 50 nt homology 
upstream and downstream to the neighboring part. Overlaps to the genomic target sites were found to 
be at least 100 nt for a integration without extra homology block to confer correct assembly. Using an 
extra homology block, that is, a 300-500 nt dsDNA block identical to the upstream and downstream 
integration site, 50 nt overlap to such a block are sufficient to yield correct integrations. 2-4 pmol/part 
were mixed with 0.5 µg p414-Cas9 and 1 µg p425-gRNA. Transformations were conducted according 
to the instructions provided with the Frozen-EZ Yeast Transformation II Kit from Zymo Research and 
spread on appropriate SCD drop-out agar plates (see below for details on growth medium and protocol). 
As may be deduced from the genotype of this strain, neither integration site could be exploited for a 
phenotypic screening to detect locus destruction. However, it was found, in accordance with the 
developers of the method, that integration efficiency as confirmed by yeast colony PCR was between 
80-100 % for both loci, using primer pairs within and upstream or downstream of the integration sites. 
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5.2.2.2 Cultivation of yeast 
The Frozen-EZ Yeast Transformation II Kit was used for the preparation of competent yeast cells from 
strain RS453α and their subsequent transformation on appropriate SCD drop-out plates (0,2% YNB w/o 
AA (Difco), 0,15% Yeast Synthetic Drop-out Medium w/o uracil, leucine and tryptophan (Sigma Aldrich), 
2% dextrose (Carl Roth) and 1,8% agar (Carl Roth). Uracil, leucine and tryptophan were added as 
indicated on the complete formula of the Yeast Synthetic Drop-out Medium.  
After 3 d growth at 30°C in a humidified incubator, single colonies were cultured in 5 ml SCD drop-out 
medium for 24 h, then diluted to an OD600 of approx. 0.05 (flow cytometry) or 0.01 (microfluidic 
measurements) and grown for additional 10 h (flow cytometry) or 5 h (microfluidic measurements) in 5 
ml SCD drop-out medium to obtain actively growing cells in early to mid-log phase for the subsequent 
experiments. 
Cells for bulk measurements were grown in 3 ml SCD drop-out medium without repressors or 
supplemented with 100 µM neomycin and /or 250 µM tetracycline in 12-well plates for 24 h and analyzed 
in two independent triplicates. Fluorescence of all cultures was OD600- and background-corrected and 
is displayed relative to a positive control that is not riboswitch-controlled, but treated equally.  
5.2.2.3 Cytometry 
All cytometry measurements were performed on a CytoFlex S instrument from Beckman Coulter 
equipped with a 488 nm laser and a 561 nm laser for excitation of GFP and mCherry, respectively. 
Emission light was bandpass-filtered at 510/20 nm or 610/20 nm, respectively. 
Cells taken from the 10 h pre-culture were split to 12-well plates at an OD600 of 0.05 and cultured for 10 
h at 30 °C in 3 ml SCD drop-out medium. This protocol generates yeast cultures that are in the mid-log 
phase at the time point of induction and grow until late log phase over the time course of the experiment. 
4 separate experiments with regard to the timing of repression at −1 h, 0 h, +1 h and +2 h relative to 
the induction with 10 nM ß-estradiol at 0 h were performed. 10 µl - 30 µl samples were drawn hourly for 
7 h (Figure 3). Experiments to investigate dose-dependencies of the gate on repressor and inducer 
concentrations were conducted with 2.5, 5 or 10 nM ß-estradiol and 2, 10, 50 and 100 µM neomycin 
and 0.5, 2, 10, 250 µM tetracycline. Here, repressors were added +2 h relative to induction and 10 µl - 
30 µl samples were drawn at 0 h, 2 h, 3 h, 5 h and 7 h. 
5.2.2.4 Gating 
10,000 events were recorded for each sample. Doublets were removed by drawing a gate in the FCS-
H and FSC-A dot plot. Doublets are events displaying larger signal integration values (FSC-A) compared 
to other events with the same FSC-H value. This subpopulation was then subjected to a dot plot 
fluorescence gating (FL1-510 and FL2-610) to remove non-responsive cells. Non-responders are cells 
emitting no mCherry fluorescence and thus no GFP fluorescence. The final subset was plotted over 
time. 
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5.2.2.5 Time-lapse Microscopy 
For in vivo time-lapse experiments, cells from the 5 h pre-culture were trapped on a PDMS-based 
microfluidic chip, inspired by the Alcatraz chip 218. Single yeast cells were kept in place in a continuous 
flow for several hours and images were recorded every 10 min at 3 different focal planes. Imaging was 
performed on a Nikon Eclipse TI with a 100x NA 1.45 objective, ORCA Flash4.0 camera (Hamamatsu) 
with SpectraX light engine (Lumencor) at 470/24 nm for GFP and 575/25 nm for mCherry. Cells were 
kept at 30˚C with an incubator box (life imaging services). Concentrations of inducer and repressors 
were used according to the cytometry measurements: 10 nM ß-estradiol, 100 µM neomycin and 250 µM 
tetracycline. Cells were induced for 2 h, then exposed to single or both repressors. Single cell traces 
were extracted with a FIJI/Matlab script. 
5.2.3 Tc-Dimers 
5.2.3.1 Cloning 
Standard cloning protocols as described in chapter 5.1.1 were applied and scaled up accordingly. All 
reactions were performed in PCR reaction tubes and 96-well format. Primers were ordered as 96-well 
plates containing all forward and all reverse primers in two separate plates. As PCR template a dsDNA 
stretch of the 3’-aptamer was used and amplified with fwd and rev primers attaching new stems and 
thereby generating individual new aptamers. PCR reactions were precipitated by isopropanol/sodium 
acetate employing a table-top centrifuge equipped with a rotor for PCR stripes and placed in a fridge. 
The complete PCR reaction was digested with Age I and Nhe I alongside the vector pGFP3 for 16 h at 
37 °C. Restriction enzymes present in the insert digests were heat-inactivated at 80 °C for 30 min and 
stored at -20 °C. The digest of pGFP3 was gel-purified from a 1% agarose gel at 7000 nt to exclude 
enzymes and uncut plasmid. Singly cut plasmids could not be excluded, because restriction of pGFP3 
reduces the vector size only by 120 nt, which cannot be separately detected on a 1% agarose gel due 
to the broad band pattern of the migrating linearized dsDNA. Inserts and linearized pGFP3 were ligated 
at RT for 1 h in 96 separate reactions and used to transform chemo-competent Top10 cells. 
Note: the heat shock was performed in a PCR thermocycler for 60s to allow the reaction to heat up from 
0 °C and reach 42 °C.  After heat shock and cooling the transformation mixture was transferred to 1.5 
ml reaction tubes filled with 1 ml LB. Cells were spread with glass beads on LB-Amp agar plates. 
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6 Material 
The materials and instruments that were utilized in this work are listed below. The following section 
contains the lists for chemicals and reagents (Table 6.1), instrumentation (Table 6.2), kits and 
commercially available systems (Table 6.3), enzymes and proteins (Table 6.4), protein standards and 
DNA ladders (Table 6.5), consumables (Table 6.6), antibodies (Table 6.7), cell strains (Table 6.8), 
buffers and solutions (Table 6.9), oligonucleotides (Table 6.10) and plasmids (Table 6.11).  
All buffers and solutions were produced using deionized water or aqua valde purificata. If necessary, 
buffers and solutions were sterilized by autoclaving at 121°C and 2 bar for 20 min. Oligonucleotides 
were ordered from Sigma-Aldrich, Munich (desalted or RP1 purified). Cloned sequences were analyzed 
by Seqlab, Göttingen using Sanger-Sequencing and capillary electrophoresis.  
6.1 Chemicals, instrumentation and consumables 
Table 6.1 List of employed chemicals and reagents. 
Chemicals and reagents Manufacturer 
Adenine Roth, Karlsruhe 
Agar Oxoid, Heidelberg 
Agarose peqGold Universal Peqlab, Erlangen 
Ammonium sulfate Roth, Karlsruhe 
Ampicillin Roth, Karlsruhe 
Bromophenol blue Roth, Karlsruhe 
1-Butanol Roth, Karlsruhe 
Calcium chloride Roth, Karlsruhe 
Chloroform, p.a. Roth, Karlsruhe 
Deoxynucleotide triphosphate (dNTP) Peqlab, Erlangen 
Dimethyl sulfoxide Peqlab, Erlangen 
Dulbecco’s Phosphate buffered Saline (PBS)  Life Technologies, USA 
Dithiothreitole (DTT) Roth, Karlsruhe 
Ethanol absolute, p.a. Merck, Darmstadt 
Ethanol, denatured VWR, Darmstadt 
Ethidium bromide  Roth, Karlsruhe 
Ethylenediaminetetraacetic acid (EDTA) Roth, Karlsruhe 
Glucose, water-free Roth, Karlsruhe 
Glycerol, p.a. Roth, Karlsruhe 
Hydrochloric acid (HCl) Roth, Karlsruhe 
Isopropanol, p.a.  VWR, Darmstadt 
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Leucine Roth, Karlsruhe 
MEM Amino acids, 50X Sigma Aldrich 
Magnesium chloride  Roth, Karlsruhe 
Nicotinamide adenine dinucleotide (NAD) Roth, Karlsruhe 
PEG-8000 Roth, Karlsruhe 
Sucrose Roth, Karlsruhe 
Sodium chloride (NaCl) Roth, Karlsruhe 
Sodium dodecyl sulfate (SDS), pellets Roth, Karlsruhe 
Tris Roth, Karlsruhe 
Tryptone Oxoid, Heidelberg 
Tryptophane Roth, Karlsruhe 
Triton-X-100 Roth, Karlsruhe 
Uracil Roth, Karlsruhe 
Xylene cyanole Roth, Karlsruhe 
Yeast extract Oxoid, Heidelberg 
Yeast nitrogen base (w/o ammonium sulfate) Difco 
Yeast synthetic drop-out (-Ura/Leu/Trp) Sigma Aldrich 
Table 6.2 List of utilized instruments. 
Instrument Manufacturer 
Accuracy weighing machine Acculab, USA 
Centrifuges Heraeus Christ, Osterode 
CytoFlex S (flow cytometer) Beckman-Coulter, Krefeld 
Electroporator MicroPulser™ Bio-Rad, Munich 
Flourescence Stereo Microscope Leica Microsystems, Wetzlar 
Fluorolog FL3-22 Horiba, Darmstadt 
Gel documentation with UV screen INTAS, Göttingen 
Heating block  VWR, Darmstadt 
Incubation Shaker Multitron Infors AG, Bottmingen 
Incubator Heraeus Christ, Osterode 
Infinite® M200 plate reader  Tecan Trading AG, Switzerland 
Magnetic stirrer IKA RET basic IKA, Staufen 
Milli-Q® water purification system with RNase filter EMD Millipore, France 
NanoDrop® ND-1000 spectral photometer Peqlab, Erlangen 
Scale Acculab, USA 
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T100™ Thermal Cycler  Bio-Rad, Munich 
Titramax 100, 1000 (platform shakers) Heidolph, Schwabach 
Inkubator 1000 Heidolph, Schwabach 
Thermomixer comfort   Eppendorf AG, Hamburg 
Table 6.3 List of kits and commercially available systems. 
Kits and commercially available systems Manufacturer 
Frozen-EZ Yeast Transformation II  Zymo Research, USA 
QIAquick Gel Extraction QIAGEN, Hilden 
QIAprep® Spin Miniprep Kit QIAGEN, Hilden 
QIAquick PCR Purification Kit  QIAGEN, Hilden 
Table 6.4 List of employed enzymes. Buffers were used as supplied and recommended by the 
manufacturer unless otherwise stated. 
Enzymes and proteins Manufacturer 
Q5 High-Fidelity DNA Polymerase [2 U/µl] New England Biolabs, USA 
Phusion Polymerase Thermo Fisher Scientific, Bremen 
T4 DNA Ligase [400 U/µl] New England Biolabs, USA 
T4 DNA Polymerase [3 U/µl] New England Biolabs, USA 
T4 Polynucleotide kinase [10 U/µl] New England Biolabs, USA 
Taq DNA Polymerase [5 U/µl] New England Biolabs, USA 
Taq DNA Ligase [40 U/µl] New England Biolabs, USA 
T5 Exonuclease [10 U/µl] New England Biolabs, USA 
Restriction endonucleases 
AgeI-HF [20 U/µl] New England Biolabs, USA 
ClaI [10 U/µl] New England Biolabs, USA 
Dpn I [20 U/µl] New England Biolabs, USA 
NheI-HF [20 U/µl]  New England Biolabs, USA 
SacI-HF [20 U/µl] New England Biolabs, USA 
SpeI-HF [20 U/µl] New England Biolabs, USA 
XbaI [20 U/µl] New England Biolabs, USA 
 [20 U/µl] New England Biolabs, USA 
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Table 6.5 List of used DNA ladders. 
Protein standards/ DNA ladders Manufacturer 
peqGold Ultra Low Range DNA ladder II PeqLab, Erlangen 
peqGold 1 kB DNA ladder PeqLab, Erlangen 
Table 6.6 List of utilized consumables. 
Consumables Manufacturer 
Cellstar® cell culture plates, 12-well/ 24-well Greiner Bio-One, Austria 
Cuvettes, acrylic  Sarstedt, Nürnbrecht 
Dispenser tips Greiner, Nürtingen 
Micro Pulser Electroporation Cuvettes, 0.1 cm gap Bio-Rad, Munich 
Breathseal, gas permeable, sterile Greiner Bio-One, Austria 
96-well U bottom/ flat bottom Greiner Bio-One, Austria 
Nitrile Gloves  Starlab, Hamburg 
Petri dishes, plastic Greiner, Nürtingen 
Pipette tips, plastic 
Greiner, Nürtingen 
Starlab, Hamburg 
Nerbe Plus, Winsen 
Pipettes, plastic Nerbe Plus, Winsen 
Polyethylene tubes Sarstedt, Nürnbrecht 
Reaction tubes (1.5 ml, 2 ml) Greiner, Nürtingen 
Syringes Becton Dickinson, Heidelberg 
6.2 Prokaryotic and eukaryotic cell strains 
Table 6.7 List of employed cell strains. 
Cells Genotype/ Description Reference 
Bacterial strains 
E. coli Top10 
F- mcrA Δ( mrr-hsdRMS-mcrBC) Φ80lacZΔM15 Δ 
lacX74 recA1 araD139 Δ( araleu)7697 galU galK 
rpsL (StrR) endA1 nupG 
Invitrogen, USA 
Eukaryotic cell lines 
RS453α matα ade2-1 trp1-1 can1-100 leu2-3 his3-1 ura3-52 Hillen Lab 
CEN.PK111-27B matα leu2-3 trp1-1 Entian Lab 
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6.3 Buffers and solutions 
Table 6.8 List of buffers and solutions and their composition. 
Buffer/ solution Ingredients Concentration 
5x ISO buffer 
Tris-HCl pH 7.5 
MgCl2 
Each dNTP 
DTT 
PEG-8000 
NAD 
0.5 M 
50 mM 
1 mM 
50 mM 
25% (w/v) 
5 mM 
STET buffer 
Sucrose 
Tris-HCl, pH 8 
EDTA 
Triton-X-100 
8% (w/v) 
50 mM 
50 mM 
5% (v/v) 
YPD 
Yeast extract 
Peptone 
Glucose 
Agar for plates 
1% (w/v) 
2% (w/v) 
2% (w/v) 
1.8% (w/v) 
SCD -Ura 
50x MEM Amino acids  
Adenine 
Ammonium sulfate 
YNB 
Glucose 
Agar for plates 
1x 
12 µg/ml 
0.55% (w/v) 
0.2% (w/v) 
2% (w/v) 
1.8% (w/v) 
SCD –Ura/Leu/Trp 
Yeast synthetic drop-out (-
Ura/Leu/Trp) 
Ammonium sulfate 
YNB 
Glucose 
Uracil, if needed 
Leucine, if needed 
Tryptophan, if needed 
Agar for plates 
0.15% (w/v) 
 
0.55% (w/v) 
0.2% (w/v) 
2% (w/v) 
0.076 mg/ml 
0.38 mg/ml 
0.076 mg/ml 
1.8% (w/v) 
50x TAE 
Tris 
Acetic acid 
EDTA 
pH 8.3 
2 M 
1 M 
50 mM 
 
6x DNA loading dye 
Tris-HCl pH 7.6 
EDTA 
Acetic acid 
40 mM 
1 mM 
20 mM 
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Glycerol 
Bromophenol blue 
Xylene cyanole 
50% (v/v) 
Spatula point 
Spatula point 
Ampicillin, stock solution 
Ampicillin 
In 70% (v/v) EtOH 100 mg/ml 
LB medium 
 
 
LB-Amp plates 
Tryptone 
Yeast extract 
NaCl 
Agar 
Ampicillin  
1% (w/v) 
0.5% (w/v) 
1% (w/v) 
2% (w/v) 
100 µg/ml 
SOC-medium 
Yeast Extract 
Tryptone 
NaCl 
KCl 
MgCl2 
MgSO4 
Glucose 
0.5% 
0.2% 
10 mM 
2.5 mM 
10 mM  
10 mM 
20 mM 
6.4 Oligonucleotides 
List of oligonucleotides synthesized by Sigma Aldrich for cloning purposes. 
Table 6.9 Primers for Project I: Aptamers from literature 
# stock Primer name 5‘->3‘ sequence 
2 fw CS1-fw-Atra 
CCGGTGGGCTAGCATGAGGCGGGGTAAAATTGCTCCGATAAAAACGCAAAGTCCTAAA
ATGG 
2 rev CS1-r-Atra 
CTAGCCATTTTAGGACTTTGCGTTTTTATCGGAGCAATTTTACCCCGCCTCATGCTAGC
CCA 
3 fw CS1-fw-DMHBI 
CCGGTGGGCTATTGCTGGAGGGGCGCCACATTTCGGTGGTGGTTGGGTGCGGTCGG
CGATAGCTCAAAATGG 
3 rev CS1-r-DMHBI 
CTAGCCATTTTGAGCTATCGCCGACCGCACCCAACCACCACCGAAATGTGGCGCCCCT
CCAGCAATAGCCCA 
5 fw CS1-fw-MG*AgeI CTCTTCACCGGTGGATCCCGACTGGCGAGAGCCAGGTAACGAATG 
5 rev  CS1-r-MG*NheI CTCTTCGCTAGCCATTTTAGGATCCATTCGTTACCTGGCTCTCGC 
6 fw CS1-fw-StrepT*AgeI CTCTTCACCGGTGATCGCATTTGGACTTCTGCCCGCAAG 
6 rev CS1-r-StrepT*NheI CTCTTCGCTAGCCATTTTGGATCCGACCGTGGTGCCCTTGCGGGCAGAAGTCCAAATG 
7 fw  CS1-fw-TobD1*AgeI CTCTTCACCGGTACTTGGTTTAGGTAATGAG 
7 rev CS1-r-TobD1*NheI CTCTTCGCTAGCCATTTTACTCATTACCTAAACCAAGTACCGG 
13 fw CS1-fw-DIR 
CCGGTGCGCCTTGAAAAGCCTGCTTCGGCAGCTGGTGAATGACAGCTATGGCGCTTA
AAATGG 
13 rev CS1-r-DIR 
CTAGCCATTTTAAGCGCCATAGCTGTCATTCACCAGCTGCCGAAGCAGGCTTTTCAAG
GCGCA 
14 fw CS1-fw-TPP*AgeI 
CTCTTCACCGGTATCGGGGTGCCCTTCTGCGTGAAGGCTGAGAAATACCCGTATCACC
TG 
14 rev CS1-r-TPP*NheI 
CTCTTCGCTAGCCATTTTCCCTACGCTGGCATTATCCAGATCAGGTGATACGGGTATTT
CTCAG 
15 fw CS1-fw-L-Arg 
CCGGTCTGCAAGATAAACCGATGCTGGGCGATTCTCCTGAAGTAGGGGAAGAGTTGTA
GAAAATGG 
15 rev CS1-r-L-Arg 
CTAGCCATTTTCTACAACTCTTCCCCTACTTCAGGAGAATCGCCCAGCATCGGTTTATC
TTGCAGA 
16 fw CS1-fw-Ade*AgeI CTCTTCACCGGTACTCATATAACCTCAATAATATGGTTTGAGGGTGTCTACCAGGAACC 
16 rev CS1-r-Ade*NheI CTCTTCGCTAGCCATTTTACCCATAATCAGGATTTTACGGTTCCTGGTAGACACCCTCA 
17 fw CS1-fw-Gua*AgeI 
CTCTTCACCGGTACTCATATAATCGCGTGGATATGGCACGCAAGTTTCTACCGGGCAC
C 
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17 rev CS1-r-Gua*NheI CTCTTCGCTAGCCATTTTACCCATAGTCGGACATTTACGGTGCCCGGTAGAAACTTGC 
18 fw CS1-fw-TMRlg 
CCGGTGGGACGCGTAAAGAGTGCTGCTTCGGCAGAGAGGTCTTCGCGTCCCTAAAAT
GG 
18 rev CS1-r-TMRlg 
CTAGCCATTTTAGGGACGCGAAGACCTCTCTGCCGAAGCAGCACTCTTTACGCGTCCC
A 
19 fw CS1-fw-TMRsh CCGGTGGGACGAGAGAGCTGCTTCGGCAGAGAGGTCTCGTCCCTAAAATGG 
19 rev CS1-r-TMRsh CTAGCCATTTTAGGGACGAGACCTCTCTGCCGAAGCAGCTCTCTCGTCCCA 
20 fw CS1-fw-HAP 
CCGGTGCAGCCAACTAGCGAGAGCTTAAATCTCTGAGCCCGAGAGGGTTCAGTGCTG
CAAAATGG 
20 rev CS1-r-HAP 
CTAGCCATTTTGCAGCACTGAACCCTCTCGGGCTCAGAGATTTAAGCTCTCGCTAGTT
GGCTGCA 
21 fw CS1-fw-Theo CCGGTGGCGATACCAGCCGAAAGGCCCTTGGCAGCGTCAAAATGG 
21 rev CS1-r-Theo CTAGCCATTTTGACGCTGCCAAGGGCCTTTCGGCTGGTATCGCCA 
22 fw CS1-fw-SRB 
CCGGTGAACCTCGCTTCGGCGATGATGGAGAGGCGCAAGGTTAACCGCCTCAGGTTC
AAAATGG 
22 rev CS1-r-SRB 
CTAGCCATTTTGAACCTGAGGCGGTTAACCTTGCGCCTCTCCATCATCGCCGAAGCGA
GGTTCA 
23 fw CS1-fw-TMRV1 CCGGTGAGAGAGCTGCTTCGGCAGAGAGGTCTCAAAATGG 
23 rev CS1-r-TMRV1 CTAGCCATTTTGAGACCTCTCTGCCGAAGCAGCTCTCTCA 
24 fw CS1-fw-TMRV2 CCGGTGAGAGAGTGCTGCTTCGGCAGAGAGGTCTCAAAATGG 
24 rev CS1-r-TMRV2 CTAGCCATTTTGAGACCTCTCTGCCGAAGCAGCACTCTCTCA 
25 fw CS1-fw-DFX CCGGTGAGGCTCCTGTGAAGCAACCGAATGGACTCAAAAATGG 
25 rev CS1-r-DFX CTAGCCATTTTTGAGTCCATTCGGTTGCTTCACAGGAGCCTCA 
28-fw CS1-fw-KanB(8-1-1) CCGGTGGGAGCTCGGTACCGAATTCTCAAAATGG 
28-rev CS1-r-KanB(8-1-1) CTAGCCATTTTGAGAATTCGGTACCGAGCTCCCA 
 
Table 6.10 Primers for Project I: CFX in vivo screening 
# stock Primer name 5‘->3‘ sequence 
42-fw CS7-fw-HR-pRS453a 
CAAGCTATACCAAGCATACAATCAACTCCAAGCTAGATCTACCGGTGGGAGACGCAAC
TGAATGAA 
42-rev CS7-r-HR-pRS453a 
CAAGAATTGGGACAACTCCAGTGAAAAGTTCTTCTCCTTTGCTAGCCATTTTGTGACGC
GACTAGTTACGGA 
55-fw CS9-fw-2B-10 
ATACCAAGCATACAATCAACTCCAAGCTAGATCTACCGGTACTGAATGAAGTTGGGATC
AGAG 
55-rev CS9-r-2B-10 
GGGACAACTCCAGTGAAAAGTTCTTCTCCTTTGCTAGCCATTTTTAGTTACGGATCGTG
TAACTTCGAC 
56-fw CS9-fw-2B-20 
ATACCAAGCATACAATCAACTCCAAGCTAGATCTACCGGTGTTGGGATCAGAGCGGAT
CTC 
56-r CS9-r-2B-20 
GGGACAACTCCAGTGAAAAGTTCTTCTCCTTTGCTAGCCATTTTTCGTGTAACTTCGAC
CAGATGA 
57-fw CS9-fw-2B-30 
ATACCAAGCATACAATCAACTCCAAGCTAGATCTACCGGTGAGCGGATCTCTTCAATCT
CTC 
57-r CS9-r-2B-30 
GGGACAACTCCAGTGAAAAGTTCTTCTCCTTTGCTAGCCATTTTTCGACCAGATGAATT
GAGTTCC 
58-fw CS9-fw-6H-10 
ATACCAAGCATACAATCAACTCCAAGCTAGATCTACCGGTACTGAATGAAAGCACGGC
ATTG 
58-r CS9-r-6H-10 
GGGACAACTCCAGTGAAAAGTTCTTCTCCTTTGCTAGCCATTTTTAGTTACGGACCTCC
GTGTAAC 
59-fw CS9-fw-6H-20 
ATACCAAGCATACAATCAACTCCAAGCTAGATCTACCGGTAGCACGGCATTGAGATTCT
C 
59-r CS9-r-6H-20 
GGGACAACTCCAGTGAAAAGTTCTTCTCCTTTGCTAGCCATTTTCCTCCGTGTAACTTC
GAACC 
60-fw CS9-fw-6H-30 
ATACCAAGCATACAATCAACTCCAAGCTAGATCTACCGGTTGAGATTCTCAATAGTCAA
GGCTGAAG 
60-r CS9-r-6H-30 
GGGACAACTCCAGTGAAAAGTTCTTCTCCTTTGCTAGCCATTTTACTTCGAACCAGAAT
AACTTCAGCC 
61-fw CS9-fw-10A-10 
ATACCAAGCATACAATCAACTCCAAGCTAGATCTACCGGTACTGAATGAACATAAGTGA
ACGCG 
61-r CS9-r-10A-10 
GGGACAACTCCAGTGAAAAGTTCTTCTCCTTTGCTAGCCATTTTTAGTTACGGATCGTG
TAACTCCGTG 
62-fw CS9-fw-10A-20 
ATACCAAGCATACAATCAACTCCAAGCTAGATCTACCGGTCATAAGTGAACGCGACTCT
ATCTC 
62-r CS9-r-10A-20 
GGGACAACTCCAGTGAAAAGTTCTTCTCCTTTGCTAGCCATTTTTCGTGTAACTCCGTG
CCG 
63-fw CS9-fw-10A-30 
ATACCAAGCATACAATCAACTCCAAGCTAGATCTACCGGTCGCGACTCTATCTCCCTAA
ACTAG 
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63-r CS9-r-10A-30 
GGGACAACTCCAGTGAAAAGTTCTTCTCCTTTGCTAGCCATTTTCCGTGCCGCTATATG
ACTC 
70-rev CS9-r-10A-4 CTCTTCGCTAGCCATTTTCGCGACTAGTTACGGATCGTG 
Table 6.11 Primers for Project II: Tc-dimers 
# stock Primer name 5‘->3‘ sequence 
121-fw CS15-fw-GFP15a CCGGTCAACAACAACAACAACAACAACAACAAAGAGGCCTAAAACATACCAG 
121-rev CS15-r-GFP15a 
GCGGGTGGCGATCTGGTATGTTTTAGGCCTCTTTGTTGTTGTTGTTGTTGTTGTTGTTG
A 
122-fw CS15-fw-GFP15b 
ATCGCCACCCGCGCTTTAATCTGGAGAGGTGAAGAATACGACCACCTAGGCCTCTAAA
AAATGG 
122-rev CS15-r-GFP15b CTAGCCATTTTTTAGAGGCCTAGGTGGTCGTATTCTTCACCTCTCCAGATTAAAGC 
123-fw CS15-fw-GFP16a CCGGTCAACAACAACAACAACAACAACAACAAAGAACCTAAAACATACCAG 
123-rev CS15-r-GFP16a GCGGGTGGCGATCTGGTATGTTTTAGGTTCTTTGTTGTTGTTGTTGTTGTTGTTGTTGA 
124-fw CS15-fw-GFP16b 
ATCGCCACCCGCGCTTTAATCTGGAGAGGTGAAGAATACGACCACCTAGGTTCTAAAA
AATGG 
124-rev CS15-r-GFP16b CTAGCCATTTTTTAGAACCTAGGTGGTCGTATTCTTCACCTCTCCAGATTAAAGC 
125-fw CS15-fw-GFP17 
CTCTTCACCGGTCAACAACAACAACAACAACAACAACAATACCAGCGAAACATACCAGA
TCGCCACCCGCGCTTTAATCTG 
125-rev CS15-r-GFP17 
CTCTTCGCTAGCCATTTTTTTACCAACGGGTGGTCGTATTCTTCACCTCTCCAGATTAAA
GCGCGGGTGGCGATCTG 
126-fw CS16-fw-GFP18 
CTCTTCACCGGTCAACAACAACAACAACAACAACAACAAGTTCCTAAAACATACCAGAT
CGCCACCCGCGCTTTAATCTG 
126-rev CS16-r-GFP18 
CTCTTCGCTAGCCATTTTTTGTTCCTAGGTGGTCGTATTCTTCACCTCTCCAGATTAAAG
CGCGGGTGGCGATCTG 
127-fw CS15-fw-GFP19a CCGGTCAACAACAACAACAACAACAACAACAAGGAGTGAAACATACCAG 
127-rev CS15-r-GFP19a GCGGGTGGCGATCTGGTATGTTTCACTCCTTGTTGTTGTTGTTGTTGTTGTTGTTGA 
128-fw CS15-fw-GFP19b 
ATCGCCACCCGCGCTTTAATCTGGAGAGGTGAAGAATACGACCACCCACTCCAAAAAA
TGG 
128-rev CS15-r-GFP19b CTAGCCATTTTTTGGAGTGGGTGGTCGTATTCTTCACCTCTCCAGATTAAAGC 
129-fw CS15-fw-Tc2cnst AAACATACCAGATCGCCACCCGCGCTTTAATCTGGAGAGGTGAAGAATACGACCACC 
129-rev CS15-r-Tc2cnst GGTGGTCGTATTCTTCACCTCTCCAGATTAAAGCGCGGGTGGCGATCTGGTATGTTT 
130-fw CS15-fw-GFP20 
CTCTTCACCGGTCAACAACAACAACAACAACAACAACAAGCGATCGCAAACATACCAG
ATCGCCACC 
130-rev CS15-rev-GFP20 CTCTTCGCTAGCCATTTTTTACGATCGCGGTGGTCGTATTCTTCACCTC 
131-fw CS15-fw-GFP21 
CTCTTCACCGGTCAACAACAACAACAACAACAACAACAAACACGCGAAACATACCAGAT
CGCCACC 
131-rev CS15-r-GFP21 CTCTTCGCTAGCCATTTTTTACACACGGGTGGTCGTATTCTTCACCTC 
132-fw CS15-fw-GFP22 
CTCTTCACCGGTCAACAACAACAACAACAACAACAACAACCTGGGAAACATACCAGATC
GCCACC 
132-rev CS15-r-GFP22 CTCTTCGCTAGCCATTTTTTCCTAGGGGTGGTCGTATTCTTCACCTC 
 
Tables 6.12 Primers for Project III: ROC’n’Ribo 
2µ plasmid-based NOR gate expression 
PADH1 
# stock Primer name 5‘->3‘ sequence 
31-fw CS5-fw-Tc 
CTCTTCACCGGTCAAACAAACAAACAAACAAACAAACAAACCGGTAAAACATACCAGAT
CGCCACCCG 
31-rev CS5-r-Tc CTCTTCGCTAGCCATTTTCCGGTAGGTGGTCGTATTCTTCACCTCTCC 
32-fw CS5-fw-Tc2 
ACCAAGCATACAATCAACTCCAAGCTAGATCTACCGGTCAACAAGGCCTAAAACATACC
AGATCGCC 
32-rev CS5-r-Tc2 TTTGTTTGTTTGTTTGTTTGTTTGTTTGGGCCTAGGTGGTCGTATTCTTC 
33-fw CS5-fw-Neo CTCTTCACCGGTCAAACAAACAAACAAACAAACAAACAAACCGGCTTAGCTTGTCC 
33-rev CS5-r-Neo CTCTTCGCTAGCCATTTTGCGACTTAGGACCATTAAAGGACAAGCTAAGCCGGTTTG 
34-fw CS5-fw-Neo2 
TACCAAGCATACAATCAACTCCAAGCTAGATCTACCGGTCAACAACGCTGTTAGCTTGT
CCTTTAATGG 
34-rev CS5-r-Neo2 
TTTGTTTGTTTGTTTGTTTGTTTGTTTGGGCCGTTAGGACCATTAAAGGACAAGCTAACA
GCG 
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PGAL1 
# stock Primer name 5‘->3‘ sequence 
72-fw CS11-fw-Gal1-prom GCCAGCAACGCGGCCCGACCTCGACGCATGCTATATTGAAGTACGGATTAGAAGCCG 
72-rev CS11-r- Gal1-prom CCATTAAAGGACAAGCTAACAGCGTTGTTGACCGGAATCC  
87-rev CS11-r-Gal1-I.BB 
CAGTGAAAAGTTCTTCTCCTTTGCTAGCGAAGAGACCGGTAATCCGGGGTTTTTTCTCC
TTG 
88-rev CS11-r-Gal1-601 
ATTGGGACAACTCCAGTGAAAAGTTCTTCTCCTTTGCTAGCCATCTTAAGAATCCGGGG
TTTTTTCTCCTTG 
 
pGLC modifications 
PSTE5/MRP7 
# stock Primer name 5‘->3‘ sequence 
99-fw CS13-fw-mrp7prom 
CAAGCGCGCAATTAACCCTCACTAAAGGGAACAAAAGCTGCCTCCCTTATCAATGAAA
CATACG 
99-rev cS13-rev-mrp7prom 
TAGAAGACAGTAGCTTCATCCGCGGGAATTCTTTGTAATTATTCTCACCTTAGGTTAAG
CTTG 
100-fw CS13-fw-ste5prom 
CAAGCGCGCAATTAACCCTCACTAAAGGGAACAAAAGCTGTAGAAGGCGTATTGCTCA
ATAGT 
100-rev CS13-rev-ste5prom 
TAGAAGACAGTAGCTTCATCCGCGGGAATTCTTTGTAATTTTAAAAGTTGTTTCCGCTG
TATCCT 
 
Genomic integrations – insert preparation 
NOR gate 
# stock Primer name 5‘->3‘ sequence 
76-fw CS13-fw-HR-Ade2 CAGGCGCATAACATAAGTCACAAATATTGTCCTTGCCTCGACGCATGCAACTTC 
76-rev CS13-rev-HR-Ade2 GGTTTAGTGTTTTCTTACCCAATTGTAGAGACTATGCATGCCGGTAGAGGTGTG 
92-fw CS13-fw-HR2-Ade 
ATTTGATTGCATTTTCTGCCAACAACTTCGCCTTAAGTTGAACGGAGTCCGGAACTCTA
GCAGGCGCATAACATAAGTCACA 
92-rev CS13-r-HR2-Ade 
TGGGCACCATTTACTAAAGAATTAGCAGTCATGATTGTGAGATCTGTTAACGGTTTAGT
GTTTTCTTACCCAATTGTAGA 
94-fw CS13-fw-Ade100 ATTTGATTGCATTTTCTGCCAACAAC 
94-rev CS13-r-ade100 TGGGCACCATTTACTAAAGAATTAGCAG 
 
GLC  
# stock Primer name 5‘->3‘ sequence 
160-fw CS18-fw-GEV1 
GAAGCAGGCGGCAGAAGAAGTAACAAAGGAACCTAGAGGCCTTTTGATGTCCCTCACT
AAAGGGAACAAAAGC 
161-fw CS18-fw-GEV2 
CATTACGAATGCACACGGTGTGGTGGGCCCAGGTATTGTTAGCGGTTTGAAGCAGGC
GGCAGAAGAAG 
160-rev CS18-r-GEV1 
CTTTGTCGCTCTTCGCAATGTCAACAGTACCCTTAGTATATTCTGCCGCAAATTAAAGC
CTTCGAG 
161-rev CS18-r-GEV2 
CCTTCATCTCTTCCACCCATGTCTCTTTGAGCAATAAAGCCGATAACAAAATCTTTGTCG
CTCTTCGCAATGTC 
162-fw CS18-fw-GEV-OL ATGACCTGCTGCTGGAGATG 
162-rev CS18-r-GEV-OL GTGGCCAAGTGGCTTTGGT 
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6.5 Plasmids 
Tables 6.13 List of plasmids generated and used in this work. 
Plasmids for Project I: Aptamers from literature 
# stock Plasmid name Description  
1 I.601 pWHE601, adopted from Dr. Julia Weigand 
2 I. BB pWHE601*, substitution of AflII for AgeI, deletion of start codon 
3 I. MG-Apt 
Insertion of respective aptamer 
4 I. StrepT-Apt 
5 I. TobD1-Apt 
7 I. Atra-Apt 
8 I. TPP-Apt 
9 I. DIR-Apt 
11 I. DMHBI-Apt 
12 I. L-Arg-Apt 
13 I. Ade-Apt 
14 I. Gua-Apt 
15 I. Neo-Apt Adopted from Dr. Julia Weigand, M4 riboswitch 
16 I. Tc-AN32sh-Apt Adopted from Dr. Julia Weigand, AN32sh riboswitch 
17 I. TMRlg-Apt 
Insertion of respective aptamer 
18 I. TMRsh1-Apt 
19 I. TMRsh2-Apt 
25 I. Theo-Apt 
26 I. HAP-Apt 
27 I. DFX-Apt 
28 I. TMRV1-Apt 
29 I. TMRV2-Apt 
30 I. SRB-Apt 
31 I. KanB(8-1-1)-Apt 
 
Plasmids for Project I: CFX in vivo screening 
# stock Plasmid name Description  
 V.pool-R6 
The pools from SELEX cloned by homologous recombination in yeast. 
 V.pool-R9 
 V.2B 
Unique sequences obtained after in vivo screening that display minor riboswitching 
properties. 
 V.6H 
 V.10A 
 V.12A 
-- V.2B1 
Truncations of the indicated sequences. Refer to Figure 4.9 for the exact modifications.  
All stored in PCR-strips and numbered according to plasmid name. 
- V.2B1 
- V.2B1 
- V.2B1 
 V.2B1 
- V.2B1 
- V.2B1 
- V.2B1 
- V.2B1 
- V.6H1 
- V.6H1 
- V.6H1 
- V.6H1 
- V.6H1 
- V.6H1 
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- V.6H1 
- V.6H1 
- V.6H1 
- V.10A1 
- V.10A1 
- V.10A1 
- V.10A1 
- V.10A1 
- V.10A1 
- V.10A1 
- V.10A1 
- V.10A1 
56 V.6144 10A truncations: 10 nt from 5‘-end 
57 V.6244 10A truncations: 20 nt from 5‘-end 
58 V.6344 10A truncations: 30 nt from 5‘-end 
59 V.6370 10A truncations: 30 nt from 5‘-end  and 4 nt from 3’-end 
 
Plasmids for Project II: Tc-dimers 
# stock Plasmid name Description  
87 VIII.GFP3 
Adopted from Dr. Julia Weigand and Lara Gorini 
105 VIII.GFP7 
117 VIII.GFP15 
Tc-dimers used to explore the ranges of basal expression and switching factor. Stem 
length of the 3’-Tc vary between 6-8 nt. 
118 VIII.GFP16 
119 VIII.GFP17 
120 VIII.GFP18 
121 VIII.GFP19 
122 VIII.GFP20 
123 VIII.GFP21 
124 VIII.GFP22 
1st set Plate 1 Plasmids are stored in a 96-well plate and named according to the plate coordinates 
2nd set Plate 2 Plasmids are stored in a 96-well plate and named according to the plate coordinates 
 
Plasmids for Project III: ROC’n’Ribo 
2µ plasmid-based NOR gate expression 
PADH1 
# stock Plasmid name Description  
40 III.Neo 3‘-Neo with 5‘-(CAAA) spacer 
40.1 III.NeoNeo Neo-dimers 
40.2 III.NeoTc 5‘-TcNeo 
40 III.Tc 3‘-Tc with 5‘-(CAAA) spacer 
41.1 III.TcTc Tc-dimers 
41.2 III.TcNeo 5‘-NeoTc 
 
PGAL1 
# stock Plasmid name Description  
73 pRS303-gal1 GAL1 promoter source 
41.6 III.Tc1+C-Neo-gal1 5’-NeoTc with GAL1 promoter instead of ADH1 promoter 
74 I.BB-gal1 pWHE601* with GAL1 promoter instead of ADH1 promoter 
75 I.601-gal1 pWHE601 with GAL1 promoter instead of ADH1 promoter 
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pGLC modifications 
PSTE5/MRP7 
# stock Plasmid name Description  
80 pSP-212-pMRP7-GEV GEV driven by PMRP7 without linker between GEV and mCherry 
81 pSP-212-pSTE5-GEV GEV driven by PSTE5 without linker between GEV and mCherry 
141 III.GEVlinkerCherry 
GEV driven by PTEF1 with linker between GEV and mCherry, 
resulted in only a minor increase of mCherry fluorescence 
 
Genomic integrations – insert preparation 
NOR gate 
# stock Plasmid name Description  
82 III.pJET-BB-gal1p Subcloning of pWHE601*-gal into pJET1.2 for PCR amplification 
83 III.pJET-601-gal1p Subcloning of pWHE601-gal into pJET1.2 for PCR amplification 
84 III.pJET-5'NTc-gal1p Subcloning of 5’-NeoTc into pJET1.2 for PCR amplification 
 
GLC 
# stock Plasmid name Description  
141 III.GEVlinkerCherry 
GEV driven by PTEF1 with linker between GEV and mCherry, 
resulted in only a minor increase of mCherry fluorescence. Used as 
template to amplify two halves of the expression cassette 
 
CRISPR  
# stock Plasmid name Description  
62 p426-SNR52p-gRNA.CAN1.Y-SUP4t Addgene plasmid #43803 72 
63 p414-TEF1p-Cas9-CYC1t Addgene plasmid #83946 217 
68 III.p425 Standard yeast shuttle vector, gift from group of Prof. Bertl 
69 425-antiAde-gRNA gRNA expression cassette for the indicated loci. Amplified from #62 
in two parts and cloned by Gibson assembly into p425. The 
exchange of the gRNA was simultaneously performed. 
70 425-antiUra-gRNA 
71 425-antiHis-gRNA 
 
6.5.1 Basic plasmids 
6.5.1.1 pWHE601, pHWE601* 
Vector pWHE601 155 was used as a positive control for all reporter gene assays in Project I and II and 
III. For selection in bacteria a β-lactamase gene is encoded conferring resistance against ampicillin. To 
select for the plasmid in yeast URA3 is expressed that codes for orotidine-5'-phosphate (OMP) 
decarboxylase enabling Ura- strains to grow on synthetic media without uracil. The vector contains a 2µ 
origin of replication (ori) for its replication in yeast cells. The expression cassette is comprised of an 
ADH1 promoter and terminator and a GFP+ reporter gene that is 5’-scarred with the NheI restriction 
site. Vector pWHE601* represents a derivatives of pWHE601 with the following minor modifications. (i) 
The AflII restriction site was exchanged for the restriction site for AgeI, (ii) the start codon was deleted 
and substituted by CTCTTC now spacing AgeI and NheI. This vector was used as a negative control in 
all reporter gene assays and as a basis for introducing all aptamers in Project I via the two described 
restriction sites as well as the NOR and NOT gates from Project III.  
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Figure 6.1 Plasmid map of pWHE601. 
6.5.1.2 pGFP3 
The vector pGFP3 constitutes the basis vector for all cloning in Project II and was adopted from Dr. Julia 
Weigand and Lara Gorini. Derived from pWHE601, it contains all features displayed in Figure 6.1. The 
vector map is displayed linearly and deprived of the redundant sequence homology to pWHE601 for 
clarity. The differences are described as follows. (i) The 5’-UTR from the transcription start site (TSS) to 
the beginning of the first riboswitch measures 41 nt (45 nt for pWHE601). It contains a SacII restriction 
site used for previous cloning experiments to introduce the tc-dimers. The dimers are separated by a 9 
copies of a CAAA spacer. The Kozak sequences used here reads AAAAA-ATG and is immediately 
followed by the GFP+ reporter gene. The highlighted sequences for stem 5’ and stem 3’ indicated the 
positions of randomization for the tc-dimers set 1 and 2.  
 
Figure 6.2 Take-out of the plasmid map of pGFP3 that is otherwise isogenic to pWHE601. 
 
6.5.1.3 pGLC 
Vector pGLC (GEV-Linker-mCherry) expresses the chimeric transcription factor (TF) GEV that was used 
in Project III. GEV is composed of a Gal4 DNA binding domain (Gal4 BD), the human estrogen receptor 
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(hER) and a virus particle 16 transcription activation domain (VP16) that is not shown in the map 
(compare Figure 4.21). The TF is fused to mCherry by a short linker promoting independent folding of 
both proteins. Transcription is driven by the TEF1 promoter and terminated by the CYC1 terminator. For 
selection in bacteria a β-lactamase gene is encoded conferring resistance against ampicillin. To select 
for the plasmid in yeast LEU2 is expressed that codes for beta-isopropylmalate dehydrogenase enabling 
Leu- strains to grow on synthetic media without leucine. The vector contains an autonomous replication 
sequence (ARS) and a centromeric region (CEN) for replication by mitosis in yeast cells.    
 
 
Figure 6.3 Plasmid map of pGLC. 
 
6.5.1.4 p425-gRNA 
Vector p425-gRNA is the host plasmid for expression of the gRNA targeting Ura3, Leu2 and His3. The 
gRNA expression cassette was cloned from vector p426-PSNR52-gRNA.CAN1.Y-TSUP4 (Addgene plasmid 
#43803)72 and inserted into p425 changing URA3 for LEU2 (compare chapter 5.2.2.1). The gRNA 
expression cassette consists of a SNR52 promoter to recruit RNA Pol III, the actual 20 nt of the gRNA, 
the structural gRNA recognized by Cas9 and the SUP4 terminator. The gRNAs were substituted 
according to the targeted locus when cloned from the Addgene plasmid. Thus, three different p425-
gRNA exist. For selection in bacteria a β-lactamase gene is encoded conferring resistance against 
ampicillin. To select for the plasmid in yeast LEU2 is expressed that codes for beta-isopropylmalate 
dehydrogenase enabling Leu- strains to grow on synthetic media without leucine. The vector contains a 
2µ origin of replication (ori) for its replication in yeast cells. 
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Figure 6.4 Plasmid map of p425-gRNA. 
6.5.1.5 p414-Cas9 
Vector p414-Ca9 equals vector p414-PTEF1-Cas9-TCYC1 (plasmid #83946) 217 purchased from Addgene. 
The vector expresses the CAS9 gene coding for the endonuclease Cas9 recruited by the gRNA to 
introduce a double-strand break within the targeted locus. Expression is driven by TEF1 promoter and 
terminated by CYC1 terminator. For selection in bacteria a β-lactamase gene is encoded conferring 
resistance against ampicillin. To select for the plasmid in yeast TRP1 is expressed that codes for 
phosphoribosylanthranilate isomerase enabling Trp- strains to grow on synthetic media without 
tryptophane. The vector contains an autonomous replication sequence (ARS) and a centromeric region 
(CEN) for replication by mitosis in yeast cells.  
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Figure 6.5 Plasmid map of p414-Cas9. 
6.5.2 Construction of plasmids 
All established constructs were precipitated with butanol after ligation and transformed into E.coli Top10. 
Then, the bacterial clones were tested in a CoPCR and sequenced to confirm construct integrity. 
Described cloning schemes should be regarded as examples for all similarly designed constructs. 
6.5.2.1 Project I: Aptamers from literature 
Vector pWHE601* was used for aptamer insertion. Aptamers were cloned with AgeI and NheI restriction 
sites. Therefore aptamers were either ordered as self-priming oligonucleotides that needed to be 
restricted after PCR with the corresponding enzymes or as “pre-cut” dsDNA hybrids that were annealed 
and 5’-phosphorylated and ligated. Every aptamer featured the Kozak-ATG (AAA-ATG) sequence that 
was thus introduced alongside the aptamer. The example shows the inserted theophylline aptamer 
cloned by primer hybridization, 5’-phosphorylation and subsequent ligation. Integration was confirmed 
by sequencing with GFP-rev.   
 
Figure 6.6 Cloning scheme of various aptamers into pWHE601*. 
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6.5.2.2 Project I: CFX in vivo screening 
The cDNA pool from R6 and R9 of the SELEX was cloned by yeast homologous recombination. Vector 
pWHE601* was prepared by linearization using AgeI and NheI restriction sites. The pool was PCR-
amplified with fwd and rev primers featuring 40 nt 5’-overhangs homologous to sequence stretches 
upstream of AgeI or downstream of NheI, respectively (compare Figure 5.1). The Kozak-ATG sequence 
was introduced as part of the rev primer. 5’- and 3’-randomization indicate the in total N64 randomized 
nucleotides. The forced loop describes a sequence motif promoting hairpin formation.  
 
Figure 6.7 Cloning scheme of the homologous recombination of the CFX pool with restricted pWHE601*. 
6.5.2.3 Project II: Tc-dimers 
For the generation of the different Tc-dimers, only the closing stem of Tc2 was randomized. Therefore 
restriction sites AgeI and NheI of vector pGFP3 were used.  The core of Tc2 was used as template for 
aptamer amplification. The fwd primer introduced the 5’-stem, the (CAA)9-spacer and the AgeI restriction 
site. The rev primer was 5’-flanked by the 3’stem, the Kozak-ATG sequence and the NheI restriction 
site. Constructs GFP15-22 were cloned either by amplification from the Tc2 core or by ligation assembly 
in four parts as indicated by the a, b pairs in the primers list.   
 
Figure 6.8 Cloning scheme of the Tc-dimers. 
6.5.2.4 Project III: ROC’n’Ribo 
2µ plasmid-based NOR gate expression 
PADH1 
The NOR gate 5’-NeoTc was generated using pWHE601* as backbone and AgeI and NheI restriction 
sites to insert the Tc aptamer with the CAAA-spacer. The Neo aptamer was cloned by Gibson assembly 
using AgeI site to linearize pWHE601*-Tc. Primers to amplify the Neo aptamer from its original plasmid 
were 5’-flanked with sequences homologous to the upstream sequence of AgeI and to the CAAA-spacer. 
The other NOR gate and both NOR gates were prepared analogously.  
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Figure 6.9 Cloning scheme of the 5’-NeoTc NOR gate. 
 
PGAL1 
The ADH1 promoter of all NOR and NOT gates as well as pWHE601 and pWHE601* was substituted 
for PGAL1. The target plasmid was linearized with AgeI and a Gibson assembly used to fuse the amplified 
PGAL1 with the linearized vector. The PGAL1 was amplified from another plasmid with primers that had 40 
nt 5’-flanking sequences homologous to the upstream sequence of the PADH1 to exclude the former 
promoter and to the downstream sequence of the AgeI site. Substitution increased the 5’-UTR length 
upstream of the riboswitch to 75 nt and introduced a second AgeI site.  
 
Figure 6.10 Exchange of the ADH1 promoter for GAL1 promoter 5’-NeoTc NOR gate. 
 
pGLC modifications 
PSTE5/MRP7 
The TEF1 promoter was substituted for PSTE5 or MRP7  in pGLC. pGLC was linearized with SacII and the 
new promoters introduced by homologous recombination in yeast or Gibson assembly. Therefore both 
promoters were amplified from the genomic DNA of yeast strain RS453α and 5’-flanked with sequences 
exhibiting 40nt homology to the upstream sequence of the TEF1 promoter and 40 nt to GEV. Thus PTEF1 
was eliminated and the new promoter introduced.  
 
Figure 6.11 Exchange of the TEF1 promoter for STE5 or MRP7 promoter. 
 
Genomic integrations – insert preparation 
NOR gate 
All gates and pWHE601 and pWHE601* were subcloned into a pJET1.2 vector after they had been 
amplified from their pWHE601*-backbones with primers attaching 100 nt homology to the ade2 locus 
up- and downstream of the integration site targeted by the gRNA. They were amplified from pJET1.2 to 
yield high concentrations for the genomic integration. The amplicon spans ~1900 nt in case of the insert 
5’-NeoTc. 
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Figure 6.12 Cloning scheme of the insert 5’-NeoTc as prepared for genomic integration. 
 
GLC  
The preparation of the genomic integration of GLC was conducted by dividing the fusion protein in two 
parts (US/DS part GLC) that were separately amplified from pGLC and exhibited 100 nt homology 
between them and 100 nt homology to the integration site (US/DS Ura). The 100 nt homology to the 
integration site were attached in two subsequent PCR reactions with two primer sets. 
 
Figure 6.13 Cloning scheme of the GLC inserts as prepared for genomic integration. 
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7 Appendix 
7.1 Abbreviations 
Table 7.1 List of abbreviations. 
Abbreviations Abbreviations 
% (v/v) % (volume/volume) PCR polymerase chain reaction 
% (wv) % (weight/volume) Prom promoter 
ADH1 Alcohol dehydrogenase 1 rev/r reverse 
Amp ampicillin RNA ribonucleic acid 
bp base pair SCD Synthetic complete dextrose 
CYC1 Cytochrome C1 SDS Sodium dodecyl sulfate 
DMSO dimethylsufoxide shRNA small hairpin RNA 
dNTP 
deoxynucleoside 
triphosphate 
siRNA small interfering RNA 
et al. et alii STET5 STErile  
EtOH ethanol TBS tris buffered saline 
fwd/f forward tc tetracycline 
LB lysogeny broth TEF1 
Transcription elongation factor 
EF-1 alpha 
MRP7 
Mitochondrial Ribosomal 
Protein 7 
UTR untranslated region 
mRNA messenger RNA 
neo neomycin 
nt nucleotides 
PBS phosphate buffered saline 
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7.2 Units 
Table 7.2 List of units.    
Units 
°C degree Celsius 
Da Dalton 
g gram 
h hours 
l liter 
M molar 
min minutes 
rpm  rounds per minute 
sec seconds 
U unit 
V volt 
v/v volume per volume 
w/v weight per volume 
7.3 Prefixes 
Table 7.3 List of used prefixes. 
Dimensions 
k kilo (103) 
m milli (10-3) 
µ micro (10-6) 
n nano (10-9) 
p pico (10-12) 
7.4 Nucleobases 
Table 7.4 Abbreviations for nucleobases. 
Nucleobases 
A adenine 
C cytosine 
G guanine 
T thymine 
U uracil 
N A, C, G, T, U 
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